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8Scope of the thesis
In 2009 the President of the United States of America Barrack Obama developed a 
comprehensive plan to fight cancer. He pledged: “A new effort to conquer a disease that has 
touched the life of nearly every American by seeking a cure for cancer in our time” [1]. But will 
there ever be a cure for cancer? And if yes, when will that be? To be able to state something 
about these matters it is important to put cancer research in a broader perspective. To do 
that, we can visualize the human body as a balance. Under normal conditions the weight 
at both ends of the balance is equal, however due to hereditary disorders or a hazardous 
lifestyle the balance can become unstable, weighing more to one side, letting that side go 
down and thereby raising the other. The way the two sides of a balance are interconnected 
is, in a way, very similar to how cells, organs and all the different parts of the human body 
are connected to one another. Cancer is a disease that arises from accumulating genetic 
mutations that lead to genetic instability and the subsequent formation of a tumor due 
to the gain or loss of cellular functions [2]. But why does not everybody get cancer? The 
balance may sometimes already be unevenly distributed from the beginning, meaning less 
or more weight on either side of the balance. Some families carry genetic mutations that 
makes them more prone to developing cancer [3]. Also during the course of someone’s life 
the balance may get distorted. Exposure to radioactive compounds or a non-healthy lifestyle 
such as smoking will increase the chance of gaining mutations [4, 5]. Therefore the cells of 
some individuals are genetically more unstable or accumulate mutations more easily than 
others. The time it takes to form a tumor may vary largely in a given population for these 
reasons. For individuals carrying inherited genetic cancer susceptibility it may be easier to 
predict what cellular processes might get deregulated, although these are never the same for 
every person. Like for people that do not carry any known genetic risk, the course of tumor 
formation greatly depends on chance. Although we define cancers mainly based on location 
and characteristics, all tumors are distinct and cancer can therefore not be defined as one 
disease. The genetic component is becoming more and more important in differentiating 
tumors [2, 6]. Life expectancy and therapy success seem to be greatly dependent on the 
tumors genetic characteristics and therefore to understand cancer we must be able to 
identify the tumors unique ‘genetic barcode’ and act accordingly [7]. Knowing the genetic 
barcode may not be enough however, which processes are disrupted in the tumor, how 
precisely are they affected and what is the relationship of these processes to each other? 
In order to rebalance we need to know how much weight and at which side we have to 
place it, questions that can be answered only through the practice of fundamental scientific 
research. In addition, one cure for cancer does not exist. Instead, individual treatments can 
be made more efficient on the basis of the tumors genetic information [8-10]. The time it 
will take to get to that point is dependent on the success of biomedical research in creating 
more mechanistic insight into cellular processes and uncovering new connections between 
pathways. 
Recent advancements have been made into this direction, and highlight the course of future 
research in the fight against cancer. An enormous effort was taken into resolving the DNA 
sequence of the human genome, published in 2001 [11, 12], followed by the first cancer 
genome in 2007 [13]. Besides unraveling the content of the healthy human and cancer 
genome, these efforts have also conducted to the rapid advancements in large scale DNA 
sequence technology for clinical use. Scientific researches creating further insight into 
cellular processes that are linked to cancer have been recently awarded with the Nobel 
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Prize. In 2001, Hartwell, Hunt and Nurse were awarded for the discovery of key regulators 
of the cell cycle [14-16]. And in 2009, Blackburn, Greider and Szostak received the award for 
the discovery of how chromosomes are protected by telomeres and the enzyme telomerase 
[17-19]. Both findings generated more understanding into the process of cell division and 
the maintenance of genome integrity with vast implications for cancer development.
It is within the context laid out above that, in this thesis, we study the ATR-mediated 
checkpoint response that helps to protect cells from becoming genetically instable after DNA 
damage. The source of genotoxic DNA lesions that may eventually result in a mutation arise 
mostly from exogenous sources like ultra violet (UV) light, nuclear radiation and cigarette 
smoke and from endogenous cellular metabolic processes. Different cellular mechanisms 
have evolved, which efficiently remove most genotoxic lesions from the DNA before they 
become incorporated as a mutation. Important in the process of lesion removal and 
subsequent repair of the DNA is the detection of DNA damage. The ATR-Chk1 pathway is 
involved in sensing DNA alterations and the subsequent activation of this process will result 
in a temporal halt of the cell cycle to create time for the repair of the damaged DNA. Thereby 
it functions as a so called ‘checkpoint’, controlling the integrity of the genome. In recent 
years biochemical work has provided invaluable insight into the requirements, substrates 
and activities of proteins involved in the ATR-mediated checkpoint pathway [20-22], yet 
not much was known about how the ATR-Chk1 pathway operates in living cells and how 
the spatio and temporal behaviour of proteins in this pathway influence the DNA damage 
response. Here, we set out to investigate the biological and functional involvement of the 
ATR-ATRIP, Rad17-RFC and Rad9-Rad1-Hus1 (9-1-1) putative DNA damage sensor complexes 
in ATR-mediated checkpoint signalling. To study the behaviour of the involved proteins, we 
generated human cell lines that stably express GFP-fusion proteins from the ATR-mediated 
checkpoint pathway. In chapter 3 we describe how we generated and validated these cell 
lines and show results showing a differential dynamic behaviour of the 9-1-1 and ATR-ATRIP 
damage sensor complexes and downstream effector kinase Chk1 in response to UV-induced 
DNA damage.
We observed that GFP-Rad9 nuclear foci induced by DNA damage were not visible in all 
irradiated cells, suggesting a cell cycle-dependent regulation of DNA lesion processing. To 
address this we took advantage of the existence of various cell cycle markers and additionally 
generated cells with two fluorescent-fusion proteins that enabled us to discriminate S and 
G1/G2 phase in living cells. Thereby we uncovered a relationship between the cell cycle, DNA 
repair mechanisms and Rad9 focus formation, which is discussed in chapter 4. In chapter 5, 
we continue to investigate the cell cycle-dependent regulation of the DNA damage response 
upon UV damage specifically in G2 cells. We showed that UV-induced checkpoint activation 
in G2 is regulated in a different manner compared to G1 and S-phase and in addition is 
distinct from ionizing radiation-induced checkpoint activation in G2 phase.
It is known that ATR is responsible for the phosphorylation of Chk1 in a 9-1-1-dependent 
manner, indicating a direct relationship between the ATR-ATRIP and 9-1-1 complexes. 
In chapter 6 we investigated this relationship in more detail and showed that the 
phosphorylation of Rad17 by ATR is necessary for stable recruitment of the 9-1-1 complex 
to sites of damage. This indicates that although recruitment of the 9-1-1 and ATR-ATRIP 
complexes to damaged DNA might be independent, maintaining checkpoint activation is 
dependent on their functional interaction. Overall, these results demonstrate that protein 
mobility measurements are an excellent addition to classical biochemical assays because 
they enable us to study the effect of transient protein-protein interactions and post-
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translational modifications such as phosphorylation on protein behaviour in more detail. 
Additionally, another type of post-translational modifications might influence 9-1-1 protein 
complex dynamics. In chapter 7 we demonstrated that the Hus1 component of the 9-1-
1 complex is modified by ubiquitination. Mass-spectrometry analysis identified a lysine 
in Hus1 that is ubiquitinated. Moreover we identified a number of potential candidate E3 
ubiquitin ligases that might be involved in 9-1-1 ubiquitination. The data in this last chapter 
might give us new insights into the regulation of the 9-1-1 complex.
Will there ever be a cure for cancer? The work presented in this thesis reflects on a 
particular topic of the DNA damage response, which is linked to cancer development. What 
is presented here will not cure cancer, but this scientific contribution, like many others, may 
help to understand the basic workings of the human cell and thereby as a whole, help to 
fight cancer in a rational and decisive manner [23, 24]. 
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Cell cycle checkpoints maintain genomic integrity by delaying cell division in the presence 
of DNA damage or replication problems. A crucial player in this process is the ATR kinase. 
The rapid localization of ATR to sites of genotoxic stress and the central role of this kinase 
in the checkpoint response lead to the suggestion that ATR functions as a sensor of DNA 
lesions. After activation, ATR phosphorylates and activates the effector kinase Chk1, thereby 
causing an inhibition in cell cycle progression. However, this would not be possible without 
the existence of many other proteins operating in this pathway. Here we review current 
progress in our understanding of the regulatory factors involved in the ATR-mediated 
checkpoint response, as well as resumption of cell cycle progression upon repair of the 




To protect against the continuous threat of DNA damage by environmental factors and 
intracellular processes, eukaryotic cells have developed DNA damage checkpoint and repair 
mechanisms, which help to ensure transmission of an intact genome. Cell cycle checkpoints 
and DNA repair together determine the ultimate response of a cell to DNA damage. The 
importance and relevance of such surveillance mechanisms in ensuring genomic stability is 
underscored by the fact that checkpoint responses and DNA repair mechanisms are highly 
conserved throughout evolution. In addition, inherited defects in regulators of checkpoint 
signalling and repair pathways result in severe hereditary human genetic disorders with 
susceptibility to cancer. For example, Ataxia Telangiectasia (AT), Ataxia Telangiectasia-Like 
Disorder (AT-LD), Nijmegen Breakage Syndrome (NBS), and the recently described Seckel 
Syndrome are thought to be the result of defects in the checkpoint pathway [1], whereas 
Xeroderma Pigmentosum (XP) is caused by a deficiency in the nucleotide excision repair 
(NER) pathway, that removes UV-induced DNA lesions [2].
DNA damage checkpoints are signal transduction cascades, in which ATM and ATR, members 
of the family of phosphoinositide 3-kinase like kinases, are the master regulators. ATM and 
ATR are proteins of approximately 300 kDa, with a conserved C-terminal catalytic domain 
that preferably phosphorylates serine or threonine residues followed by a glutamine, i.e. 
an SQ or TQ motif [3, 4]. Both kinases respond to various forms of genotoxic stress by 
phosphorylating key proteins in the DNA damage response, such as p53 and the effector 
kinases Chk1 and Chk2. ATR rapidly relocalizes to sites of damage, seen as the formation of 
nuclear foci after the induction of DNA lesions [5]. ATM autophosphorylation on Ser1981 is 
quickly detected in response to DNA damage and can also be found in nuclear foci [6]. These 
data, together with their critical function upstream in the checkpoint signalling cascade, 
support a role for these kinases in sensing the damaged DNA. 
ATM, Ataxia-Telangiectasia Mutated, was originally identified as the product of the gene that 
is mutated in the heritable chromosomal instability disorder AT [7] and is the main kinase 
required for early responses to DSBs induced by, for example, ionizing radiation (IR), such as 
phosphorylation of p53 and Chk2. ATR (ATM and RAD3-related) on the other hand, mainly 
activates Chk1 in response to UV light-induced damage and stalled replication forks [3]. 
Chk1 activation leads to the phosphorylation of a variety of substrates, thereby regulating 
different aspects of the DNA damage response such as cell cycle arrest, stabilization of 
stalled replication forks and DNA repair [8]. Interestingly, recent data demonstrate crosstalk 
between the ATM and ATR pathways. ATM was shown to be required for ATR recruitment 
and subsequent activation of Chk1 in response to DSBs, exclusively in S and G2 phases of 
the cell cycle [9-11].
In the past decade it has become clear that activation of the DNA damage checkpoint involves 
more than the kinase cascade initiated by ATM/ATR. A multitude of mediator proteins were 
discovered (including Claspin and BRCA1) that function in the recruitment of substrates 
to DNA lesions or as scaffolds on which complexes are assembled. The relocalization of 
DNA damage response proteins to sites of damage, shown as nuclear foci, was shown 
to be of crucial importance for downstream checkpoint events, although how, is not yet 
fully understood. Also regulation of proteins by ubiquitination or other post-translational 
modifications appeared to be an important factor in the surveillance mechanisms controlling 
genomic stability. Current progress in our understanding of the ATR-mediated checkpoint 
response and its regulatory factors, as well as resumption of cell cycle progression upon 
repair of the damage, is discussed in this review.
16
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ESSENTIAL FUNCTION OF ATR 
While ATM and ATR act in concert to protect the integrity of the genome, a major difference 
between these two kinases is that ATR is essential for viability [12, 13], whereas mammals 
that lack functional ATM are viable, even though they have a limited life span. The early 
embryonic death in ATR knock out mice indicates that ATR is essential for cell growth and 
differentiation at an early stage of development [12, 13]. In addition, disruption of ATR in 
mouse or human cells results in cell cycle arrest or death, even in the absence of exogenous 
DNA damage [5, 14]. Interestingly, not only ATR is essential, but also other members of 
the ATR pathway. Inactivation of Chk1 in mice results in lethality at early embryonic stages 
[15, 16], Hus1 knock out mice are not viable [17] and mutation of mouse Rad17 leads to 
embryonic lethality during early/mid-gestation [18]. Together these studies suggested 
Figure 1: ATR can be activated by different types of DNA lesions.
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that ATR-dependent signalling is not only required to protect cells against exogenous DNA 
damage, but also to deal with spontaneous DNA lesions or replicative stress.
Although complete inactivation of ATR is lethal, a hypomorphic mutation was found in 
humans suffering from the rare autosomal recessive disorder Seckel syndrome, characterised 
by growth retardation and microcephaly. In homozygosity, this mutation affects ATR splicing 
which results in a reduction of ATR protein levels to almost undetectable, yet the remaining 
protein is sufficient for viability [19]. A recently developed mouse model of ATR-Seckel 
syndrome confirms the essential role of ATR during normal embryonic development, as the 
diminished function of ATR results in high levels of replication stress in Seckel embryos, 
which is reduced to marginal amounts in tissues of the adult mouse [20]. The origin of the 
observed replicative stress in the ATR-Seckel embryo is not entirely clear. Several lines of 
evidence suggest that ATR signalling is required to stabilise replication forks and/or prevent 
replication fork collapse. First, conditional deletion of ATR in mouse embryonic fibroblasts 
(MEFs) leads to accumulation of DNA DSBs during S phase [12]. Second, both loss of ATR 
and Chk1 activity leads to break formation at fragile sites, which are thought to represent 
chromosomal regions that are particularly difficult to replicate [21, 22]. Third, Chk1-deficient 
cells fail to maintain viable replication forks when DNA polymerase is inhibited [23]. Studies 
in yeast also show that Mec1 (ATR) is required to maintain viability when cells are exposed to 
the alkylating agent MMS [24], confirming the fork-stabilization activity of ATR signalling. In 
addition to stabilising replication forks, Chk1 was also demonstrated to regulate replication 
initiation and fork progression [25, 26]. Together these studies suggest a general role for ATR 
signalling in the regulation of DNA replication. 
TRIGGERING ATR SIGNALLING
Lesions that activate the ATR pathway
The initial step in ATR activation is the recognition of DNA structures that are induced by 
the damaging agents. As discussed above, the ATR pathway is predominantly triggered by 
UV lesions and stalled replication forks. A biochemical study demonstrated preferential 
binding of purified ATR to DNA with UV photoproducts, suggesting that ATR binding to 
unprocessed DNA could initiate signalling [27]. However, recent data indicate that ATR 
signalling is initiated by a wider range of DNA lesions, including DSBs. This raises the 
question how the ATR pathway sensor proteins can detect such different types of lesions. A 
structure that is commonly generated by genotoxic stress is single stranded DNA (ssDNA), 
which is, for example, generated at DNA replication forks when the coordination between 
DNA polymerase activity and DNA helicase activity is compromised [28]. Upon detection 
of DSBs, ssDNA can be formed by resection of broken ends and in addition, ssDNA gaps 
are introduced during several DNA repair processes such as NER and mismatch repair [29]. 
Interestingly, in vitro studies using Xenopus egg extracts demonstrate that ATR-dependent 
Chk1 phosphorylation can be initiated by single-stranded DNA (ssDNA) and ssDNA-double 
stranded DNA junctions [30]. 
In eukaryotes, DNA damage-induced ssDNA is first detected by ssDNA-binding protein 
complex RPA, and the resulting stretches of RPA-coated ssDNA seem to function as the 
key structure for initiating checkpoint signalling by ATR [31, 32]. Processing of DNA lesions 
into ssDNA has consequently been proposed to be involved in triggering ATR-dependent 
checkpoint responses. Upon IR treatment and in S and G2 phases of the cell cycle, CtIP/
18
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scSae2, together with Mre11, is involved in nucleolytic processing of DSBs into short ssDNA 
overhangs, thereby recruiting ATR to sites of DNA damage [11, 33]. Recent publications show 
that subsequent resection by BLM/scSgs1 and scExo1 generates longer stretches of ssDNA, 
further promoting ATR-mediated checkpoint signalling such as Chk1 phosphorylation [34-
36].
The way by which UV lesions lead to ssDNA and ATR activation seems not to involve 
resection. UV light induces the formation of cyclobutane pyrimidine dimers and 6-4 
photoproducts which can form obstacles during DNA replication. Stretches of ssDNA at 
the resulting stalled replication forks were suggested to be sufficient for activation of the 
ATR checkpoint pathway upon exposure to UV during S phase [37, 38]. Other data suggest 
that ATR signalling can also be triggered outside S and in non-cycling cells. Several reports 
implicate NER, which involves lesion processing by nucleotide excision of the damaged DNA 
resulting in an ssDNA gap intermediate, in ATR checkpoint activation during such phases of 
the cell cycle [19, 38, 39]. From these data it can be concluded that ATR and/or other sensor 
proteins in the ATR pathway recognise a DNA intermediate, further supporting the evidence 
of RPA-coated ssDNA as initial trigger for ATR-mediated checkpoint signalling (Figure 1).
The role of ATRIP and TopBP1
ATR forms a stable complex with its co-factor ATR-Interacting Protein, ATRIP. Deletion of ATR 
in cells resulted in the loss of not only ATR but also ATRIP and in addition, downregulation of 
ATRIP caused a decrease in ATR levels, indicating that formation of the complex is important 
for the stability of both proteins [5]. As RPA stimulates binding of ATRIP to ssDNA in vitro, it 
was proposed that the interaction between ATRIP and RPA-coated ssDNA recruits the ATR-
ATRIP complex to sites of genotoxic stress [31]. In vitro studies indeed identified a conserved 
domain in the N-terminus of ATRIP required for RPA binding and localization to sites of DNA 
damage [40]. Recruitment of ATR to damaged chromatin was additionally shown to depend 
on a C-terminal ATRIP domain that regulates its binding to ATR. Interestingly, this conserved 
domain was also found in Nbs1, which functions as a similar co-factor for ATM [41]. 
Based on the above studies the current model for initiation of ATR signalling is that ATRIP-
mediated binding of ATR to RPA-coated ssDNA facilitates recognition of ATR substrates for 
phosphorylation.
Downregulating ATRIP leads to checkpoint defects [5] and expression of ATRIP mutants that 
cannot bind ATR lead to defective Chk1 phosphorylation [41, 42], demonstrating the necessity 
of the ATR-ATRIP interaction in this process. However, the essential function of ATRIP in 
binding RPA-coated ssDNA for ATR signalling was questioned as Chk1 phosphorylation is still 
observed under conditions in which ATRIP is not able to bind RPA-ssDNA [32, 42], indicating 
a more complicated model for activation of ATR in response to DNA lesions. 
Reports demonstrating the involvement of TopBP1, a mediator protein containing eight BRCT 
phospho-recognition motifs, in the activation of ATR shed new light on this mechanism. Chk1 
phosphorylation was demonstrated to be reduced in the absence of TopBP1 [43]. Kumagai 
and co-workers subsequently showed that the addition of recombinant TopBP1 to Xenopus 
egg extracts induces an increase in ATR kinase activity. TopBP1 binds ATR through its ATR 
activation domain (AAD), located between the sixth and seventh BRCT repeat, in an ATRIP-
dependent manner and this interaction is required for ATR stimulation [44]. Interestingly, 
triggering the ATR kinase activity by TopBP1 can occur independently from the interaction 
of ATRIP with RPA [40]. Recent data explained the involvement of ATRIP in ATR activation 
by demonstrating that ATRIP contains a conserved TopBP1 interacting region, required for 
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the association of TopBP1 and ATR and the subsequent TopBP1-mediated triggering of ATR 
activity [45]. Together these data support a multistep model for ATR checkpoint signalling 
in which recruitment of ATR to sites of DNA lesions occurs partially through binding of 
ATRIP with RPA. As will be discussed later, the activation of ATR by TopBP1 depends on 
the assembly of TopBP1 by Rad9, which is required for ATR activation and the subsequent 
phosphorylation of ATR substrates (Figure 2).
Rad17 and Rad9-Rad1-Hus1
The localization of ATR-ATRIP to sites of DNA lesions, and activation by TopBP1 is not enough 
to activate the DNA damage checkpoint response fully. Instead, it requires additional 
regulators including Rad17 and the Rad9-Rad1-Hus1 (9-1-1) complex. The human Rad9, Rad1 
and Hus1 proteins and their orthologs in yeast share sequence similarity with homotrimer 
PCNA, that is loaded onto the DNA during unperturbed DNA replication by the RFC clamp 
loader complex. Encircling the DNA helix and tethering DNA polymerase to the substrate 
increases polymerase processivity and thereby facilitates genome replication. The recently 
resolved crystal structure of the 9-1-1 complex demonstrates a toroidal structure with a 
similar architecture to PCNA [46-48], confirming earlier biochemical data that proposed a 
heterotrimeric ring formed by the three proteins [49, 50]. These data suggest that the 9-1-1 
complex is a second PCNA-like structure that may be critical for checkpoint function.
Although MEFs lacking only Hus1 cannot be grown, inactivation of p21waf1 results in 
proliferating Hus1-deficient cells in culture. These cells are hypersensitive to hydroxyurea 
(HU) and UV light, but are only slightly sensitive to IR [17]. Also knocking out Rad9 in 
mouse embryonic stem cells or chicken DT40 cells resulted in increased sensitivity for 
these agents [51, 52]. Furthermore, Hus1 and Rad9 were shown to be required for Chk1 
and Rad17 phosphorylation [52-54]. Whereas the intra-S phase checkpoint upon IR is intact 
in Hus1 deficient cells, these cells display problems in responding to blocked replication 
[55]. Together these studies suggest that the 9-1-1 complex functions in the maintenance of 
genome stability by facilitating ATR-signalling. 
Similar to PCNA-loading by the RFC complex, Rad9 was shown to be loaded onto chromatin 
in response to DNA damage by Rad17, in an ATP-dependent manner [54, 56]. Rad17, and 
its yeast homolog Rad24, share homology with RFC1, a subunit of the RFC clamp loader 
complex. Rad17 forms a complex with RFC2-5, the four small subunits of the replicative RFC 
complex and associates with chromatin prior to damage [54, 57]. Rad17 is phosphorylated 
by ATR on chromatin after damage but this phosphorylation is not required for Rad9 loading 
onto chromatin [54]. As is the case for ATR-ATRIP, RPA-coated ssDNA is thought to be an 
important structure for recruitment of the Rad17 and 9-1-1 complexes to sites of DNA 
damage, as RPA was shown to stimulate the binding of Rad17 to ssDNA and also facilitates 
the recruitment of 9-1-1 by Rad17 [58]. 
Loading of the 9-1-1 checkpoint clamp onto chromatin by the Rad17/RFC complex in response 
to DNA damage was shown to be required for the phosphorylation of several ATR substrates 
including Rad17 and Chk1 [53, 54, 59] (Figure 2). However, both Rad17 and ATR are recruited 
independently to sites of DNA lesions [54]. The necessity of the 9-1-1 complex in the ATR 
branch was explained by showing that Rad9 recruits the ATR-activator TopBP1 near sites of 
DNA damage, which was consisted with earlier reports showing interaction between Rad9 
and TopBP1 [60, 61]. The N-terminal region of TopBP1, consisting of BRCT regions I-II, binds 
the C-terminus of Rad9 in Xenopus egg extracts and mammalian cells. More precisely, the 
interaction between Rad9 and TopBP1 depends on the phosphorylation of serine 373 in the 
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C-terminal tail of Rad9 [44, 62, 63]. In the current model for ATR activation, ATR-ATRIP and 
Rad17 are recruited to RPA-coated ssDNA appearing around DNA lesions. Rad17 mediates 
the loading of the 9-1-1 complex, which recruits TopBP1, resulting in further stimulation of 
ATR activity and the subsequent phosphorylation of ATR substrates, including RPA, ATRIP, 
Rad17, components of the 9-1-1 complex and effector kinase Chk1 (Figure 2). Furthermore 
it should be mentioned that the removal of TopBP1 from Xenopus chromatin preps results 
in less aphidicolin-induced chromatin accumulation of Rad9, suggesting a positive feedback 
loop in recruitment of Rad9 and TopBP1 to sites of genotoxic stress [64].
Apart from its involvement in ATR-mediated checkpoint signalling, the 9-1-1 complex is also 
thought to play a role in DNA repair.  Data from Schizosaccharomyces pombe (S. pombe) and 
Saccharomyces cerevisiae (S. cerevisiae) show that the 9-1-1 clamp can physically interact 
with polymerases specific for translesion synthesis (TLS) [65, 66] and evidence suggests that 
also human 9-1-1 might be involved in this process [67]. TLS is a DNA damage tolerance 
process that allows the replication machinery to replicate past DNA lesions by switching from 
regular DNA polymerases to specialised translesion polymerases. This polymerase switching 
Figure 2: Factors involved in the ATR pathway, resulting in activation of effector kinase Chk1.
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is thought to be mediated by post-translational modification of homotrimer PCNA. Mono-
ubiquitinated PCNA interacts with TLS polymerases, resulting in the recruitment of these 
polymerases to sites of blocked forks [68, 69]. Interestingly, regulation of the 9-1-1 complex 
by ubiquitination has also recently been demonstrated in yeast. Monoubiquitination of 
the Rad1 ortholog in S. cerevisiae (scRad17) was not only reported to be required for the 
transcriptional induction in response to DNA damage, but also for promoting the activation 
of downstream effector kinase scRad53, possibly through the recruitment or maintenance 
of the S. cerevisiae 9-1-1 complex at sites of DNA lesions [70]. Future experiments will show 
if a similar regulation mechanism exists for mammalian 9-1-1. 
Claspin and other mediators implicated in ATR signalling
Another protein that binds chromatin independently of ATR or Rad17/9-1-1, and is 
required for the ATR-mediated activation of Chk1 in response to genotoxic stress is 
Claspin. Immunodepletion of Claspin abolished Chk1 activation induced by DNA templates 
in Xenopus egg extracts [71] and downregulation of Claspin protein levels in HeLa cells 
decreased Chk1 phosphorylation upon HU [72]. Interestingly, Claspin appears to selectively 
regulate phosphorylation of Chk1, but not other ATR-substrates [73].
As Claspin was shown to bind Chk1 and ATR in response to genotoxic stress in both Xenopus 
egg and human cell extracts, Claspin was proposed to function as an adaptor molecule 
bringing ATR and Chk1 together [71, 72]. The Claspin-Chk1 interaction depends on ATR-
mediated phosphorylation of Claspin and is required for Chk1 phosphorylation by ATR [71, 
72]. Subsequent studies identified repeated phosphopeptide motifs in Claspin, which are 
required for association with a phosphate-binding site in the N-terminal kinase domain of 
Chk1, resulting in full activation of Chk1 [71, 74, 75]. Next, fully phosphorylated Xenopus 
Chk1 dissociates from Claspin [74] (Figure 2).  
Two other adaptor proteins that have been implicated in Chk1 activation are BRCA1 and 
MDC1. In BRCA1 mutant cells, less Chk1 phosphorylation upon IR is detected as compared 
to wild type cells [43], whereas expression of BRCA1 in such mutant cells induces 
Chk1 kinase activity [76]. Likewise, IR-induced Chk1 phosphorylation decreases after 
downregulation of BRCA1 protein levels [77]. In addition, MDC1 knock down also results 
in a defect in phosphorylation of Chk1 in response to DNA damage [78]. However, BRCA1 
and MDC1 generally function as mediators in the ATM signalling pathway and have mainly 
been implicated in IR-induced phosphorylation of Chk1. It is therefore unclear at this stage 
whether these proteins are directly involved in Chk1 activation, or act via mediating the 
ATM-dependent activation of ATR in response to DSBs. 
Finally, additional, yet less characterised, mediators of ATR signalling are Nbs1 [79], Tim [80], 
Tipin [80, 81], CEP164 [82] and hClk2 [83]. Less HU- or UV-induced Chk1 phosphorylation is 
observed in the absence of these proteins. 
ATR SUBSTRATES AND DOWNSTREAM RESPONSES
 
A multitude of proteins have been identified as ATR substrates. In fact, a recent large-scale 
proteomic screen of proteins phosphorylated in response to DNA damage on ATM/ATR 
consensus sites identified over 700 proteins [84]. Among the better characterised substrates 
of ATR are ATRIP, Rad17, Rad9, TopBP1, Claspin, BRCA1 and p53. Accumulating evidence, 
as described earlier in this review, suggests that the majority of these proteins, with the 
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exception of p53, functions to regulate the cell cycle arrest by controlling the well-studied 
effector kinase Chk1 [43, 52, 73, 85]. Interestingly, also ATR-mediated phosphorylation of 
some of these substrates has been implicated in Chk1 activation. An example is Rad17, 
which is phosphorylated by ATR in vitro on serine 635 and serine 645. Expression of 
kinase-inactive ATR consequently suppresses the phosphorylation of these sites induced 
by HU or UV. ATR-mediated phosphorylation of Rad17 was proposed to be required for 
functioning of the DNA damage-induced G2 checkpoint [59]. Subsequent work showed 
that cells expressing a Rad17 phosphorylation mutant fail to sustain HU-induced Chk1 
phosphorylation [86], which could be explained by the fact that phosphorylation of Rad17 
regulates maintenance of Rad9 as sites of genotoxic stress [87], as will be discussed later. 
Adaptor protein Claspin contains many SQ/TQ motifs, potential phosphorylation sites of 
ATM/ATR. HU-induced phosphorylation of Claspin was demonstrated to be inhibited by 
caffeine-treatment, suggesting that this modification was indeed dependent on ATM/ATR 
[72] and phosphorylation of serine 864 in the phosphopeptide motif of Xenopus Claspin is 
not observed in extracts lacking ATR [75]. That phosphorylation of Claspin by ATR is thought 
to be involved in binding and activation of Chk1 was discussed above.
Also Chk1 has several SQ/TQ phosphorylation sites in the C-terminal regulatory domain. Of 
these sites, serine 317, serine 345 and the recently identified serine 366 are phosphorylated 
after genotoxic stress [88, 89]. Serines 317 and 345 were shown to be phosphorylated by 
ATR in vitro and phosphorylated in an ATR-dependent manner in vivo [15, 89]. Mutation 
of these residues in S. pombe and mammalian Chk1 compromises checkpoint arrest, 
indicating that ATR-mediated phosphorylation of Chk1 is required for the function of this 
effector kinase in the DNA damage response [26, 88, 90, 91]. Phosphorylation of Chk1 
directly increases kinase activity and non-phosphorylatable mutants are poorly activated in 
response to DNA damage [88, 89]. Interestingly, recent data indicate that phosphorylation 
of serine 345 is essential for Chk1 functioning, and phosphorylation of this residue depends 
on the modification of serine 317 and 366, suggesting a sequential order of events [26, 88]. 
In addition to elevating its kinase activity, ATR-mediated Chk1 phosphorylation also directs 
the dissociation of Chk1 from chromatin in response to genotoxic stress [92, 93]. Chromatin 
release was shown to be required for an efficient DNA damage-induced checkpoint arrest 
and spreading of phosphorylated Chk1 throughout the nucleus, suggesting that chromatin 
dissociation of Chk1 provides a mechanism to ensure that active Chk1 reaches its substrates 
[92, 94]. 
Activated Chk1 slows down cell cycle progression during S phase and prohibits the G2/M 
transition as long as damaged or incompletely replicated DNA is present by inactivating 
downstream Cdc25 phosphatases. Cdc25 proteins regulate the timely activation of cyclin-
dependent kinases by dephosphorylating the inhibitory phosphorylation of tyrosine 15. 
Early reports demonstrate that S. pombe or human Chk1 phosphorylates Cdc25C on serine 
216, thereby creating binding sites for the 14-3-3 scaffold proteins, which is thought to 
subsequently promote the nuclear exclusion of the phosphatase [91, 95-97]. On the other 
hand, evidence for direct inhibition of Cdc25C emerged from experiments concluding that 
Cdc25C activity is abolished upon incubation with recombinant Chk1 [98, 99]. Studies in 
mammalian cells showed that Chk1 is also able to phosphorylate Cdc25A in vitro and in 
vivo [100], resulting in regulation of checkpoint arrest during all phases of the cell cycle. 
Inactivation of this phosphatase is regulated differently though, as DNA damage-induced 




Chk1 seems to have functions additional to controlling cell cycle arrest by phosphorylating 
Cdc25 proteins. In response to DNA damage, phosphorylation of Histone H3 was shown 
to rapidly reduce, correlating with the repression of several genes. Phosphorylation 
of Histone H3 in unperturbed cells is dependent on Chk1 and the described release of 
Chk1 from chromatin upon genotoxic stress is thought cause the reduction in Histone H3 
phosphorylation. Based on these data, Chk1 was hypothesized to function as a Histone 
kinase, responsible for DNA damage-induced transcriptional repression of a variety of genes 
related to cell cycle progression [103]. Moreover, evidence for the involvement of Chk1 in 
a completely different DNA damage response came from data showing that inhibition or 
downregulation of Chk1 results in decreased DNA repair by homologous recombination. 
This effect that was explained by demonstrating that Chk1 interacts with Rad51 and the fact 
that phosphorylation of Rad51 occurs in a Chk1-dependent manner, presumably regulating 
the localization of Rad51 at sites of DNA lesions [104]. An alternative explanation comes 
from data demonstrating that Chk1 phosphorylates BRCA2 in a domain that is essential for 
interaction with Rad51 and the recruitment of Rad51 into nuclear foci [105]. Finally, a role 
for Chk1 in regulating DNA cross-link repair was suggested by the observation that FANCE, a 
Fanconi Anemia core complex protein, is phosphorylated by Chk1 [106].
SPATIO-TEMPORAL ORGANISATION OF CHECKPOINT REGULATION
Perhaps unsurprisingly, numerous studies over the past years indicated that DNA damage 
checkpoint pathways do not function by linear signal transduction only. Apart from the 
crosstalk between the different pathways, it also became clear that the accumulation of 
DNA damage response proteins at sites of damage is of crucial importance for downstream 
checkpoint events. Although many proteins involved in checkpoint regulation are (partially) 
bound to chromatin in unperturbed cells, the majority of these relocalize at or near sites of 
DNA lesions to form so-called nuclear foci. Although the biological function of such large 
protein aggregations is still not entirely clear, the concentration of factors in the vicinity of the 
lesion is thought to enhance checkpoint pathways and the repair of DNA lesions, possibly by 
amplification of signalling. This also raised the question whether the DNA lesion might just 
serve as a platform to accumulate these proteins. Two elegant publications answered that 
question by showing that targeting of individual proteins involved in the early checkpoint 
responses to chromatin in the absence of DNA damage activates a DNA damage response 
[107, 108]. Toczyski and co-workers did so by fusing S. cerevisiae orthologs to ATRIP (scDdc2) 
and Rad9 (scDdc1) proteins to the LacI repressor and expressing them in cells harbouring 
Lac operator arrays. Artificial colocalization of these fusions resulted in phosphorylation 
of downstream effector kinase scRad53 and a cell cycle arrest. Interestingly, artificial 
localization of scDdc1 bypasses the requirement of the S. cerevisiae Rad17 (scRad24) clamp 
loader. From these data can be concluded that colocalization of the sensor proteins is 
sufficient to activate the DNA damage response [107]. Soutoglou and Misteli performed the 
experiment in mammalian cells using a similar approach and reached the same conclusion. 
Artificial targeting of ATM, sensor proteins Nbs1/Mre11 or mediator MDC1 to a Lac operator 
array resulted in an ATM-dependent checkpoint response as other proteins of the pathway 
were recruited and a G2 phase delay was triggered. In contrast, targeting Chk1 or Chk2 to 
chromatin did not result in a downstream checkpoint response [108].
The latter result is in accordance to the observation that the effector kinases Chk1 and Chk2 
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do not accumulate into nuclear foci in response to DNA damage, in contrast to ATM/ATR, 
TopBP1, 9-1-1 and many checkpoint mediator proteins. Instead, as mentioned earlier, Chk1 
associates to chromatin in unperturbed cells and is released from the chromatin in response 
to DNA damage [92]. In vivo imaging experiments using fluorescently labelled proteins 
confirm the absence of a stably chromatin-bound fraction for effector kinases Chk1 and 
Chk2. It was shown that although these proteins are phosphorylated at or near sites of DNA 
lesions, this association is very transient and phosphorylated proteins are found throughout 
the entire nucleoplasm [92, 109] (Warmerdam et al. in press). The rapid disassembly of the 
activated proteins was hypothesized to ensure the access of additional Chk1/Chk2 molecules 
to ATM/ATR and the transmission of the damage signal throughout the nucleus [94].
Live cell imaging also gave insight into the dynamic aspect of the DNA damage response. 
Are proteins in established DNA damage-induced foci immobile or are such foci more 
dynamic structures existing of proteins that actively turnover? Initial studies following 
repair proteins of the Rad52 group of homologous recombination proteins and ATM-sensor 
Nbs1 by videomicroscopy revealed that even though these proteins accumulate at sites 
of DNA damage, as seen by the formation of nuclear foci, this assembly with damaged 
regions is transient. In fact, these proteins still underwent a dynamic exchange in the close 
proximity of DNA lesions [109, 110]. More recently, similar results were shown for Rad9. 
Whereas Rad9 is highly mobile in undamaged cells, in response to genotoxic stress Rad9 
forms Rad17-dependent foci and turnover of Rad9 in such foci was comparatively slow. 
However, as for Rad52 proteins and Nbs1, the majority of the Rad9 proteins still display 
turnover, arguing against foci as being static protein structures [87]. Additional experiments 
demonstrated regulation of the mobility of Rad9 at sites of DNA lesions. First, Rad9 was 
shown to accumulate faster, and the proportion of immobilization was higher upon damage 
induction during S phase [38]. And second, the turnover of Rad9 molecules in foci was higher 
in the absence of ATR or the expression of a Rad17 mutant that cannot be phosphorylated 
by ATR [87]. These results indicate that although the initial recruitment of the 9-1-1 complex 
to sites of DNA lesions might be ATR-independent, ATR and Rad17 seem to collaborate in 
the retention of this complex at sites of genotoxic stress. This process critically depends 
on ATR-mediated phosphorylation of Rad17 and might have implications for checkpoint 
maintenance.
RECOVERY FROM CHECKPOINT ACTIVATION
Triggering checkpoint activation is of critical importance for an efficient DNA damage 
response and the maintenance of genome stability. Once a cell has arrested due to DNA 
damage, there are generally two options. When the DNA lesions cannot be repaired, the 
cell can undergo apoptosis or stay irreversibly arrested. Alternatively, the cell will repair 
the DNA and re-enter the cell cycle. In the case of cell cycle resumption, switching off the 
checkpoint once the damage has been repaired is an important process. The basic principles 
of controlling such checkpoint recovery are only just starting to emerge but indicate that 
active signalling is also required at this level of checkpoint regulation.
Direct inactivation of Chk1
As many of the steps during checkpoint activation are regulated by phosphorylation, it is 
not surprising that phosphatases have been implicated in switching off the checkpoint once 
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DNA repair has been completed. Direct inactivation of effector kinase Chk1, the main target 
of ATR signalling, mediated by several phosphatases indeed has been reported. In human 
cells, phosphatase PPM1D/Wip1 binds Chk1 and dephosphorylates serine 345, resulting in 
inhibition of Chk1 kinase activity in vitro. Inducible expression of PPM1D leads to a reduced 
DNA damage-induced cell cycle arrest [111], suggesting that a way to control checkpoint 
recovery is via regulation of PPM1D. Also purified phosphatase PP2A has been shown 
to dephosphorylate serines 317 and 345 of Chk1 in vitro and knock down of this protein 
leads to an increased phosphorylation of Chk1 on these residues in vivo. Interestingly, as 
dephosphorylation of wild-type Chk1 occurred more rapidly than of kinase-inactive Chk1, 
a model was hypothesized in which Chk1 dephosphorylation is (partially) regulated by its 
own kinase activity [112]. Chk1 activity was also shown to regulate its own degradation as 
at later time points after the exposure to genotoxic stress, Chk1 levels are downregulated 
in a proteasome-dependent manner and this process was triggered by ATR-mediated 
phosphorylation of serine 345 [93]. Recently the ubiquitination of Chk1 was demonstrated 
to be mediated by the Fbx6-SCF ubiquitin ligase [113]. Together these data point to the 
existence of several ways to regulate Chk1 inactivation. However, it should be mentioned 
that the involvement of such phosphatases and Chk1 degradation in the recovery of a DNA 
damage-induced cell cycle arrest is yet to be experimentally demonstrated.
Plk1, Claspin and Wee1
As mentioned above, protein degradation is, next to direct inhibition, a way to inactivate 
checkpoint signalling. Several groups have recently identified the role of mitotic kinase 
Plk1 in mammalian checkpoint recovery by regulating the degradation of crucial cell cycle 
mediators. The Medema group first published that knock down of Plk1 results in a delay in 
mitotic entry following the recovery from a G2 DNA damage arrest. However, this effect could 
be rescued by depletion of Wee1, the kinase that targets the inhibitory phosphorylation of 
tyrosine 15 of Cdc2, indicating that Wee1 functions downstream of Plk1. Indeed, Plk1 was 
shown to be involved in the degradation of Wee1 at the onset of mitosis, a process that 
likely to be dependent on b-TrCP ubiquitin ligase [114, 115]. Three reports subsequently 
described Claspin as additional Plk1 target regulating checkpoint recovery. Claspin was 
shown to be transiently stabilised upon DNA damage, but degraded upon mitotic entry. 
Claspin degradation was triggered by its binding to b-TrCP. The phosphorylation of Claspin 
was dependent on Plk1 and essential for the interaction with this ubiquitin ligase and the 
degradation of Claspin. Expression of a stable Claspin mutant prolongs activation of Chk1, 
thereby delaying the G2/M transition after the recovery from DNA damage or replication 
stress [116-118]. Finally, the mechanism behind the activation of Plk1 was identified by 
demonstrating that Aurora A activates Plk1 by phosphorylation. Aurora A-dependent 
phosphorylation of Plk1 was shown to be required for promoting the G2/M transition 
after DNA damage checkpoint arrest [119]. How Aurora A is activated to trigger checkpoint 
recovery remains a subject of investigation. Together these results suggest a model for 
checkpoint recovery in which Aurora A activates Plk1, which leads to the degradation of 
both Claspin and Wee1, resulting in simultaneous downregulation of Chk1 activation and 




Correct functioning of DNA damage responses is of crucial importance for the maintenance 
of genomic stability and the mechanisms of checkpoint functioning have therefore been 
the focus of attention in many laboratories in the past decade. It should be mentioned 
that numerous studies using model systems like S. pombe and S. cerevisiae have been 
of major benefit for the rapid progress in our understanding of checkpoint regulation in 
mammalian cells. From several observations throughout the years it has become clear that 
the checkpoint pathways initiated by the activation of ATM or ATR cannot be seen as static 
protein cascades, but are dynamic and highly regulated mechanisms, and new proteins 
involved in this regulation are still being discovered. 
First, data showing that ATM and cofactors are required for the activation of ATR in response 
to DSBs indicates interplay between the two pathways [9-11]. Interestingly, ATM activation 
in response to replication fork stalling or UV light was demonstrated to be ATR-dependent 
[120]. Second, although ATR signalling mainly functions as a kinase cascade, phosphorylation 
is not the only post-translational modification involved in regulating this pathway. Regulation 
of proteins by ubiquitination or modification by ubiquitin-like molecules appears to be of 
importance for checkpoint regulation as well [121, 122]. This involves protein turnover such 
as Cdc25A [101] and Chk1 [93], but also checkpoint regulation for example by ubiquitination 
of S. cerevisiae 9-1-1, a PCNA-like complex [70]. The latter observation is especially interesting 
since the process of SUMOylation, monoubiquitination and subsequent polyubiquitination 
of PCNA serves as a molecular switch between various DNA damage bypass processes [68]. 
Future experiments will demonstrate if similar modifications of mammalian 9-1-1 also 
play a key role in the ATR-dependent checkpoint response. Fourth, new technology has 
made it possible to study protein dynamics at sites of DNA lesions and have lead to the 
conclusion that the accumulations of proteins seen as foci, are actually not static structures. 
Instead, the majority of the proteins recruited to DNA damage sites only bind to chromatin 
transiently, and then actively turnover, which is hypothesized to facilitate the recruitment of 
new molecules to ensure activation of the entire pool of proteins. It was additionally shown 
that this protein turnover can be regulated by checkpoint signalling, as ATR-mediated 
phosphorylation of Rad17 regulates the retention time of the 9-1-1 complex at sites of 
genotoxic stress [87]. Finally, as the basics of recovery from a DNA damage-induced cell 
cycle arrest are only just starting to emerge, research will without doubt concentrate more 
on this subject. Protein degradation by the ubiquitin system was shown to play a crucial 
role in checkpoint recovery. The involvement of deubiquitin enzymes in the regulation of 
checkpoint initiation [123, 124] therefore raises the possibility that these enzymes might 
equally be important in switching off the checkpoint after DNA repair has been completed.
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ABSTRACT
Cell cycle checkpoint activation and DNA repair pathways govern genomic stability after 
genotoxic stress. Genotoxic insult results in activation of an interwoven network of DNA 
damage checkpoints and DNA repair pathways. Post-translational modifications on a number 
of proteins involved in both checkpoint activation and DNA repair play an important role in 
this cellular response. Genotoxic stress can induce a wide variety of DNA lesions. Among 
these DNA alterations are double-stranded breaks and single-stranded DNA gaps. Repair 
of these DNA alterations requires damage recognition and resection. Here we discuss how 
DNA repair and DNA damage checkpoints cooperate and deal with DNA damage. Processing 
of DNA lesions by structure-specific nucleases results in DNA-protein intermediates, which 
form the basis for checkpoint activation and DNA repair. Post-translational modifications 
like phosphorylation and ubiquitination modulate the DNA damage response in a spatial 
and temporal manner. Cell cycle-dependent regulation additionally plays a key role in the 
regulation of both DNA repair and checkpoint activation. We highlight recent advances in in 
vivo imaging that greatly expand our knowledge on the relationships between DNA damage 




Many cells in our body divide and thereby renew the tissue they are part of. For this to 
happen, DNA encoding the genetic material has to be duplicated. During the cell cycle, all 
necessary transactions take place in order for a cell to divide into two daughter cells. Proper 
timing of different cell cycle phases is crucial since growth, DNA replication and cell division 
need to occur in the correct order. A complex regulatory network controls the cell cycle 
on multiple levels. Transcriptional control regulates the expression of genes in time, in a 
relatively slow process that operates within a timeframe of several hours. Fast responses 
(within minutes), are propagated through direct protein-interactions and post-translational 
modifications, either of which will cause activation or inhibition of specific activities of a 
protein or protein complexes. Cell cycle related post-translational modifications also play 
a key role in the initial reactions to DNA damage. Since damaged DNA is a major threat 
to the integrity of genetic information, fast actions need to be taken to preserve genomic 
integrity. Cell cycle checkpoints control the transition of the DNA through the cell cycle, 
thereby safeguarding the integrity of the genome. In this review we explore the relationship 
between activation of different DNA repair pathways by different DNA lesions and the rapid 
associated activation of cell cycle checkpoints. 
We discriminate three phases in the cell cycle (Fig 1), before the physical separation of 
the two daughter cells in mitosis. Different types of Cyclins, which associate with Cyclin-
dependent kinases (CDKs), drive the progression of the cell cycle [1]. During the beginning 
G1 phase, D type Cyclins are expressed. The Cyclin – CDK complexes positively control the 
release and activation of growth stimulating proteins during this phase of the cell cycle [2]. 
Expression of E type Cyclins during G1 phase initiates entry into S-phase [3]. During replication 
Cyclin A expression comes up, controlling the onset and transition of DNA replication. 
Cyclin B expression rises at the end of S phase. In G2, Cyclin B – CDK2 is responsible for 
the entry into mitosis. The activities of the Cylin – CDK complex are negatively controlled 
by posttranslational modification [4]. Wee1 and Myt1 phosphorylate CDK2 on two specific 
residues. These phosphorylation events are counteracted by the CDC25 phosphatases that 
remove the phosphate groups. Specific inhibitor proteins called CDK inhibitors (CKIs) inhibit 
Cyclin – CDK activity through direct binding to the CDK subunit [5]. 
During an unperturbed cell cycle, the described cell cycle events are carried out in an orderly 
manner. However, genotoxic environmental agents, irradiation and cellular metabolism are a 
constant threat for cycling and non-cycling cells [6, 7]. Cell cycle checkpoints ensure a proper 
and intact passing of DNA into the next cell cycle phase by regulating Cyclin – CDK activity [8]. 
Phosphorylation of CDK reduces activity of the Cyclin – CDK complex and therefore cell cycle 
progression is temporarily halted [9]. The DNA damage induces activation of the effector 
kinases Chk1 and Chk2. The phosphorylation of the Cdc25 phosphatase by Chk1 and/or 
Chk2 targets Cdc25 for proteasomal degradation, thereby enhancing CDK phosphorylation 
and inhibition of cell cycle progression [10]. Checkpoint proteins at the same time are able 
to induce and/or facilitate DNA repair and stimulate either apoptosis or checkpoint recovery.
DNA DAMAGE CHECKPOINTS
Due to the complex chemical nature of DNA the variety of structurally diverse DNA lesions 
that can occur is vast. Repair of a huge set of possible DNA alterations requires detection 
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by DNA structure-specific recognition proteins or processes that track along DNA such as 
transcription or replication [11]. Checkpoints however are less diverse. They do not act on 
the DNA lesion directly, but respond to a common DNA-protein complex that builds up at a 
lesion, in general after incision(s) in the DNA phosphodiester backbone have been made by 
nucleases in a specific DNA repair pathway [12]. In this review we concern ourselves with 
DNA lesions such as DNA double strand breaks (DSBs) and single-stranded DNA (ssDNA) 
gaps. 
The DNA damage checkpoint response is under control of members of the phosphoinositide 
three-kinase-related kinase (PIKK) family [13, 14]. In response to DNA damage the PIKK 
family kinases ATM and ATR phosphorylate target proteins on serine and threonine residues, 
thereby activating the DNA damage checkpoint.
ATM signalling
In response to DSBs, ATM activation is necessary for checkpoint activation [15, 16]. The full 
activation of ATM is dependent on its autophosphorylation on Ser1981 and the interaction 
with the Mre11-Rad50-Nbs1 (MRN) complex at the DSB sites [17]. However it is still unclear 
which DNA structures stimulate ATM activation. In unperturbed cells, ATM is an inactive dimer. 
In response to DSBs, ATM is quickly autophosphorylated on Ser1981, which coincides with 
ATM forming active monomers [18-20]. Besides Ser1981, ATM is also autophosphorylated 
at Ser367 and Ser1893. Cells harbouring mutations in these sites are more sensitive to 
DSBs and show defective checkpoint signalling [21]. ATM is dephosphorylated by the Wip1 
phosphatase on Ser1981 [22]. Wip1 knockout cells, in unstressed state show elevated levels 
of ATM Ser1981 and p53 phosphorylation. 
In human cells, ATM recruitment to a specific DSB is dependent on autophosphorylation 
of Ser1981, the presence of Nbs1 and ATM kinase activity [23]. These data indicate the 
important role for ATM autophosphorylation in the checkpoint response. Therefore it 
was surprising that mice expressing ATM Ser1987A (human homologue of ATM Ser1981) 
show a normal ATM-dependent checkpoint response after DNA damage [24]. In addition, 
experiments performed with Xenopus egg extracts showed that ATM monomers are formed 
even in the absence of ATM autophosphorylation [25]. The reasons for these discrepancies 
may come from inherent differences between the species used in these studies. Another 
explanation is the presence of other autophosphorylation sites on ATM that may suggest 
a redundant function. In this context it is interesting that mice lacking H2AX, a histone 
variant phosporylated by PIKK kinases in response to DSBs, do not show the expected strong 
phenotype in response to DSBs [26, 27]. Possibly, some components of the damage induced 
signalling response are not crucial for checkpoint activation, potentially due to redundancy 
in the system.
Besides the role of Ser1981 autophosphorylation in ATM activation, the MRN complex 
plays an important function (Fig 3). ATM activation is hampered in Mre11 and Nbs1 mutant 
cell lines [28, 29]. Biochemical experiments show that MRN and ATM directly interact and 
thereby increase substrate affinity [19]. MRN is thought to act as a sensor for DNA damage 
that tethers DNA ends together before repair [30, 31]. Through binding and unwinding of 
DNA ends by the MRN complex ATM activation is increased [20]. The endonuclease activity 
of Mre11, involved in further processing of DSBs for repair, is critical for ATM activation, 
since cells expressing a mutant form of Mre11 that is not able to resect DSBs shows defective 
downstream checkpoint signalling [28, 32].  
A two step model for ATM activation was proposed to explain the functional relationship 
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between MRN and ATM activation in response to DSBs [25]. Initially after induction of a DSB 
there is MRN-dependent DNA tethering, ATM recruitment and ATM monomerization. In the 
second step, monomeric ATM is further activated through an interaction with MRN subunit 
Nbs1. ATM directly interacts with the C-terminus of Nbs1, thereby recruiting ATM to sites of 
damage [33]. However, autophosphorylation of ATM occurs in Nbs1 mutant cells, although 
no damage-induced ATM Ser1981 foci are formed in these cells [34]. MRN may therefore 
recruit ATM to sites of damage in an already activated state, placing it in close proximity to 
its substrates and thereby facilitating the downstream checkpoint response [35]. These data 
indicate a strong network of interdependencies. However using live cell imaging techniques 
it was shown that even in the absence of damage the mere recruitment of DNA damage 
response factors to the chromatin was enough to elicit checkpoint activation [36, 37]. 
Further requirements for an efficient ATM-mediated checkpoint response are the 
phosphorylation of a number of ATM targets. A large scale screen revealed a series of target 
proteins involved in a wide range of cellular processes [38]. Among these are Nbs1, H2AX 
and Artemis. Nbs1 is phosphorylated by ATM on Ser278, Ser343 and Ser615 [39, 40]. Nbs1 
mutant cells wherein the Serine434 has been mutated to alanine show a partial checkpoint 
defect [41, 42]. It was suggested that the phosphorylation of Nbs1 by ATM acts to recruit 
specific substrates to sites of damage [43]. The phosphorylation of specific substrates in a 
spatio-temporal manner may direct DSB processing steps in time and amplify the checkpoint 
when necessary. For example, the ATM-mediated phosphorylation of Artemis, a nuclease 
involved in one of the DSB repair pathways (see section on the processing of DNA lesions), 
is important for the resection of specific types of DNA lesions [44]. Chromatin-modifications 
also play a role in ATM activation [18], but since this is not the topic of this review the 
interested reader is referred to other papers for further information [18, 45, 46]. 
ATR signalling
After DNA damage infliction, ATR signalling is initiated in response to RPA that is loaded onto 
ssDNA gaps or resected DSBs (Fig 2). ATRIP, which is in complex with ATR is then recruited to 
these sites of damage.  Independently, the Rad17-RFC complex is loaded onto these sites of 
damage [47-49]. The Rad17-RFC complex consists of the Rad17 subunit and four additional 
subunits named RFC2-RFC5. During normal replication the RFC complex, containing RFC1 
instead of Rad17, plays a role in the loading of PCNA onto DNA. PCNA is a processivity factor 
for DNA polymerases. Both the Rad17-RFC and RFC complex require RPA for their loading 
onto DNA [50, 51]. However Rad17-RFC requires 5’ dsDNA-ssDNA junctions, rather than the 
3’ ended junctions preferred by PCNA [52, 53]. These types of structures are specifically 
created by the resection of DSBs, stalled replication forks and UV-induced ssDNA gaps. The 
Rad17-RFC protein complex facilitates the loading of the Rad9-Rad1-Hus1 sliding clamp onto 
the DNA. The 9-1-1 sliding clamp shows high structural similarity to the PCNA clamp [53].
The PCNA and 9-1-1 sliding clamps, preferably load onto different DNA substrates. In the 
case of a DNA damage-induced ssDNA gap the two clamps would be placed opposite of each 
other at the ssDNA gap, since PCNA loads onto 3’ ended junctions and 9-1-1 onto 5’ ended 
junctions. Live cell imaging revealed that during S-phase PCNA forms replication-associated 
foci [54-56]. In response to DNA damage Rad9 also localizes into foci [57] indicating a specific 
function for the 9-1-1 complex in the DNA damage response. This is further supported by 
the fact that in response to damage the loading of the 9-1-1 complex onto DNA is necessary 
for Chk1 activation by ATR and subsequent checkpoint signalling [58]. 
Artificial localization of the Mec1 and Ddc1, the S. cerevisiae equivalents of ATR and Rad9 
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is enough to trigger a checkpoint response without the presence of DNA damage [37]. 
This suggests that ATR kinase activation and subsequent checkpoint activation is merely 
dependent on the close proximity of these two complexes to each other on DNA. However 
another protein, called TopBP1, stimulates ATR activity in human cells. Like ATRIP-ATR and 
the 9-1-1 complex, TopBP1 also localizes to sites of damage [57]. TopBP1 binds to the Rad9 
subunit of the 9-1-1 complex, thereby locating it near the ATRIP-ATR heterodimer. ATR only 
becomes fully activated through an interaction with the ATR-activating domain of TopBP1 
[59, 60]. Besides the phosphorylation of Chk1, other ATR targets are Rad17, TopBP1, RPA, 
ATRIP, 9-1-1 and Claspin (Fig 2). The phosphorylation of Rad17 is involved in the localization 
of Rad9 to sites of DNA damage [57]. These and other data suggest that the phosphorylation 
of Rad17 acts as a positive feedback loop in amplifying checkpoint activation [57, 61, 62]. 
A similar mechanism was proposed for the ATR-mediated phosphorylation of TopBP1 [63]. 
The phosphorylation of Xenopus TopBP1 on Serine 1131 by ATR enhances the interaction 
between ATRIP-ATR and TopBP1. 
ATR-mediated phosphorylation of Claspin is important for Chk1 activation. Claspin mediates 
Chk1 phosphorylation and subsequent activation by ATR. Claspin levels are tightly regulated 
throughout the cell cycle by the SCF ubiquitin ligase in a Plk1-dependent manner [64]. 
Damage-induced ATR-mediated phosphorylation of Claspin reduces its targeting for 
degradation and thereby enhances Chk1 activation. The amplification of the checkpoint 
signal through post-translational modifications actually sustains the initial signal and 
broadens it in both the spatial and temporal directions [65, 66]. 
The effector kinases Chk1 and Chk2 are important for the spreading of the checkpoint signal 
throughout the cell [67]. Activated Chk1 and Chk2 phosphorylate Cdc25A during the G1/S-
phase transition and Cdc25C during G2/M, thereby stopping cell cycle progression. DNA 
damage-induced phosphorylation of Chk1 releases the protein from chromatin [68].  Unlike 
the PIKK kinases these so called effector kinases are not stably recruited to sites of damage 
and do not localize in damage-induced foci. Furthermore live-cell studies have shown that 
GFP-tagged versions of Chk1 and Chk2 are highly mobile proteins even in the presence of 
DNA damage [69, 70]. 
Figure 1: Cyclin - CDK regulation throughout the different phases of the cell cycle. During the G1 
phase, the Cyclin D – CDK4/6 complex is responsible for cell cycle progression after which the Cyclin 
E – CDK2 complex come up, leading to further progression into S phase and duplication of the DNA. 
Cyclin A – CDK2 levels rise during S and G2 phase and finally Cyclin A/B – CDK1 drives cells into mito-
sis with segregation of cells into two identical daughters. The G1/S and G2/M borders together with 
replication (intra S phase) function as checkpoints to maintain genomic stability after DNA damage.
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The DNA damage-induced checkpoint inhibits initiation of new replicons during replication, 
thereby slowing it down. However, at or behind the replication forks, nucleotide incorporation 
can continue due to translesion synthesis (TLS) polymerases [71]. These polymerases are 
loaded onto the DNA when damaged bases block replication forks and are able to replicate 
over the damaged area. Besides many phosphorylation events that relay the checkpoint 
signal after DNA damage, other types of post-translational modifications take place. For 
example, PCNA is involved in the initiation of translesion synthesis [72]. Rad6/Rad18-
dependent mono-ubiquitination of PCNA leads to the recruitment of TLS polymerases at 
the site of damage [73, 74]. The S. cerevisiae Rad17 (human homologue Rad1) of the Ddc1-
Figure 2: Genotoxic stress leads to many ATR-mediated phosphorylation events and subsequent 
checkpoint activation, amplification and maintenance. RPA coated ssDNA functions as the initial sig-
nal for ATR-mediated checkpoint activation, through the independent recruitment of the ATR-ATRIP 
and Rad17-RFC(2-5) complexes. ATR activation is dependent upon the loading of the 9-1-1 com-
plex by Rad17-RFC(2-5) and subsequent recruitment of TopBP1. ATR activation leads to transient 
cell cycle arrest through the phosphorylation of effector kinase Chk1. ATR-mediated phosphory-
lation of Rad17 and TopBP1 are involved in checkpoint maintenance and amplification. The phos-
phorylation of Claspin, Rad9, ATRIP and H2AX by ATR are all suggested to play a role in checkpoint 
regulation, indicating the importance of signalling through phosphorylation in checkpoint control.
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Rad17-Mec3 (human homolgues Rad9-Rad1-Hus1 complex) is ubiquitinated in a Rad6/
Rad18-dependent manner, similar to PCNA. Ubiquitination of S. cerevisiae Rad17 is involved 
in checkpoint regulation after DNA damage. A strain harbouring the Rad17-K197R mutation, 
that block the ubiquitination, shows reduced Ddc2 (homologue to human ATRIP) focus 
formation in response to HO-endonuclease-induced DNA breaks [75]. These data suggest 
a role for Rad1 ubiquitination in the recruitment of the 9-1-1 and ATR-ATRIP complex to 
chromatin in response to DNA damage. It has been suggested that the 9-1-1 complex has a 
role in TLS, during replication [76]. In yeast, the 9-1-1 clamp can physically interact with TLS 
polymerases [77, 78] and therefore ubiquitination of the 9-1-1 complex may likely play a 
role in these processes. However no evidence has been found to support this in mammalian 
cells. That ubiquitination plays an important role in the DNA damage response was recently 
shown. In response to both DSBs and UV irradiation histone H2A becomes ubiquitinated [79, 
80]. These modifications are important for the recruitment of checkpoint mediators 53BP1 
and MDC1 [81-83]. These data implicate ubiquitination as an important post-translational 
modification in the DNA damage response and also directly link chromatin modifications 
to the DNA damage response. Other modifications like SUMOylation and NEDDylation may 
very likely also play a role in the DNA damage response [84-88].
DNA REPAIR PATHWAYS
There are a wide variety of DNA repair pathways that are necessary to repair structurally 
diverse DNA lesions. Here we will discuss the dominant pathways involved in the repair of 
DSBs and ssDNA gaps. 
Double strand break repair
Repair pathways that are associated with the repair of DSBs are non homologous end 
joining (NHEJ) and homologous recombination. In human somatic cells NHEJ is an important 
repair pathway for DSBs. This is surprising since NHEJ-mediated repair is more error-prone 
than repair via homologous recombination, which uses the genetic information on the 
duplicate strand for repair of the damaged bases. Since DSB repair mediated by NHEJ does 
not require an identical sister chromatid template it might be a fast and easy method to 
seal a two-ended break arising from the effects of chemicals or X-rays on DNA to counter 
potentially oncogenic translocations [6, 7]. Two-ended breaks that are repaired by NHEJ are 
first recognized by the Ku70/80 heterodimer (Fig 3). This ring-shaped complex has a high 
affinity for DNA ends [89]. DNA-PK
CS
 (DNA-PK catalytic subunit) locates and binds to the Ku 
complex at the site of damage. The binding of DNA-PK
CS
 mediates the recruitment of XRCC4, 
XLF and DNA ligase IV [89-92]. These latter proteins are responsible for the completion of 
the ligation reaction, resulting in the reannealing of the two broken DNA ends back together. 
Certain chemicals that induce DSBs, like topoisomerase II inhibitors (Etoposide) do not 
induce a directly ligatable DNA end, because of the covalent attachment of topoisomerase 
to the DNA end [44]. For repair through NHEJ, these types of DNA ends are cleaned up by 
the Artemis nuclease [93-95]. Artemis interacts directly with DNA-PK
CS
 and locates to sites 
of damage in vivo. 
Homologous recombination is very important in the repair of replication-associated DNA 
damage. ssDNA and one-ended DSBs can arise during replication and cause stalling of 
replication forks especially after DNA damage [98]. Because homologues recombination 
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uses the information on the undamaged sister chromatid, the repair process is error-free. 
Homologous recombination is initiated by the binding of the MRN complex to the DNA ends. 
Together with the CtIP nuclease MRN is responsible for the initial resection of the DNA ends 
to produce short 3’ overhangs [96, 97]. The nucleases ExoI or Dna2 in combination with the 
Sgs1 helicase create larger 3’ overhangs through further resection of the DNA end. These 
stretches of ssDNA are covered by RPA which later on is replaced by Rad51 nucleoprotein 
filaments (Fig 3). Homologous recombination proceeds through strand invasion of the Rad51 
covered ssDNA into the homologous double-stranded DNA (dsDNA) template, producing a 
joint molecule. Branch migration will lead to the forming of so called Holliday junctions 
that will be resolved to result in an error-free repaired DSB [98, 99]. The above reactions 
are facilitated by many proteins among which are BRCA2, Rad51AP1, BLM and Rad54 [100, 
101]. 
Nucleotide excision repair
UV-induced DNA lesions are typically repaired by Nucleotide Excision Repair (NER). As a 
result of UV-irradiation helical distortions are formed in DNA, due to covalent linkage of 
bases on the same strand of the DNA double helix. These do not directly induce DNA breaks 
but are able to stall replication forks [102]. Unrepaired UV lesions can lead to base changes 
which become fixed in DNA as mutations and thereby increase the risk of tumorigenesis. 
NER works in two distinct pathways, either via transcription-coupled NER (TC-NER) or 
through global genome NER (GG-NER). These two pathways differ in the way nucleotide 
damage is recognized. TC-NER damage recognition involves active transcription of the 
template and requires CSA and CSB whereas during GG-NER XPC is responsible for damage 
detection. The two major UV-induced DNA helical distortions are 6-4 photoproducts (6-4 
PPs) and cyclobutylpyrimidine dimers (CPDs). Both lesions are recognized and processed by 
NER; 6-4 PPs are more rapidly removed than CPD lesions since these are recognized better 
and faster by the NER machinery [103]. For the recognition of CPD lesions during GG-NER, 
DDB1 and DDB2 are required accessory proteins involved in the damage recognition process 
[104, 105]. After the initial recognition step, TFIIH is recruited [106]. This large, 10-subunit 
protein complex unwinds the DNA in an ATP-dependent process, thereby opening up the 
DNA to gain further access to the damaged bases [107]. RPA and XPA bind TFIIH and the 
open DNA structure, respectively stabilizing and validating the DNA lesion. The 3’ and 5’ 
endonucleases named XPG and XPF/ERCC1 are recruited to either side of the lesion to 
perform a dual incision of approximately 35 nucleotides including the damaged bases [108]. 
The introduced ssDNA gap is filled and sealed with the aid of post-incision proteins including 
PCNA, XRCC1, DNA polymerases and DNA ligase III [109]. The NER mechanism has been 
extensively investigated. Live cell imaging of NER proteins revealed some of their spatial and 
temporal behaviour. Combining these data with the use of computer modelling will gain 
further insight into how the NER pathway as a whole behaves in real time in the context of 
the nucleus [110, 111]. 
PROCESSING OF DNA LESIONS
In response to DNA damage, the checkpoint is activated only when the DNA alterations 
are processed into intermediate structure. Consequently the lesions must be recognized 
and processed first, before the DNA damage checkpoint becomes fully activated. Recently 
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a number of (structure-specific) nucleases have been implicated in the DNA damage 
response.. In the current model for resection of DSBs the first resection step requires MRN 
and CtIP, producing small ssDNA overhangs [96]. The subsequent action of ExoI or Dna2 
in combination with Sgs1 (a helicase) which both act redundantly results in long stretches 
of ssDNA [112-114]. The long stretch of ssDNA can act as a substrate for Rad51 filament 
formation and further DNA repair via homologous recombination [112]. 
ssDNA and specifically ssDNA-dsDNA overhangs in vitro using Xenopus egg extracts induce 
Figure 3: Cell cycle-dependent processing of DSBs and subsequent checkpoint activation. DSBs gener-
ated in G1 and S/G2 can be repaired by NHEJ. The Ku70/80 complex binds the broken DNA ends first. 
ATM becomes activated inducing a checkpoint response. The Artemis nuclease trims down the DNA 
end creating a ligatable substrate. DNA-PKcs binds Ku and thereafter functions as a platform for the 
recruitment of DNA ligase IV, XLF and XRCC4, which are ultimately responsible for direct ligation of the 
two broken DNA ends. During S and G2 phase, ATM becomes activated via the MRN complex eliciting 
an early checkpoint response. DSBs are processed first by the MRN complex and CtIP, creating a small 
stretch of ssDNA bound by RPA. Secondary processing is performed by ExoI (or Sgs1/Dna2), creat-
ing longer stretches of RPA coated ssDNA. This initiates an additional checkpoint response through 
ATR. Finally RPA is exchanged for Rad51 that initiates repair through homologous recombination.
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ATR-dependent checkpoint activation [115]. In response to DSBs, ss/dsDNA junctions are 
important in the activation of ATM and in later instance ATR [116]. Using HeLa nuclear 
extracts Zou and co-workers showed that MRN and CtIP activate ATM in response to DNA 
ends that are actively resected. After the initial resection MRN is released and ExoI is 
responsible for further resection, which leads to a larger stretch of ssDNA and subsequent 
ATR activation. The larger stretch of ssDNA is responsible for the loss of activated ATM and 
the switch to increased ATR activation. All in all these data indicate that the DSB response in 
vitro is driven by resection. Resection and checkpoint control directly regulate each other. 
The nuclease ExoI for example is phosphorylated by ATR in a DNA damage-dependent 
manner. Moreover, its protein levels are also regulated by ubiquitination after damage, 
indicating a post-translational feedback mechanism for controlling ExoI activity [117, 118].
Proteins containing nuclease activity, such as XPG and ERCC1/XPF, also play roles during the 
later steps of repair reactions, as detailed below for UV-induced DNA damage. In addition 
to the role of ERCC1/XPF in NER, its nuclease activity is also crucial for repair of interstrand 
Figure 4: NER-dependent checkpoint activation after UV-irradiation. UV lesions are recognized by NER 
and thereafter either directly repaired or processed further to create ssDNA gaps. RPA quickly accumu-
lates at the ssDNA gap after which the ATR-ATRIP and Rad17-RFC(2-5) complexes independently local-
ize to the site of damage. Rad17-RFC(2-5) loads the 9-1-1 complex onto the 5’ ssDNA-dsDNA junction. 
ATR is activated through the interaction with TopBP1, which binds to a C-terminal domain of Rad9.
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DNA crosslinks [119]. Interstrand crosslink repair also requires the action of a ERCC1/XPF 
related structure-specific endonuclease called Mus81/EmeI [120]. Mus81/EmeI also plays 
an important role in restart of blocked DNA replication forks [121]. Replication stress can 
give rise to complicated DNA lesions and appears to require multiple structure-specific 
nucleases. The SLX4 (human homologue BTBD12) protein functions as a scaffold for the 
recruitment of different structure-specific endonucleases to replication-associated DNA 
lesions. In response to DNA damage SLX4 can bind and enhance the nuclease activity of 
ERCC1/XPF, Mus81/EmeI and SLX1 [122-126]. SLX4 in combination with Mus81/EmeI cleaves 
branched DNA structures, like 3’ and 5’ DNA flaps and replication forks. As mentioned above 
repair of DSBs through homologous recombination can physically join two sister chromatids 
through a Holliday junction. Resolution of these junctions can be performed by resolvases. 
Gen1 was recently identified as a Holliday junction resolvase [127]. SLX4 in complex with 
SLX1 can also perform Holliday junction cleavage and resolution. Interestingly SLX4 is also 
phosphorylated in response to DNA damage by ATM and ATR kinases, suggesting a form of 
regulation, possibly through a feedback mechanism [38, 123]. Thus, many endonucleases, 
some part of the same protein complex, have been identified that play a role in the repair of 
replication-associated DNA damage and recombination. It will be interesting to determine 
what the precise DNA substrates are for individual nucleases. Potentially there is a lot of 
redundancy between nucleases that will make this task an interesting challenge. 
INTEGRATION AND COOPERATION BETWEEN DNA REPAIR AND CELL CYCLE CHECKPOINTS
In the previous sections we discussed the mechanism of DNA damage checkpoint activation 
and the functions of dedicated DNA repair pathways. These events take place in the context 
of the cell cycle however. In the next section we will discuss these processes in the context 
of three cell cycle phases.
G1/S checkpoint 
The G1 phase of the cell cycle is characterized by the fact that only one copy of the DNA 
is present. Homologous recombination can therefore not be efficient during this time. The 
major DNA repair pathway for DSBs during G1 is NHEJ [128]. Since many cells in the human 
body are post-replicative and thus non-cycling, error-free DNA repair is often not essential 
for cell viability. Whether proteins involved in homologous recombination are still active in 
the G1 phase is a question that remains. Do they simply not fulfil their job due to the need 
for an identical template? Or is the homologous recombination machinery actively being 
shutdown during the G1 phase? Core proteins involved in homologous recombination, 
like Rad51 and BRCA2 do not form DSB-induced foci in G1, suggesting that homologous 
recombination is not active during this phase. In S. cerevisiae, Sae2 is involved in the 
resection of DSBs thereby facilitating repair via homologues recombination. The protein is 
under control of the Cdc28/Cdk1 complex (Cyclin B/CDK2 in humans), which is expressed 
during S and G2 phase. Through the phosphorylation of specific residues on Sae2 by Cdc28/
Cdk1, the protein becomes active and homologous recombination becomes more favourable 
[129]. These CDK residues also exist in the human Sae2 homologue CtIP, for which they work 
according to the same mechanism [130]. 
The nature of the DNA lesion also facilitates the choice of repair in G1. In S. cerevisiae cells 
synchronized in G1, so called ‘dirty ends’ (DNA ends whose chemical composition precludes 
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direct ligation) are recognized more efficiently by the MRN complex and are consequently 
subjected to DNA end-resection. These resected breaks are then further repaired in the next 
round of replication by homologous recombination. HO-endonuclease induced breaks on 
the other hand, leaving a 3’-hydroxyl and 5’-phosphate group at the DNA end can be directly 
ligated. These ends are a substrate for the Ku70/80 end-binding complex and thus favour 
repair by NHEJ [12, 131, 132].  Thus, both the cell cycle and the type of DNA lesion that is 
induced control the DNA damage response.
Intra S phase checkpoint
During S phase, CtIP becomes active due to an increased CDK2 activity, thereby stimulating 
DNA repair via homologous recombination. BRCA2 is another example of a DNA damage 
response protein under cell cycle control. BRCA2 is involved in the repair of DSBs by 
homologous recombination, wherein it interacts directly with Rad51 via its C-terminus [133-
135]. The BRCA2 C-terminus is phosphorylated in a CDK-dependent manner on Ser3291 
[136]. This phosphorylation event blocks the interaction with Rad51. In unperturbed cells 
phosphorylation is lowest during replication after which it increases towards mitosis. 
After DNA damage, CDK-dependent phosphorylation of BRCA2 goes down immediately, 
stimulating the interaction with Rad51 and repair via homologous recombination.
In response to UV-induced DNA lesions, gap-sealing by ligase I occurs in a cell cycle-
dependent manner [109, 137]. Ligase I is phosphorylated by CDK2, thereby restricting its 
activity to S phase. Since DNA ligase III is active throughout the cell cycle, gap-sealing after 
NER is able to function even in the absence of functional ligase I. The function of ligase I is 
critical however during DNA replication [138, 139], when it associates with the PCNA sliding 
clamp in joining adjacent Okazaki fragments [140, 141]. After DNA damage ligase I displays a 
more enhanced binding to Rad17 [142] and the 9-1-1 complex [143], suggesting a functional 
interaction between the checkpoint and ligase I during DNA damage.
ATR-dependent checkpoint signalling is activated in response to UV irradiation [144, 145]. 
The UV-induced helical distortions are recognized and processed by NER, however further 
widening of the NER-induced ssDNA gap may result into a longer stretch of ssDNA [146]. 
It is likely that nucleases are involved in the processing of these ssDNA gaps [147]. The 
involvement of NER in ATR-mediated checkpoint activation in reaction to UV damage has 
been puzzling (Fig 4). UV-induced damage stalls replication forks and induces a checkpoint 
response. This is due to the formation of ssDNA during the uncoupling of replicative helicases 
from stalled forks [148]. Nevertheless UV-irradiation induces ATR-dependent signalling also 
outside of S phase [149-151]. UV-induced lesions outside of S phase will also be recognized 
by NER. During NER-dependent processing of the DNA for nucleotide excision a small ssDNA 
gap is created [106]. This small ssDNA gap recruits RPA, although whether these structures 
are enough to trigger the checkpoint response is not known. Nonetheless, the Rad9 
checkpoint protein is recruited to UV-induced lesions during G1 [152]. Additionally, Rad9 
binds to chromatin in G1-enriched cells after DNA damage [153]. NER-dependent Rad9 
focus formation during G1 is dependent on both XPC and XPA, whereas during replication 
XPA is more important [152]. A specific role for XPA outside of classical NER had been shown 
for replication-induced checkpoint activation [154]. XPA also directly interacts with ATR 
[155]. However, experiments performed with primary cells from patients with defects in 
NER do not support this. In these type of cells, phosphorylation of Chk1 in response to UV is 
dependent on NER in non-replicating and nocodazol-arrested cells and not during replication 
[144]. The basis for these conflicting results might originate from cell type specific effects, 
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and/or from the methods used in each study. Another reason could be that the degree of 
Chk1 phosphorylation is different during each cell cycle phase. 
G2/M checkpoint
Before the cell goes into mitosis it must go through the G2/M checkpoint. When cells 
enter mitosis with DSBs, this can lead to gross chromosomal rearrangements and an 
uneven separation of chromosomes between the two daughter cells. Therefore the G2/M 
checkpoint must work effectively enough to turn off the cell cycle progression. In this regard 
it is surprising that it is not essential to repair all DSBs to continue entering into mitosis 
[156]. Similar results were obtained after UV-irradiation for yeast cells. These cells do not 
stop at the G2/M boarder after low doses of UV. High doses on the other hand can trigger a 
delay in cell cycle progression at the G2/M boarder [157]. It will be interesting to determine 
what type of DNA structures activate the checkpoint after DNA damage in G2, given that 
the chromosomal properties of the DNA are dramatically changed in G2. The cohesion 
complex may play a role here, since cohesion is required for DSB repair by homologous 
recombination in G2 cells [158]. Additionally cohesion subunit SMC1 is a downstream target 
of the ATM kinase [159]. 
PERSPECTIVE
Interwoven networks of DNA damage checkpoints and DNA repair pathways are of crucial 
importance for maintaining genomic integrity after DNA damage induction, because they 
enable cells to respond in both a cell cycle-dependent and lesion-specific manner. To fully 
understand these networks, numerous questions remain to be answered. How precisely 
are DNA damage checkpoints activated? Single-stranded DNA can trigger a response in a 
length dependent-manner and either a 3’ or a 5’ DNA end is required for Chk1 activation 
[115]. Since these are the requirements for checkpoint activation why do they not induce a 
checkpoint response during normal replication? 3’ ends are generated during both lagging 
and leading strand synthesis, also seen as PCNA replication-associated foci during S phase. 
5’ ends are specifically generated during lagging strand synthesis. What then makes the 
situation different from normal replication to stalled replication forks? The first option could 
be that checkpoint activation requires blocking of the fork for efficient activation. Many of 
the proteins involved in checkpoint control, such as Claspin, ATR and Chk1, also play a role 
in replication fork stabilization. In the second option, the checkpoint is actively repressed 
during normal ongoing replication. However when the forks are stalled the repression is 
alleviated and the checkpoint becomes active. The third option implies a threshold for 
checkpoint activation. During replication the sum of the total amount of ssDNA and primed 
ends is not enough to significantly induce checkpoint activation. We favour a fourth option 
that is not necessarily incompatible with the mentioned possibilities; checkpoint activation 
is achieved by the build-up of specialized nucleoprotein structures at the sites of damage, 
thereby creating checkpoint response specificity [12]. Evidence for this hypothesis exists, 
since checkpoint activation can be achieved through artificial recruitment of checkpoint 
proteins to chromatin in an undamaged state [36, 37]. This implies that spatial distribution 
of proteins is important for checkpoint control. Additionally in vivo checkpoint activation 
is controlled by dynamic protein-protein interactions in a spatial and temporal manner. 
Namely, checkpoint regulators ATM and ATR are dependent on other proteins for their full 
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activation and recruitment to sites of DNA damage. ATM requires the MRN complex for its 
localization to DSBs and for complete kinase activation [19, 20, 33, 34]. ATR recruitment and 
activation on the other hand relies on RPA coated ssDNA and a loaded 9-1-1 complex at the 
5’ ssDNA/dsDNA junction [51, 58, 160]. These arguments suggest that checkpoint activation 
is simply controlled through recruitment and activation of specific proteins and protein 
complexes. Future work should provide further insight into these remaining questions.
What happens when DNA repair is completed? Given that DNA intermediate substrates act 
as the primary signal for checkpoint activation, fewer intermediates become present in time 
when damage is repaired. By reducing the amount of intermediates, checkpoint signalling 
will also be reduced, which results in a restart of the cell cycle. Experiments show, however, 
that cells resume cycling when breaks are still present [156]. It was suggested that cells 
arrest only when a damage threshold is reached and therefore also start cycling again with 
some DNA damage still present. A similar threshold was suggested for the activation of the 
checkpoint [161].
Cell cycle-dependencies influence the DNA damage response extensively. This makes the 
situation more complicated, as DNA damage repair and checkpoint pathways should not 
be seen as static protein cascades but as dynamic and highly regulated mechanisms. To 
study the cell cycle dependent regulation of checkpoint and repair pathways onto specific 
types of DNA damage in the future, we need to use and develop better ways of inducing 
DNA damage. For example, recent studies make use of specific types of sources and lasers 
to induce specific subsets of DNA lesions [162-166] and, with the use of live cell imaging 
and specific cell cycle markers [54, 152, 167], cell cycle-dependency can be studied in more 
detail. 
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Dynamics of the ATR-Chk1 pathway
ABSTRACT
The ATR-Chk1 checkpoint pathway is activated by UV-induced DNA lesions and replication 
stress. Little was known about the spatio and temporal behaviour of the proteins involved 
and we therefore examined the behaviour of the ATRIP-ATR and Rad9-Rad1-Hus1 putative 
DNA damage sensor complexes and the downstream effector kinase Chk1. We developed 
assays for the generation and validation of stable cell lines expressing GFP-fusion proteins. 
Photobleaching experiments in living cells expressing these fusions indicated that after UV-
induced DNA damage, ATRIP associates more transiently with damaged chromatin than 
members of the Rad9-Rad1-Husus1 complex. Interestingly, ATRIP directly associated with 
locally induced UV damage, whereas Rad9 bound in a cooperative manner, which can be 
explained by the Rad17-dependent loading of Rad9 onto damaged chromatin. Although 
Chk1 dissociates from the chromatin upon UV damage, no change in the mobility of GFP-




Eukaryotic cells are continuously threatened by DNA damage caused by environmental 
factors and intracellular metabolic processes. To protect themselves against these 
potential threats, cells have developed DNA damage checkpoint and repair mechanisms, 
which help to ensure transmission of an intact genome. Cell cycle checkpoints and DNA 
repair mechanisms together determine the ultimate faith of the cell after suffering DNA 
damage. Activation of the DNA damage checkpoint involves the activation of transducer 
kinases ATR/ATM and subsequently the effector kinases Chk1/Chk2 [1]. So called mediator 
proteins, including Claspin and BRCA1, were additionally discovered, and function either 
in the recruitment of substrates to DNA lesions or as scaffolds on which protein complexes 
are assembled [2, 3]. In response to a variety of DNA damaging agents like UV light and 
replication stress, the ATR-mediated checkpoint pathway is activated. Biochemical data 
indicates that ATRIP, in complex with ATR, binds to RPA-coated single stranded DNA (ssDNA) 
[4]. Independently, the Rad17-RFC complex is also recruited to sites of damage. The Rad17-
RFC protein complex facilitates the loading of the Rad9-Rad1-Hus1 (9-1-1 complex) sliding 
clamp onto the DNA [5-7]. Subsequently, TopBP1 is recruited to DNA lesions by binding to 
the Rad9 subunit of the 9-1-1 complex, thereby locating near the ATRIP-ATR heterodimer. 
Through an interaction with TopBP1, ATR becomes fully active, resulting in the activation of 
effector kinase Chk1 and subsequent checkpoint arrest [8-10]. 
Detection of DNA alterations after genotoxic stress is essential for the survival of cells 
and gaining more insight into the early events of the DNA damage response will give a 
better understanding of how DNA damage checkpoints function, how genome stability 
is achieved and how cancer can develop. In recent years, biochemical work has provided 
invaluable insight into the requirements, substrates and activities of proteins involved 
in the ATR-mediated checkpoint pathway [11-13]. Although the importance for protein 
localization after DNA damage induction has been reported for proteins involved in the 
response to double-stranded breaks (DSBs), not much is known about how the ATR-Chk1 
pathway operates in living cells and moreover, how the spatio and temporal behaviour of 
proteins in this pathway influence the DNA damage response [14, 15]. We set out to study 
the behaviour of ATRIP-ATR and 9-1-1 DNA damage sensor complexes by creating cDNA 
constructs expressing GFP (green fluorescent protein)-tagged proteins in human cells. The 
use of GFP-fusion proteins creates advantages over using standard immunofluorescence 
techniques as it avoids fixation methods and antibody artefacts. In addition, GFP-labelled 
proteins can be followed in time using live cell video microscopy. Furthermore, due to the 
spectral qualities of GFP and its variants it has become possible to perform quantitative 
fluorescent analysis [16-18]. The use of GFP-labelled proteins opens up a number of new 
possibilities in the DNA damage response field. First, the localization GFP-fusion proteins 
can be directly followed into DNA damage-induced nuclear foci. Second, the ability to 
measure in time makes it possible to establish an order of events occurring directly after 
DNA damage induction. Third, the existence of multiple spectral GFP-variants allows for 
the simultaneous detection of several fluorescently labelled proteins in a single cell [19-
21]. Forth, live cell video microscopy in combination with GFP-photobleaching experiments 
can be applied to quantitatively determine changes in protein mobility in response to DNA 
damage. Collectively, these tools help to increase our understanding of cellular mechanisms 
involved in DNA damage response.
The accumulation of DNA damage response proteins at sites of damage, shown in cells as 
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nuclear foci, is essential for downstream checkpoint events, although how, is not yet fully 
understood [22-24]. Many, if not most, proteins in the ATR-mediated checkpoint pathway 
are recruited to sites of damage into nuclear foci. As a result a proportion of the total 
amount of free proteins becomes immobilized in these foci due to interactions with either 
the damaged chromatin or other proteins at the DNA lesion. To gain more understanding 
of the DNA damage-induced behaviour of a protein, its localization and mobility can be 
determined. The DNA damage-induced change in protein mobility has been studied for 
several proteins involved in the DNA damage response, mainly in DNA repair and in response 
to double stranded breaks (DSBs) [17, 25-27]. The studies performed on proteins involved 
in nucleotide excision repair (NER) for example, have been important in understanding 
this DNA repair process and helped explain some of the phenotypic characteristics seen in 
patients that harbour mutations in proteins in this pathway. This indicates the importance 
of these types of studies for research in cancer and related diseases associated with genome 
instability [28, 29]. 
A method was setup for the generation of stable cell lines expressing GFP-fusion proteins 
and different assays to validate and characterize GFP-expressing cell lines were developed. 
We analyzed the dynamic behaviour of multiple proteins involved in the ATR checkpoint 
pathway including all three components of the 9-1-1 complex, ATRIP and of the downstream 
kinase Chk1. We compared the mobility changes of these proteins after UV-irradiation and 
together the results indicated a distinct dynamic behaviour of the studied proteins. Whereas 
effector kinase Chk1 was highly mobile and did not immobilize upon DNA damage, Rad9 and 
ATRIP associated to sites of DNA damage. ATRIP directly bound to DNA lesions but in a more 
transient manner than Rad9, which displayed a relatively slow exchange with damaged 
chromatin. Together these data demonstrate the importance of spatio and temporal protein 
regulation in the cells response to DNA damage.  
MATERIALS & METHODS
Cell culture
U2OS, Hela and 293T cells were grown using standard procedures. U2OS and Hela cells 
stably expressing eGFP-fusion proteins were grown in standard medium supplemented with 
350-700	mg/ml of G418 (gentamicin). 
Antibodies
Antibodies obtained from commercial sources were as follows: Orc2 (BD Pharmingen), 
Grb2 (BD Transduction), RPA (Ab2, Oncogene), Rad9 (Novus), gH2AX (Upstate), Chk1-pS317 
(Cell Signaling), Chk1 (Abcam). The following antibodies were obtained from Santa Cruz 
Biotechnology: CENP-F (H-260), Cyclin A (H-432), Cyclin B1 (GNS1), Ku86 (C-20), Chk1 (G-4), 
Rad1 (N-18), Rad9 (C-20) and ATR (N-19).
Rabbit polyclonal anti-Rad9, anti-Hus1 and anti-GFP were described before and a kind gift 
by R. Freire (Tenerife, Spain) [30, 31]. Rabbit polyclonal anti-ATRIP was a kind gift by P.M. 
Reaper (UK) [32].
Transfection
Plasmid DNA was transfected into cells using the calcium phosphate transfection method. 
siRNA oligonucleotides (Dharmacon Research) were transfected into cells using 
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Oligofectamine (Invitrogen) according to the manufacturer’s instructions and as previously 




Rad9 3’UTR (CCAAGAACCUGAAGCCUGUUU / GAAUCCAGCUUUGACCUUUU)
Colony survival assays
Cells were counted and 1000 cells were seeded onto 60 mm diameter dishes where after 
left for 12 hours to attach. Cells were treated with different doses of UV (5, 10, 15, 20 J/m2) 
and incubated for 7-14 days, after which the colonies were fixed, stained and counted. All 
experiments were performed in triplicate.
Immunofluorescence
For immunostaining, cells were fixed in 2% paraformaldehyde containing 0.2% Triton X-100 
for 20 minutes at RT and then permeabilized with 0.1% Triton X-100 for 5 minutes at RT. 
Samples were blocked in 1% FCS and immunostained with antibodies as indicated. For 
detection of GFP-tagged proteins in U2OS cells, living cells were studied, or cells were fixed 
and permeabilized as above.
Images were made using a Cell Observer fluorescent microscope equipped with Axiovision 
software (Zeiss) or a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 560 nm long pass filter. For strip-FRAP experiments 
and time lapse imaging after UV laser induction, GFP-tagged proteins were detected in living 
cells using a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 488 nm 
Ar-laser and a 505-530 nm band pass filter for green fluorescence. 
Whole cell extracts and cell fractionation
For whole cell extracts, cells were washed in cold PBS, after which the cells were resuspended 
in Laemmli sample buffer (4% SDS, 20% glycerol, 120 mM Tris pH 6.8) and boiled for 5 
min. Protein concentrations were determined using the Lowry protein assay. Chromatin 
fractionation was performed as previously described [34, 35].
Generation of DNA damage and photobleaching techniques
UV-irradiation was performed using a 254 nm UV-C lamp (Philips) at 20 J/m2 and cells were 
processed 1 hour post treatment. Cells were incubated with 5 mg/ml of aphidicolin (Sigma) 
for 20 hours prior to processing of samples. Cells were incubated with 200 nM camptothecin 
(Sigma) for 20 hours before fixation. IR (10 Gy) was induced using a 137Cs source or a linear 
accelerator (LINAC) and cells were processed 2 hours after treatment. Local UV laser 
induction was performed as previously described [36]. In short, cells were grown on a 25 
mm quartz coverslip. A small area inside the nucleus was exposed for ~1 second to a 2 
mW pulsed (7.8 kHz) diode laser emitting at 266 nm. Time-lapse images were made every 
minute immediately starting after local UV induction. The time course measurements were 
normalized to the plateau phase. Start of UV irradiation was defined as t=0. Assembly curves 
were normalized to 1 and processed as previously described [26].
In the FRAP experiments, a strip spanning the nucleus was photobleached for 20 
milliseconds using an Ar-laser (488 nm) at 100% laser intensity, which irreversibly bleaches 
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all GFP molecules in that area. Subsequently, the redistribution of fluorescence in the strip 
was monitored by taking confocal images every 20 milliseconds for a total of 24 seconds 
at low laser intensity to avoid further bleaching. The fluorescence before bleaching (I
t<0
) 
was set to 1 and the intensity immediately after bleaching (I
0
) was set to 0. The recovery of 
fluorescence was plotted against time.
In the FLIP experiments, half of the nucleus was continuously bleached using an Ar-laser (488 
nm) at 50 % laser intensity. Subsequently, the loss of fluorescence in the unbleached area 
was monitored taking confocal images every 10 seconds for a total of 300 seconds at low 
laser intensity. The fluorescence before bleaching (I
t<0
) was set to 1. The loss of fluorescence 
was plotted against time. FLIP-FRAP experiments were performed as previously described 
[33, 37].
RESULTS
Generation of cell lines stably expressing GFP-tagged proteins
The limitations of conventional fixation methods were overcome by the introduction of GFP, 
the green fluorescent protein derived from Aequorea Victoria, a species of jellyfish [38, 
39]. Through the cloning of the cDNA encoding GFP, it became possible to fluorescently 
label proteins and express them, thereby creating the opportunity for monitoring proteins 
in living cells. Different fluorescent versions of the GFP exist such as the red fluorescent 
(RFP), yellow fluorescent (YPF) and cyan fluorescent (CFP) protein, and many more spectral 
variants have been created since [40]. The expression of GFP and derivatives itself in 
mammalian cells is not harmful although the protein originates from a different species. 
Nonetheless, labelling of proteins with (fluorescent) epitopes can potentially influence the 
behaviour of the labelled protein. Validation and functional analysis of a GFP-fusion protein 
construct therefore is essential for the interpretation of experimentally obtained data.
The amount of fluorescence signal in a cell population derived from a single cell clone 
is in principle identical in all cells and therefore comparing fluorescence intensities after 
different treatments becomes reliable. We setup a method for the creation, generation 
and validation of GFP-fusion proteins for the purpose of live cell imaging. The approach is 
schematically depicted in Figure 1A and discussed below. 
Creation of GFP-tagged protein constructs 
After the discovery of GFP and its potential usefulness in biology, the protein itself became 
the subject of intensive research. Certain mutations in the GFP gene lead to different spectral 
variants and improvements in the protein characteristics, such as an increase in brightness 
(fluorescent intensity) and photo stability [41]. These qualities can be found in, for example, 
the GFP variant called ‘enhanced GFP’ (eGFP). Vectors encoding for eGFP and fluorescent 
derivates are commercially available (Clontech) and have been published [40]. In the studies 
presented here we made use of vectors containing eGFP or eGFP with the addition of two 
other, non-fluorescent epitopes, namely an HA- and His-tag (eGFP will hereafter be referred 
to as GFP). The additional epitope creates the possibility to detect the GFP-fusion protein 
with antibodies directed against the HA- and/or His-tags. Additionally, these tags can be 
used for immunoprecipitation experiments to identify interaction partner proteins. 
For proper cellular function a protein needs to be folded correctly upon its expression. Since 
GFP and the cDNA of interest encode for two proteins that are attached, proper protein 
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folding might be influenced by sterical hindrance. As a possible solution to this problem, 
adding a small DNA sequence linker in between the sequence encoding for GFP and the 
cDNA this can be minimized [38, 42]. In addition, such a linker might help to restore the 
functionality of the protein, as a rigid tag might interfere with for example binding to 
(endogenous) partners.
In addition to a neomycin resistance cassette for selection, the GFP vectors contain a CMV 
promoter that is compatible with expression in immortalized cells, such as the human 
osteosarcoma (U2OS) and epithelial cervical cancer (Hela) cell lines used in this study. As 
adding a tag might influence protein functionality, it is advisable to construct both N- and 
C-terminal labelled versions of the proteins. cDNA was cloned into the GFP-vectors via PCR 
and/or restriction enzyme cutting and religating by T4 DNA ligase, resulting in plasmids 
encoding an in frame sequence of GFP and the cDNA of interest. After obtaining the right 
plasmid DNA the functionality of the GFP-fusion protein was tested by determining the 
interaction with its known binding partners. In this way a reasonable choice can be made 
to continue with either the N- or C-terminally tagged version of the protein, or both. After 
transient expression of the cDNA encoding the GFP-fusion protein and the known binding 
partner, cell extracts were prepared for immunoprecipitation using antibodies against GFP. 
The interaction with the known binding partners was determined by western blotting. The 
N- and C-terminally labelled proteins from the Rad9-Rad1-Hus1 complex were tested in this 
manner. Labelling of Rad1 at either site of the protein did not influence the interaction with 
endogenous Hus1 (Figure 1B). GFP-labelling of Rad9 at the C-terminus completely abrogated 
the interaction with its binding partners, whereas Hus1 labelling at the N-terminus decreased 
the binding to its partners (data not shown). When binding partners of a GFP-fusion protein 
are not known or do not exist and/or antibodies are not available testing for functionality 
must be performed in a different manner. Later in this section different assays that can be 
used to validate the function of the GFP-tagged protein in living cells are described. 
Expression of GFP-tagged proteins in human cells 
After obtaining cDNA encoding a GFP-fusion protein cells were transfected to achieve 
random integration of the GFP-fusion construct. We used the well studied human U2OS 
and Hela cells for the expression of the GFP-fusion protein since these cells are well 
suited for both live cell imaging and siRNA-mediated downregulation of proteins. We 
obtained a transient transfection efficiency of ~70% in both Hela and U2OS cells using the 
calcium-phosphate transfection method, where after we started with antibiotic selection. 
Importantly, multiple copies of the cDNA can be incorporated in the genome and the site(s) 
of integration additionally may create artefacts and influence cellular behaviour. In human 
cells this problem can only be tackled by using retroviral constructs that integrate only once. 
To minimize these possible artefacts we only selected individual clones expressing low 
amounts of GFP-fusion proteins.  
Selection of GFP-positive cells using an antibiotic selection marker
To obtain cells that incorporated at least one copy of the GFP-fusion cDNA we used antibiotic 
selection through the neomycin-resistance cassette present in the GFP vector. To achieve 
stable integration of the cDNA in the genome of the transfected cells, cells were seeded in 
different densities and selected using 700 mg/ml G418 for at least two weeks, refreshing the 
medium with antibiotics every 3 days.
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Figure 1: Generation of stable cell lines expressing GFP-tagged proteins. (A) Stepwise pro-
tocol for stable expression of GFP-fusion proteins in cells. (B) 293T cells were transfect-
ed with GFP-Rad1, Rad1-GFP or mock transfected, after which cells were lysed and im-
munoprecipitations were carried out using anti-GFP antibody. Western blot analysis of the 
immunoprecipitates using the indicated antibodies. (C) Protein expression analysis of differ-
ent stable clones. Western blot analysis of whole cell extracts using the indicated antibodies.
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FACS sorting of GFP-positive cells
G148 selection caused cell death of cells that did not integrate the cDNA construct in their 
genome. GFP-positive cells were sorted from the total population by FACS. Approximately 
5-10% of the cells became GFP-positive after two weeks of G418 selection. This small 
percentage is most likely due to an incorrect integration the GFP-fusion cDNA causing 
expression of only part of the construct including the G418 resistance cassette. The sorted 
GFP-positive cells were replated in different dilutions so that single cells could grow into 
discrete colonies. Cells were kept in similar conditions of antibiotic selection as previously 
used and medium was refreshed at least twice a week. 
Picking of individual cell colonies
After the multiplication of a single cell into a colony of around 50-100 cells, the colonies 
were randomly picked under sterile conditions using an inverted light microscope. At least 
24 colonies were picked for every cell line. The selected colonies were kept in individual 
wells and were cultured until completely confluent, where after split into two plates. One 
plate was frozen and the other one was used to prepare cell lysates for expression analysis.
Determining protein expression levels of the GFP-fusion
The cell lysates from individual clones were analyzed by SDS-PAGE and western blotting 
using antibodies specifically against the protein of interest and GFP. Expression levels of the 
endogenous compared to the GFP-fusion protein was determined as well as the amount of 
free GFP or the existence of degradation products. 
Selecting clones expressing relatively low amounts of GFP-tagged protein
Clones were selected on the basis of the following criteria: low expression levels of the 
GFP-fusion protein (not higher than that of the endogenous protein) and the absence of 
free GFP or other undefined products, based on the western blotting analysis. A number of 
4 clones that meet these criteria were selected and thawed for further validation. Clones 
were cultured in medium containing 350 mg/ml G418 to maintain expression of the GFP-
fusion protein.  
With the method described above stable cell lines were obtained that express a GFP-fusion 
from the ATR-Chk1 pathway, namely ATRIP, Rad17, Rad9, Rad1, Hus1 and Chk1 (Figure 1C 
and data not shown). We also generated control cell lines expressing GFP and H2B-GFP-
Chk1. 
Validation and characterization of the selected stable cell lines
To validate the functionality of the GFP-fusion protein and characterize the stable cell lines 
we utilized a number of assays:
Immunoprecipitations (IP) of the GFP-fusion protein were performed to confirm the 
interaction of the GFP-fusion with its known endogenous protein partners. We published 
before that GFP-Rad9 interacts with its endogenous partners Rad1 and Hus1 [33]. A similar 
experiment was performed with GFP-ATRIP, which demonstrated that the GFP-fusion was 
able to bind endogenous ATR (Figure 2A).
To check if stable expression of the GFP-fusion protein influences the cells response to DNA 
damage by functioning as a dominant negative, we determined the sensitivity of our cell 
lines to genotoxic stress. We compared the colony survival in response to UV light of the 
stable clones to the parental untransfected cell line. As shown in Figure 2B, the expression 
of the GFP-Rad9 in both Hela and U2OS cells did not alter the sensitivity to UV damage, 
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Figure 2: Validation and functionality of stable cells expressing GFP-fusions. (A) Two independent U2OS 
clones expressing GFP-ATRIP were lysed after which immunoprecipitations were carried out using anti-
GFP antibody. Western blot analysis of the immunoprecipitates using the indicated antibodies. (B) 
U2OS and Hela cells expressing GFP-Rad9 were seeded in low density and treated with different doses 
of UV. The number of surviving colonies after 10 days was counted. (C) Left panel: cells expressing GFP-
ATRIP or control U2OS cells were left untreated or treated with UV. One hour later, cells were lysed 
and analyzed by western blotting with the indicated antibodies. Right panel: as left panel, but with two 
clones expressing GFP-Chk1. (D) Control U2OS cells or cells expressing GFP-Chk1 were left untreated 
or treated with 10 Gy IR. After 2 hours, cells were fixed and stained with PI and MPM2 and analyzed 
by FACS. The percentage of mitotic cells is indicated. (E) U2OS cells expressing GFP-Rad9 were trans-
fected with siRNA oligos directed against Rad9 or the 3’UTR of Rad9 for the indicated time periods. 
Cell extracts were prepared and western blot analysis was performed using the indicated antibodies.
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indicating that GFP-Rad9 does not function as a dominant negative. The expression of GFP 
alone in Hela cells also did not influence sensitivity to UV-irradiation. 
The ATR-dependent checkpoint pathway is triggered in response to genotoxic stress and 
induces the ATR-mediated phosphorylation of Chk1, which results in a temporal cell 
cycle arrest [11]. To test if expression of the GFP-fusion proteins influences checkpoint 
activation we monitored the UV-induced phosphorylation of Chk1. Expression of GFP-ATRIP 
and GFP-Chk1 did not influence the levels of phosphorylated Chk1 (Figure 2C). GFP-Chk1 
is phosphorylated in response to UV damage, indicating the GFP-tagged Chk1 behaves 
similarly to the endogenous one. To study the G2 phase arrest induced by DNA damage, we 
determined the mitotic index of cells expressing GFP-Chk1 and untransfected cells. A similar 
decrease in mitotic cells upon ionizing radiation (IR) was observed in GFP-Chk1 expressing 
and control cells, indicating that expression of GFP-Chk1 does not interfere with the DNA 
damage-induced G2 checkpoint (Figure 2D).
Although these assays demonstrate the absence of a dominant negative effect of the GFP-
fusions, to definitively rule out problems due to GFP-tagging, complementation of a mutant 
or knock out cell line is required. Cells derived from Seckel syndrome patients that harbour 
a mutation in the ATR gene, leading to an abrogated expression of the ATR protein, are 
available [43], but most proteins in this pathway are essential for cell viability making a 
direct complementation impossible in human cells. In addition, knock outs of Rad9 and 
Hus1 in mouse embryonic stem cells are lethal, although the lethality of Hus1 disruption 
can be rescued by knocking out p21 [44-46]. Chicken DT40 cells can be successfully used 
for knocking out genes that are essential in mammalian cells, like Chk1, but are less suitable 
for the generation of stable GFP-fusion cell lines and live cell imaging, since these cells are 
genomically unstable and can only be cultured in suspension [47]. Another approach is siRNA-
mediated downregulation of the endogenous protein and subsequent complementation by 
expression of the GFP-tagged protein. We favour this option since in this way; we are able 
to study both the functionality of the GFP-fusion protein as well as its mobility in the same 
cell line.
To specifically downregulate the endogenous protein, different siRNA-mediated approaches 
are available. First, as the cDNA encoding for the GFP-fusion protein does not contain a 
3’UTR, the use of siRNA oligos that specifically target this region of the protein of interest 
should result in knock down of the endogenous protein only. We applied this approach in 
cells expressing GFP-Rad9. Figure 2E demonstrates that 48 hours after transfection with 
siRNA oligo number 1, endogenous Rad9 is more efficiently downregulated than the GFP-
labelled Rad9 protein. At 72 hours after transfection the efficiency of downregulation became 
less, demonstrating that knock down is optimal 48 hours after transfection with siRNA oligo 
number 1. Transfection with siRNA oligo number 2 also lowered endogenous Rad9 levels 
more than the GFP-labelled Rad9 protein levels and the efficiency of downregulation was 
similar between 48 and 72 hours after transfection. In an alternative approach a silent 
mutation is made in the cDNA of the GFP-tagged protein, thereby leaving the encoded 
protein unchanged. By using siRNA oligos that recognize the mRNA from the endogenous 
but not the GFP-fusion protein, the endogenous protein can be specifically downregulated, 
such that the functionality of the GFP-fusion protein can be assessed [33]. Collectively the 
performed validation assays indicate that the introduction and stable expression of GFP-
fusions of Chk1, ATRIP, Rad9, Rad1 and Hus1 did not change the response of these cells to 
DNA damage. These GFP-fusion proteins can therefore be seen as functional equivalents of 
their endogenous counterparts.  
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Cellular localization of GFP-fusion proteins in response to DNA damage
Numerous studies over the past years indicated that the accumulation of DNA damage 
response proteins at sites of damage is of crucial importance for downstream checkpoint 
events [14, 22, 24, 48, 49]. Although for many proteins involved in checkpoint regulation a 
(relatively small) fraction of the total pool of proteins is bound to chromatin in unperturbed 
cells, the majority of these proteins relocalize and accumulate at or near sites of DNA 
lesions to form so-called nuclear foci [50]. GFP-Rad9 for example, localizes into foci after the 
treatment with different DNA damaging agents (Figure 3A).
To investigate the specific DNA substrate onto which a protein is recruited, different DNA 
damaging agents can be tested, as well as colocalization with other proteins involved in the 
DNA damage response. Biochemical experiments indicated that the Rad17-RFC and ATRIP-
ATR protein complexes are recruited to DNA damaged-induced RPA-coated ssDNA and 
this localization induces the activation of the downstream kinase Chk1 [4, 51, 52]. Rad9, a 
component of the 9-1-1 complex, is loaded onto the DNA by Rad17-RFC in response to DNA 
damage [5, 53]. We observed colocalization of GFP-Rad9 and RPA upon treatment of cells 
with both UV light and IR, suggesting that Rad9 is recruited to sites of RPA-coated ssDNA 
(Figure 3A). In response to DNA damage, histone H2AX is phosphorylated at Ser139 by ATM/
ATR [54]. Although phosphorylation of H2AX (gH2AX) is commonly used to identify DSBs, 
gH2AX is also induced in response to UV light or treatment with other agents that do not 
directly induce DSBs, like the replication inhibitor aphidicolin (Figure 3A) [55]. We observed 
colocalization of GFP-Rad9 and gH2AX in all UV-induced foci, whereas treatment of cells 
Figure 3: DNA damage-induced foci formation of GFP-Rad9. (A) GFP-Rad9 expressing cells were 
left untreated or exposed to UV, IR or aphidicolin. GFP-Rad9 was detected by direct fluores-
cence and RPA and gH2AX by immunofluorescence. (B) GFP-Rad9 expressing cells were treat-
ed with 40 J/m2 local UV-irradiation using an isopore filter. One hour later the cells were fixed 
and stained. GFP-Rad9 was detected by direct fluorescence and TFIIH by immunofluorescence.
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with aphidicolin or IR did not result in a complete colocalization of the two proteins (Figure 
3A and data not shown). Close inspection demonstrated that foci induced by aphidicolin 
either contained both GFP-Rad9 and gH2AX or gH2AX only. Since the phosphorylation of 
H2AX is triggered in response to a wide variety of DNA lesions, we conclude that GFP-Rad9 
is only recruited to a subset of aphidicolin-induced DNA lesions. 
Not all proteins accumulate into foci, even though they are recruited to sites of DNA 
damage. Proteins involved in nucleotide excision repair for example, do not form foci in 
response to genotoxic stress. The accumulation of these proteins onto damaged DNA can be 
visualized by applying local UV damage in the nucleus. By irradiating the cells while covered 
with an isopore filter, the UV light can only penetrate the pores and as a consequence, only a 
small part(s) of the nucleus contains damaged DNA [56, 57]. As shown in Figure 3B, proteins 
involved in the ATR-mediated checkpoint pathway, such as Rad9, also accumulate onto 
local UV damage. This method requires fixation of cells and is therefore unsuitable for live 
cell imaging. The development of laser-induced DNA damage circumvented this problem 
[26, 36, 58]. Laser-induced DNA damage can be easily combined with live cell imaging and 
different types of lasers are commonly available [15, 59]. For example, recent studies make 
use of specific types of sources and lasers, specifically inducing subsets of DNA lesions such 
as CPDs and 6-4P induced by UV light, and DSBs [14, 36, 56, 60, 61]. Nonetheless caution is 
required, as often sources and lasers also produce other, unwanted, types of lesions, that 
may influence protein behaviour adversely [36, 62].
We did not observe the accumulation of the effector kinase Chk1 into nuclear foci in response 
to DNA damage nor onto locally applied UV-induced DNA damage using a filter (data not 
shown), in contrast to ATR, TopBP1, 9-1-1 members and many other checkpoint mediator 
proteins. In this sense Chk1 behaves similarly to Chk2, the effector kinase for the cellular 
response to DSBs [15]. In order to trigger a cell cycle arrest in response to DNA damage, 
these effector kinases phosphorylate a range of substrates that are present throughout the 
nucleus. Although both Chk1 and Chk2 do not associate to chromatin after DNA damage, 
Chk1 associates to chromatin in unperturbed cells and is released from the chromatin in 
response to DNA damage [35]. In the light of this, the absence of accumulated Chk1 at sites 
of DNA lesions was to be expected. 
Quantitative GFP-fusion protein dynamics
By measuring the change in mobility of a protein in response to DNA damage a number 
of parameters can be determined. First, the time the protein spends at the site of a DNA 
lesion and second, the fraction of the total amount of protein engaged in that process. 
Fluorescent Redistribution After Photobleaching (FRAP) is applied to study the mobility of 
GFP-fusion proteins in living cells. In a defined region (strip) of the nucleus the fluorescence 
is irreversibly photobleached through brief illumination at high laser intensity (strip-FRAP). 
Redistribution or recovery of the total fluorescence in the bleached area is then measured 
in time, indicative of protein mobility [16, 63, 64].
To gain further understanding of how the proteins in the ATR-pathway sense DNA lesions 
and subsequently respond to trigger the checkpoint-mediated cell cycle arrest, the dynamic 
behaviour of these proteins was studied. We demonstrated that GFP-Rad1, GFP-ATRIP and 
GFP-Rad9 form foci and are recruited to chromatin in response to DNA damage, as shown 
by chromatin fractionation (Figure 4A, data not shown) [21]. To address whether these 
proteins become immobilized at sites of DNA lesions, we determined the change in mobility 
of GFP-Rad1, GFP-Rad9, Hus1-GFP and GFP-ATRIP upon UV-irradiation. Importantly, the 
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total amount of GFP-labelled molecules could be different between cells and between GFP-
fusion protein cell lines. These two discrepancies could potentially influence photobleaching 
results since relative immobilization is dependent on the total amount of protein available. To 
adjust for cell to cell differences in a population we normalized the obtained measurements 
as described in materials and methods. Furthermore we used saturating amounts of UV-
irradiation to be sure that all possible molecules would be engaged (data not shown). 
Although we did not measure the exact amount of GFP-fusion molecules per cell, western 
blotting analysis indicates that the different GFP-fusion proteins are expressed to a similar 
extent (Figure 1C).
In response to UV light, 20-40% of the 9-1-1 complex proteins become immobilized. (Figure 
4B-E). The GFP-Rad1 and Hus1-GFP FRAP curves show more variability compared to the 
GFP-Rad9 FRAP curve, which is probably due to the fluorescent variety of the GFP-Rad1 and 
Hus1-GFP cell lines and the amount of cells that were measured (Figure 4B-D). Although 
the ATRIP-ATR complex is also recruited to sites of DNA damage, relatively less GFP-ATRIP is 
immobilized (5-10%) in response to UV damage as compared to either of the proteins of the 
9-1-1 complex (Figure 4E). These data demonstrate that the 9-1-1 and ATRIP-ATR complexes 
behave differently after DNA damage and suggest that ATRIP displays a higher turnover at 
sites of DNA lesions.
To further investigate the possible distinct behaviour between these two putative DNA 
damage sensor complexes Fluorescent Loss After photobleaching (FLIP) experiments were 
performed. During FLIP half of the nucleus is constantly bleached and the loss of fluorescence 
in the unbleached half of the nucleus is measured, representing the rate of dissociation. 
As shown in Figure 4F, non-damaged cells expressing either GFP-Rad9 or GFP-ATRIP 
completely lost fluorescence 150 seconds after start of bleaching (k1/2 ~15 seconds). After 
UV irradiation the dissociation rates were less fast. GFP-ATRIP completely lost fluorescence 
after 250 seconds (k1/2 ~25 seconds), whereas GFP-Rad9 after more than 300 seconds (k1/2 
~40 seconds). These FLIP experiments indicate that after DNA damage induction both ATRIP 
and Rad9 become less mobile, but the release (dissociation) of ATRIP from sites of damage 
is faster than Rad9. These data are in accordance to the FRAP experiments, that show 
relatively less immobilization of ATRIP upon UV irradiation as compared to the proteins of 
the 9-1-1 complex.
The rate at which proteins associate to sites of DNA lesions was addressed by measuring 
the accumulation of proteins upon local UV laser irradiation. Briefly, a small area inside 
the nucleus is irradiated with a 266 nm UV laser. GFP-Rad9 and GFP-ATRIP fluorescence 
in the locally damaged area was measured every 60 seconds until a plateau was reached. 
GFP-ATRIP quickly started accumulating at the damaged area and reaches a plateau ~20 
minutes after damage induction (k1/2 ~6 minutes) (Figure 4G). GFP-Rad9 accumulation in 
the first 8 minutes is relatively slow, but rises faster thereafter and reaches a plateau after 
~30 minutes (k
1/2
 ~12 minutes) (Figure 4G). These results indicate that ATRIP and Rad9 
associate very differently to UV-damaged DNA and suggest that ATRIP is recruited directly 
to the sites of damage in an exponential manner, following Michaelis-Menten kinetics [65], 
whereas the accumulation kinetics of Rad9 follow a sigmoidal curve (non Michaelis-Menten 
kinetics), representing cooperative binding [66]. Rad17-dependent loading of Rad9 onto the 
DNA might explain this cooperative binding of GFP-Rad9 after DNA damage induction[67], 
compared to ATRIP-ATR which binds directly to RPA-coated ssDNA [4].
Chk1 is phosphorylated at or near the DNA lesion and thereafter released from the chromatin 
[35] and consequently, the amount of immobilized GFP-Chk1 measured by photobleaching 
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experiments might become lower after DNA damage induction. To test this hypothesis, we 
performed strip-FRAP on cells expressing GFP-Chk1 treated with UV light. We compared 
the GFP-Chk1 mobility with that of free GFP and an artificially immobile form of Chk1, 
where GFP-Chk1 was fused to histone H2B (H2B-GFP-Chk1) [35]. Upon photobleaching 
GFP-Chk1 demonstrated a fast recovery of fluorescence both before and after UV damage 
(Figure 5A). The recovery was similar to that of free GFP, arguing against the existence of 
a stably bound GFP-Chk1 fraction. Since GFP-Chk1 was present in relatively high levels due 
to overexpression in addition to endogenous Chk1, we reasoned that the amount of Chk1 
might be too high to observe any change in protein mobility upon DNA damage induction. 
Therefore, we lowered the total amount of Chk1 by RNA interference. Cells expressing GFP-
Chk1 were transfected with either control luciferase or Chk1 siRNA oligos. Twenty four hours 
later cells were treated with UV light and chromatin fractions were prepared. As shown 
in Figure 5B, both endogenous and GFP-labelled Chkl were released from chromatin upon 
DNA damage induction in control downregulated cells, although the GFP-tagged version 
less efficiently than endogenous Chk1 (endogenous 64%, GFP-labelled 16%). Transfection 
of Chk1 siRNA oligos resulted in downregulation of endogenous Chk1 and did not influence 
the release of Chk1 from chromatin. Although GFP-Chk1 is less efficiently released from the 
chromatin than endogenous Chk1, a small but considerable fraction of GFP-Chk1 (~15%) 
is released in response to DNA damage, which is comparable to the previous experiment 
without the depletion of endogenous Chk1. 
Next we lowered the total amount of Chk1 in GFP-Chk1 expressing cells by siRNA-mediated 
downregulation. Subsequent strip-FRAP analysis indicated that non-damaged GFP-Chk1 
expressing cells did not contain more immobile GFP-Chk1 molecules compared to UV-
treated cells (Figure 5C). Downregulation of Chk1 did not influence the recovery of residual 
GFP-Chk1 fluorescence in untreated cells and accordingly it did not change GFP-Chk1 
mobility after UV-treatment. 
The strip-FRAP experiments demonstrated the absence of a stably bound Chk1 pool in 
these conditions. Nonetheless, these experiments were performed in a relatively short 
period of time (20 seconds). Since Chk1 released from the chromatin in response to UV-
induced DNA damage could be a more gradual and thus time-dependent process, we 
additionally addressed GFP-Chk1 mobility by determining its residence time on DNA. Chk1 
was downregulated in GFP-Chk1 expressing cells as previously described and subsequently 
the cells were irradiated with UV-light. Thereafter, half of the nucleus was bleached once 
and redistribution of GFP-Chk1 fluorescence was measured in the bleached and unbleached 
area over time. The time it takes to reach full fluorescent redistribution determines the 
proteins residence time. The results shown in Figure 5D indicated that GFP-Chk1 reached 
redistribution after 40 seconds, which is outside the timeframe of our original experiment. 
However, during the 40 seconds directly after bleaching we did not observe any difference 
in the mobility using this method. These results further indicate that Chk1 is a highly mobile 
protein and suggests that it only very transiently interacts with the chromatin.
DISCUSSION
The initial response to DNA damage is of crucial importance for cell functioning and viability, 
since an improper DNA damage response can eventually lead to cancer and other human 
diseases [1, 68]. In response to UV light, the putative DNA sensors Rad17-RFC and ATRIP-ATR 
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Figure 4: UV-induced changes in mobility of checkpoint proteins. (A) U2OS cells expressing GFP-ATRIP 
(left panel) and GFP-Rad1 (right panel) were left untreated or treated with UV. Two hours later, soluble 
and chromatin-bound proteins were isolated and analyzed by western blotting using the indicated anti-
bodies. (B-E) Hus1-GFP (B), GFP-Rad1 (C), GFP-Rad9 (D) and GFP-ATRIP (E) expressing cells were left un-
treated or treated with UV and analyzed by strip-FRAP (see materials & methods for technical details). (F) 
U2OS cells expressing GFP-Rad9 or GFP-ATRIP were left untreated or treated with UV. After 1 hour cells 
were analyzed by FLIP (see materials & methods for technical details). Plotted is the loss of fluorescence 
during continuous bleaching. (G) U2OS cells expressing GFP-Rad9 or GFP-ATRIP were locally irradiated 
using a 266 nm UV laser. Plotted is the association of fluorescent signal at the locally damaged area.
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are independently recruited to DNA regions containing RPA-coated ssDNA [4, 52]. Rad17-
RFC is responsible for the loading of the 9-1-1 complex onto the DNA [5]. These events are 
required for the subsequent activation of Chk1, which results in a cell cycle arrest [12]. To 
gain further insight into the events that take place after a genotoxic insult in living cells, we 
GFP-labelled several proteins of the ATR pathway and expressed these fusion proteins in 
human cells. We discussed how to generate and validate stable GFP-fusion cell lines. 
Figure 5: Mobility of GFP-Chk1 in response to DNA damage. (A) U2OS cells expressing GFP, H2B-
GFP-Chk1 or GFP-Chk1 were left untreated or treated with UV and analyzed by strip-FRAP (see 
materials & methods for technical details). (B) Chromatin fractionation of GFP-Chk1 expressing 
cells transfected with siRNA oligos directed against luciferase or Chk1 for 24 hours before UV treat-
ment and cell fractionation. Relative Chk1 levels as compared to untreated controls are indicated. 
Western blot analysis of the fractions was performed using the indicated antibodies. (C) GFP-Chk1 
expressing cells were transfected with siRNA oligos against luciferase or Chk1 for 24 hours and left 
untreated or treated with UV. 1 h later cells were analyzed by strip-FRAP. (D) U2OS cells express-
ing GFP-Chk1 were transfected with Chk1 siRNA oligos for 24 hours and left untreated or treated 
with UV and subsequently analyzed by FLIP-FRAP (see materials & methods for technical details).
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The quantitative analysis of GFP-fusion proteins in living cells using video microscopy 
allowed us to determine the dynamic behaviour of different individual proteins of the 
pathway in response to DNA damage. With the use of photobleaching techniques (strip-
FRAP, FLIP, FLIP-FRAP, local UV laser) we determined multiple parameters of the proteins, 
including the rate of accumulation onto locally induced UV laser damage, rate of diffusion, 
immobile fraction, and the average time of immobilization (residence time) before and after 
global UV-irradiation. These methods are useful tools to investigate the dynamics of proteins 
involved in the DNA damage response, as shown in this paper, since many of the involved 
proteins bind DNA or proteins present at the site of damage and become immobilized to a 
certain extent. 
GFP-Rad9, GFP-Rad1, Hus1-GFP and GFP-ATRIP accumulate into nuclear foci in response to 
DNA damage. However, a relatively larger fraction of the 9-1-1 complex proteins become 
immobilized in response to UV as compared to ATRIP. Biochemical experiments show 
that the 9-1-1 complex is loaded onto the 5’ ssDNA/dsDNA by Rad17-RFC, therefore its 
association to DNA lesions might take some time and is the result of cooperative binding 
[51]. In contrast, ATRIP interacts directly with RPA-coated ssDNA, explaining its exponential 
binding behaviour [4]. The results obtained by FLIP suggest that a loaded 9-1-1 complex 
cannot easily dissociate from the DNA. This dissociation might be slower because the 9-1-
1 complex forms a ring around the DNA. It therefore has to either slide off a DNA end or 
actively dissociate, which likely is a more time consuming process [69]. In addition, the FRAP 
experiments show that 20-40% of the 9-1-1 complex molecules become immobile, whereas 
only 5-10 % of the ATRIP molecules is immobilized after DNA damage. These results also 
indicate a relatively more stable association of the 9-1-1 complex with damaged chromatin 
which is consistent with the FLIP results. 
All together, the putative DNA damage sensors Rad9-Rad1-Hus1 and ATRIP-ATR show a 
different dynamic behaviour directly after induction and during the presence of UV-induced 
DNA damage. Nonetheless, both GFP-Rad9 and GFP-ATRIP molecules are exchanging rapidly 
in UV-induced foci since all the mobility measurements performed on both GFP-Rad9 
and GFP-ATRIP DNA damage induced-foci do not indicate a stable immobilized fraction, 
suggesting that these foci are not static but highly dynamic structures.
Recruitment of the ATRIP-ATR heterodimer to sites of DNA damage results in ATR kinase 
activation which leads to the phosphorylation and subsequent activation of the Chk1 kinase 
[70, 71]. To investigate the spatio and temporal behaviour of downstream effector Chk1 in 
living cells, we studied the dynamic behaviour of GFP-Chk1 in response to DNA damage. In 
vivo imaging experiments confirm the absence of a stable chromatin-bound Chk1 fraction. 
The data presented here signify that Chk1 is a very mobile protein both in the absence 
or presence of DNA damage. The observed chromatin binding of Chk1 that is observed in 
biochemical experiments is not indicative of a stably bound Chk1 chromatin fraction [35] 
(Figure 5B). This high nuclear mobility of Chk1 was hypothesized to ensure the access of 
additional Chk1 molecules to ATR and the transmission of the damage signal throughout 
the nucleus [15, 35, 72] .
Measuring protein mobility is not always as straightforward as it seems. Problems that are 
commonly faced when performing these types of experiments are monitor bleaching, influx 
of proteins from the cytoplasm and blinking. Monitor bleaching is caused by observing 
the cells before, during and after photobleaching or time lapse experiments. By using 
low amounts of laser power this can be avoided, although with low fluorescent protein 
levels this could be problematic. Lowering the laser power could result in a low resolution, 
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which in turn results in a large variability between measurements. Monitor bleaching can 
be corrected for by measuring the amount of bleaching in an unbleached area of the cell, 
but this only applies for freely diffusion proteins [63, 73]. Another potential problem is 
the presence of a cytoplasmic protein fraction that could influence nuclear measurements 
due through the influx of fluorescence from the cytoplasm. Before the start of the actual 
measurement, the cytoplasmic fraction can be bleached, thereby eliminating this potential 
influx. Blinking is the property of fluorescent molecules to be reactivated, which can also 
influence photobleaching results. By keeping experimental conditions similar in all conditions 
the influence of blinking is constant in all measurements and therefore insignificant. When 
comparing results obtained from different fluorescent variants, on the other hand, its needs 
to be taken into account that the blinking properties are different and therefore the amount 
of blinking needs to be determined for every variant and corrected for in the final analysis 
[63, 73].  
To overcome the problem of GFP-fusion protein overexpression and the (competitive) 
presence of the endogenous counterpart, a GFP knock-in strategy using mice can be utilized 
[74] (Jeroen Essers, personal communication). This method places the GFP-tag before the 
endogenous gene of interest in the mice genome, thereby being regulated by the endogenous 
promoter. As a result the expression levels of the GFP-fusion protein are identical to non-
targeted protein in wild type cells, resulting in better quantitative measurements. The 
behaviour of proteins can additionally be studied in different tissues and cell types under 
physiological conditions [75]. Performing a similar approach for proteins involved in the ATR-
Chk1 pathway may result in a more precise determination of the dynamic behaviour of this 
DNA damage checkpoint pathway. The ATR gene may act as a good candidate to start a GFP 
knock in approach, since it localizes to sites of damage and thereby becomes immobilized. 
Furthermore, ATR interacts with and phosphorylates a number of key target proteins. 
Conclusively, we show that the GFP-labelling of ATRIP, Chk1 and the 9-1-1 complex proteins 
results in functional equivalents that can be studied by live cell video microscopy and 
quantitative fluorescence photobleaching. We compared the mobility changes of GFP-
ATRIP, GFP-Chk1, GFP-Rad9, GFP-Rad1 and Hus1-GFP after UV-irradiation and collectively 
the results indicate a distinct dynamic behaviour between some of the studied proteins. 
Whereas effector kinase Chk1 is highly mobile and does not immobilize upon DNA damage, 
Rad9 and ATRIP stably associate to sites of DNA lesions. ATRIP directly binds to DNA lesions 
but more transiently than Rad9, which in contrast displays a more stable association with 
damaged chromatin. Together these data demonstrate the importance of spatio and 
temporal protein regulation in the DNA damage-induced ATR-Chk1 pathway. 
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Cell cycle-dependent localization of Rad9
ABSTRACT
The Rad9/Rad1/Hus1 complex functions to facilitate the ATR-mediated phosphorylation of 
several substrates that control the checkpoint arrest induced by DNA damage. Here we show 
that in response to genotoxic stress induced by different types of damaging agents, Rad9 
rapidly relocalized to sites of single stranded DNA, as visualized by discrete nuclear foci that 
co-localize with RPA. UV light-induced Rad9 foci also colocalized with TopBP1 and gH2AX. 
Interestingly, Rad9 foci were predominately formed in G1 and S phase after UV light, while 
treatment of cells with ionizing radiation (IR) resulted in accumulation of Rad9 into foci in S 
and G2. Photobleaching experiments in living cells revealed that the Rad9 protein is highly 
mobile in undamaged cells. However, genotoxic stress induced the immobilization of a large 
proportion of the protein. The proportion of Rad9 immobilization was larger in S phase 
and the accumulation to sites of locally damaged areas induced by UV-laser irradiation was 
faster during DNA replication. Inactivation of nucleotide excision repair by knock down of 
XPA and XPC resulted in a decrease of G1 phase cells that displayed Rad9 foci in response 
to UV light, whereas IR-induced Rad9 foci were not affected. In contrast, downregulation 
of CtIP, which promotes DSB resection, abrogated the IR-induced Rad9 foci. These findings 
show that due to processing of DNA lesions into a common intermediate, which occurs in a 





To maintain genomic stability, eukaryotic cells have developed DNA damage checkpoint and 
repair mechanisms, which help to ensure the transmission of an intact genome. The master 
regulators of the mammalian DNA damage response are ATM and ATR, members of the 
family of phosphoinositide 3-kinase like kinases. ATM and ATR respond to various genotoxic 
stresses by phosphorylating key proteins in the checkpoint pathway. ATM is the main kinase 
required for early responses to ionizing radiation (IR), such as phosphorylation of p53 and 
Chk2. ATR on the other hand, activates Chk1 in response to UV light-induced damage and 
stalled replication forks [1]. Chk1 subsequently phosphorylates a variety of substrates, 
thereby regulating different aspects of the DNA damage response such as cell cycle arrest, 
stabilization of stalled replication forks and DNA repair [2]. 
A number of other protein complexes facilitate the correct functioning of the checkpoint 
cascade initiated by ATM/ATR. Mediator proteins such as MDC1 and 53BP1 act in the 
recruitment of substrates or as scaffolds upon which complexes are assembled [3]. For the 
ATR-Chk1 pathway, loading of the Rad9/Rad/Hus1 (9-1-1) checkpoint clamp onto chromatin 
by the Rad17/RFC complex in response to DNA damage is required for phosphorylation of 
several substrates including Rad17 and Chk1 [4-6]. The recruitment of the 9-1-1 complex to 
sites of DNA lesions can additionally be visualized by the accumulation of Rad9 into nuclear 
foci. The requirement of the 9-1-1 complex in the ATR branch was explained by showing 
that Rad9 recruits the ATR-activator TopBP1 near sites of DNA damage [7-10]. Recent data 
demonstrate that the subsequent phosphorylation of Rad17 by ATR helps to retain Rad9 at 
sites of DNA damage, thereby maintaining checkpoint signalling [11].
Initially it was thought that ATM and its regulatory factors are responsible for checkpoint 
signalling in response to double strand breaks (DSBs) induced by IR, whereas ATR and the 
Rad17/9-1-1 complexes do not have a key function in the response to such lesions. Recent 
data however, demonstrate crosstalk between the ATM and ATR pathways and their regulating 
proteins. In response to IR, ATR activation and recruitment to sites of DNA damage depends 
on ATM [12, 13]. Rad17 associates with ATM upon IR treatment and under these conditions, 
Rad17 is phosphorylated in an ATM-dependent manner [4]. Furthermore, Rad9 deficient ES 
cells are not only sensitive to UV light and hydroxyurea, but also to IR [14]. Finally, Rad9 is 
phosphorylated in response to IR in an ATM-dependent manner and this phosphorylation is 
required for the IR-induced checkpoint arrest [15]. Together these data show that the ATR 
pathway and the 9-1-1 complex in particular, can respond to a wider variety of DNA lesions 
than originally anticipated, which raises the question, how checkpoint sensor proteins can 
detect such different types of lesions. An explanation comes from experiments showing that 
the proteins of the ATR pathway detect stretches of single stranded DNA (ssDNA) coated 
by RPA, which seems to function as a common intermediate that triggers the checkpoint 
[16, 17]. RPA-bound ssDNA is formed at stalled replication forks and several proteins have 
been implicated in the formation of RPA-coated ssDNA in response to different types of 
DNA lesions. Mre11 and CtIP are involved in nucleolytically processing DSBs to reveal ssDNA 
during S and G2 phases of the cell cycle upon IR treatment, thereby recruiting ATR to sites of 
DNA damage [13, 18]. How stretches of ssDNA are generated after UV light is still a matter 
of debate. Some reports suggest that the ATR pathway can be activated during nucleotide 
excision repair (NER) [19-21], whereas other studies propose that UV lesions are only 
processed during DNA replication [22].
Here we study the possible involvement of these and other factors in Rad9 localization to 
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sites of damage and show that Rad9 is able to respond to different types of genotoxic stress 




U2OS cells were grown using standard procedures. U2OS cells stably expressing EGFP-
HA-Rad9 (GFP-Rad9) were grown in standard medium supplemented with 700	 mg/ml of 
geneticin (G418). For stable expression of mCherry-PCNA, GFP-Rad9 expressing U2OS 
cells were transfected with mCherry-PCNA (kindly provided by A. Inagaki, Erasmus MC 
Rotterdam, The Netherlands) together with a pBabe puro plasmid. Positive clones were 
selected after a selection with 20 mg/ml of puromycin for one week. Thereafter, U2OS cells 
stably expressing GFP-Rad9 and mCherry-PCNA were grown in medium supplemented with 
geneticin and puromycin.
Antibodies
Antibodies obtained from commercial sources were as follows: Orc2 (BD Pharmingen), Grb2 
(BD Transduction), RPA (Ab2, Oncogene), Rad9 (Novus), gH2AX (Upstate), CtIP (Abcam). The 
following antibodies were obtained from Santa Cruz Biotechnology: CENP-F (H-260), Cyclin 
A (H-432), Cyclin B1 (GNS1), Ku86 (C-20) and XPA (FL-273).
Rabbit polyclonal anti-Rad9 and anti-TopBP1 have been described previously [23, 24]. 
Rabbit polyclonal EGFP antibody was raised against recombinant His-tagged EGFP full length 
protein.  Recombinant protein was obtained by cloning the cDNA corresponding in pET-28 
(Novagen) expressed in E. coli and soluble protein was purified and used to immunize.
Rabbit polyclonal anti-XPC was a gift from N. Wijgers and W. Vermeulen (Erasmus MC 
Rotterdam, The Netherlands).
Transfection
Plasmid DNA was transfected into cells using the calcium phosphate transfection method. 
siRNA oligonucleotides (Dharmacon Research) were transfected into cells using 
Oligofectamine (Invitrogen) according to the manufacturers instructions, and as previously 
described [11]. To downregulate CtIP, a mix of 2 different oligonucleotides was used. Cells 
were incubated for 72 hours after transfection prior to further analysis. Sequences of 
oligonucleotides were as follows: 
Luc (CGUACGCGGAAUACUUCGAdTdT), 




For immunostaining, cells were fixed in 2% paraformaldehyde containing 0.2% Triton X-100 
for 20 minutes and then permeabilized with 0.1% Triton X-100 for 5 minutes. Samples were 
blocked in 1% FCS and immunostained with antibodies as indicated. For detection of GFP-
Rad9 in U2OS cells, living cells were studied, or cells were fixed and permeabilized as above.
Cells containing >10 Rad9 foci were scored as positive. In all instances, error bars on 
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graphs represent the standard error of the mean (SEM) from at least three independent 
experiments.
Images were made using a Cell Observer fluorescent microscope equipped with Axiovision 
software (Zeiss) or a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 560 nm long pass filter. For strip-FRAP experiments 
and time lapse imaging after UV laser induction, GFP-Rad9 and mCherry-PCNA were detected 
in living cells using a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 575-615 nm band pass filter.
Cell fractionation and Western blotting
For whole cell extracts, cells were washed in cold PBS, after which the cells were resuspended 
in Laemmli sample buffer (4% SDS, 20% glycerol, 120 mM Tris pH 6.8). Protein concentrations 
were determined using the Lowry protein assay. Bromophenol blue and b-mercaptoethanol 
were added and samples were boiled for 5 minutes before loading.
Chromatin fractionation was performed as previously described [25].
Generation of DNA damage and photobleaching techniques
UV-irradiation was performed using a 254 nm UV-C lamp (Philips) at 20 J/m2 and cells were 
processed 1 hour post treatment. Cells were incubated with 5 mg/ml of aphidicolin (Sigma) 
for 20 hours prior to processing of samples. IR (10 Gy) was induced using a 137Cs source or a 
linear accelerator (LINAC) and cells were processed 2 hours after treatment. 
Local UV laser induction was performed as previously described [26]. In short, cells stably 
expressing GFP-Rad9 and mCherry-PCNA were grown on a 25 mm quartz coverslip. A small 
area inside the nucleus was exposed for ~1 second to a 2 mW pulsed (7.8 kHz) diode laser 
emitting at 266nm. Time-lapse images were made every minute immediately starting after 
local UV induction. The time course measurements were normalized to the plateau phase. 
Start of UV irradiation was defined as t=0. Assembly curves were normalized to 1 and 
processed as previously described [27].
In the FRAP experiments, a strip spanning the nucleus was photobleached for 20 milliseconds 
using an Ar-laser (488 nm) at 100% laser intensity, which irreversibly bleaches all GFP-Rad9 
molecules in that area. Subsequently, the redistribution of fluorescence in the strip was 
monitored taking confocal images every 20 milliseconds for a total of 24 seconds at low laser 
intensity to avoid further bleaching. The fluorescence before bleaching (I
t<0
) was set to 1 and 
the intensity immediately after bleaching (I
0
) was set to 0. The recovery of fluorescence was 
plotted against time.
RESULTS
Rad9 rapidly relocalizes to sites of DNA damage in response to genotoxic stress
Recently we reported that ATR and Rad17 collaborate in regulating the localization and 
maintenance of Rad9 to sites of DNA damage [11]. To gain insight into additional factors 
involved in the localization of Rad9 to sites of DNA lesions, we studied DNA damage-induced 
Rad9 focus formation in more detail, using previously described U2OS cells stably expressing 
Rad9 tagged with EGFP-HA [11]. As shown in Figure 1A, Rad9 is homogenously distributed 
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in the nucleus in unperturbed cells. In response to UV light, Rad9 rapidly relocalizes into 
discrete nuclear foci in the majority of the cells. These foci can be observed from 10 minutes 
up to 24 hours after irradiation of the cells (Figure 1A and data not shown). 
To determine the nature of the DNA lesions to which Rad9 localizes, we examined 
colocalization of GFP-Rad9 with several proteins involved in DNA damage checkpoint 
regulation by immunofluorescence. UV light-induced Rad9 foci colocalized with ssDNA-
binding protein RPA and ATR-activator TopBP1 (Figure 1B). Rad9 also formed nuclear foci 
in response to IR, which colocalized with RPA (Figure  1C), indicating that Rad9 is recruited 
to sites of ssDNA generated in response to DSBs. Interestingly, UV light-induced Rad9 foci 
displayed clear colocalization with the phosphorylated form of H2AX (gH2AX), an early 
marker of DNA damage [28]. In contrast, Rad9 and gH2AX form distinct, non-overlapping 
foci in response to IR (Figure  1D), demonstrating the complexity of lesions induced by this 
treatment. 
Recruitment of Rad9 to chromatin in response to DNA damage and replication stress leads 
to immobilization of the protein
In response to DNA damage, Rad9 is recruited to chromatin in a Rad17-dependent manner 
[6]. Upon fractionation of GFP-Rad9 expressing U2OS cells into a soluble and a chromatin-
enriched fraction, Rad9 was only present in the soluble fraction in unperturbed cells, but the 
protein was recruited to chromatin after treatment of the cells with UV light or aphidicolin, 
a DNA polymerase a inhibitor that blocks replication progression (Figure  2A). Interestingly, 
whereas GFP-Rad9 runs as multiple bands in the soluble fraction, which partially represents 
the constitutive phosphorylation of the protein (data not shown and refs. 24-26), in the 
chromatin-enriched fraction only the slow mobility form of GFP-Rad9 was detected. 
This phenomenon was also observed by others [6, 29] and indicates that only the higher 
phosphorylated form of Rad9 is able to bind to chromatin in response to genotoxic stress.  
To investigate the behaviour of Rad9 in response to DNA damage in living cells, we studied 
protein mobility in real time by fluorescence redistribution after photobleaching (FRAP). 
In this experiment, U2OS cells expressing GFP-Rad9 were left untreated, exposed to UV 
light or treated with aphidicolin. Subsequently, a narrow strip in the centre of the nucleus 
was photobleached, cells were followed in real time by video microscopy and the recovery 
of fluorescence within this region was monitored at low laser intensity (strip-FRAP). In 
undamaged cells, GFP fluorescence quickly recovered to ~85% of pre-bleach level, which 
was similar to free GFP in our experimental setup (data not shown), indicating that all GFP-
Rad9 molecules are highly mobile (Figure  2B). In contrast, treating the cells with UV light 
or aphidicolin resulted in the immobilization of a significant proportion of the protein, 
as demonstrated by recovery of fluorescence to only ~55% or ~70% of pre-bleach level, 
respectively, even when the measurement were performed over an extended period of time 
(Figure  2B and data not shown). Lowering the UV light dose from 20 J/m2 to 5 J/m2 did 
not change the amount of immobile Rad9 (data not shown), indicating that the fraction of 
immobilized Rad9 is saturated at a low dose of UV light-induced DNA damage. This suggests 
that the difference in immobile fraction of Rad9 induced by UV light and aphidicolin 
treatment is due to the different nature of DNA lesions induced rather than the amount of 
lesions. 
Next, we investigated the possibility that UV light-induced immobilization of Rad9 is 
influenced by the cell cycle phase in which the damage is detected. For this purpose, we 
generated U2OS cells stably expressing GFP-Rad9 and functional mCherry-PCNA (Figure 
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3A) [30]. Given that PCNA forms specific patterns of accumulation at different stages of S 
phase, [31, 32] we used subnuclear localization of PCNA to distinguish S phase cells from 
G1/G2 cells in asynchronously growing cultures. Interestingly, when performing strip-FRAP 
analysis for GFP-Rad9 after UV light treatment, we observed a clear difference between the 
proportion of immobilized Rad9 in S phase versus G1/G2 phase cells. Whereas UV light-
induced damage resulted in a significant proportion of immobilized protein in G1/G2 cells, 
the amount of immobile Rad9 was considerably larger when cells were exposed to UV light 
during DNA replication (Figure  2C). 
Finally, we determined whether the kinetics of GFP-Rad9 accumulation onto sites of DNA 
lesions was also influenced by the cell cycle phase by inducing DNA damage in subnuclear 
regions in living cells by low dose UVC (266 nm) laser irradiation, which induces only UV 
light-specific DNA photo-lesions [26]. As shown in Figure 2D, local UV-irradiation led to 
accumulation of GFP-Rad9 at the damaged area in living cells and maximum accumulation 
was reached around 17 minutes with t
1/2 
~500 seconds after damage induction during DNA 
replication. However, it took twice as long (36 minutes, t
1/2 
~1100 seconds) to reach maximal 
accumulation of GFP-Rad9 on locally damaged regions in cells in G1/G2 phase of the cell 
cycle, demonstrating that recruitment of Rad9 to sites of damage under such conditions is 
considerably slower. The time-lapse images of individual cells additionally showed faster 
accumulation of GFP-Rad9 to the locally irradiated area in the S phase cell as compared 
to the cell in G1/G2 phase of the cell cycle. The images also show that in S phase, most of 
GFP-Rad9 was translocated to the damaged area whereas outside S phase, part of GFP-
Rad9 remained distributed throughout the nucleus, also at later time points (Figure  2D, left 
panel), confirming the higher level of immobilization of Rad9 to sites of DNA damage during 
S phase.
DNA lesion-specific focus formation of Rad9 during the cell cycle
While studying GFP-Rad9 focus formation in the cells that also stably expressed mCherry-
PCNA a few aspects of Rad9 localization caught our attention. First, unlike PCNA [31, 32]. 
Rad9 did not relocalize into foci during DNA replication, but instead, was equally distributed 
over the nucleus throughout the cell cycle in unperturbed cells (Figure  3A). Second, Rad9 
foci in response to UV light were localized either throughout the nucleus, or situated at 
the nuclear periphery, thereby partially overlapping with PCNA (Figure  3A, B and data not 
shown). Finally, Rad9 did not only form UV light-induced foci during S phase (Figure  3A), 
but also in G1 phase cells. This was confirmed when the levels of Cyclin A were monitored in 
GFP-Rad9 cells (Figure  3B). Cyclin A is expressed in increasing levels during S and G2 phases 
of the cell cycle and can therefore be used to distinguish between cell cycle phases in an 
asynchronous culture [13].
To investigate the pattern of Rad9 foci in more detail, we treated cells with aphidicolin or UV 
light and analyzed GFP-Rad9 foci in S phase cells by selecting cells with intermediate Cyclin 
A levels. Treatment with aphidicolin resulted in the arrest of all cells at the beginning of S 
phase (data not shown) and 80% of these cells had Rad9 foci that localize throughout the 
nucleus (Figure  3C). One hour after exposing the cells to UV light, cells were still equally 
distributed over the different phases of the cell cycle (data not shown). Most of the cells 
that were exposed to UV light during S phase displayed Rad9 foci, which were located either 
throughout the nucleus or at the nuclear periphery (Figure  3C). Together these results 
indicate that Rad9 foci at the nuclear border are formed at mid- or late S phase, which, 
given the resemblance and overlap with PCNA replication foci during mid-S phase [31, 
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32], suggests that upon exposure to UV light during DNA replication, the 9-1-1 complex 
relocalizes to sites of stalled replication forks.
Interestingly, in addition to S phase cells, a significant proportion of G1 cells displayed UV-
induced GFP-Rad9 foci, whereas the amount of foci observed in G2 phase was lower (Figure 
3D). In contrast, the majority of the Rad9 foci in response to IR were present in S and G2 
phase cells (Figure  3D). This result of DNA lesion-specific regulation of Rad9 focus formation 
Figure 1: Rad9 rapidly accumulates into nuclear foci in response to genotoxic stress. (A) U2OS cells ex-
pressing GFP-Rad9 were treated with UV light. At the indicated time points, cells were fixed and analyzed 
for fluorescence. (B) GFP-Rad9 expressing U2OS cells were left untreated or exposed to UV light. GFP-
Rad9 was detected by direct fluorescence and RPA34 and TopBP1 by immunofluorescence. (C) GFP-Rad9 
expressing U2OS cells were left untreated or treated with IR. GFP-Rad9 was detected by direct fluores-
cence and RPA34 by immunofluorescence. (D) GFP-Rad9 expressing U2OS cells were left untreated or 
exposed to UV or IR. GFP-Rad9 was detected by direct fluorescence and gH2AX by immunofluorescence.
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during the cell cycle was confirmed using CENP-F as a marker for S and G2 phases of the cell 
cycle in GFP-Rad9 expressing cells (Figure  3E) or by examining the distribution of endogenous 
Rad9 in response to UV light or IR throughout the cell cycle, in which cytoplasmic Cyclin B1 
was used as a marker for G2 phase (Figure  3F). Both experiments showed that in response 
to UV light, Rad9 predominantly forms foci in S and G1, while IR-induced focus formation 
occurs in S and G2 phase cells. Together these data indicate that the localization of Rad9 to 
sites of DNA damage is cell cycle-regulated.
DNA-damage induced focus formation of Rad9 depends on processing of DNA lesions
The ATR pathway is thought to respond to a diverse range of DNA lesions through the 
generation of RPA-coated ssDNA as a common intermediate [17]. For example, processing 
of DSBs into ssDNA in S and G2 phases of the cell cycle leads to ATR-dependent checkpoint 
signalling. Mre11/CtIP have recently been implicated in facilitating such DNA end resection 
[13, 18]. In addition, some studies propose that processing of UV light-induced lesions 
during DNA replication is sufficient to trigger ATR activation, [22] whereas other reports 
suggest that instead, the ATR pathway can be activated during NER [19-21]. 
To determine whether processing of DNA lesions contributes to the recruitment of Rad9 to 
sites of damage, we downregulated XPC, XPA and CtIP by siRNA in cells expressing GFP-Rad9. 
XPC and XPA are involved in the early steps of damage recognition after UV light exposure 
and facilitate the assembly of additional factors in NER [33]. CtIP is specifically involved 
in the processing of DSBs. The efficiency of the downregulations is shown in Figure 4A. 
Downregulation of both XPA and XPC resulted in the decrease from 63% to 38% of cells that 
displayed UV-induced Rad9 foci compared to cells transfected with control oligos, whereas 
it has no effect on Rad9 focus formation upon exposure to IR (Figure  4B). In contrast, knock 
down of CtIP did not affect the formation of GFP-Rad9 foci in response to UV light, but 
almost completely abrogated (58% to 16%) the recruitment of Rad9 to sites of damage 
when cells were exposed to IR (Figure  4B). 
As inactivation of NER by the downregulation of XPA or XPC only partially affected the 
UV-induced focus formation of Rad9, we wondered whether the contribution of the NER 
machinery to the recruitment of Rad9 to sites of genotoxic stress was restricted to a certain 
phase of the cell cycle. To investigate this possibility, we scored GFP-Rad9 foci in each of 
the cell cycle phases after knock down of XPA and XPC. Interestingly, inactivation of NER 
predominantly affected UV-induced focus formation in G1 phase cells, but had a smaller 
effect during DNA replication (Figure  4C). This differential effect was most obvious with XPC, 
when focus formation in G1 drops from 68% in control cells to 19% in XPC downregulated 
cells, while knock down of XPC did not have a significant effect on the amount of GFP-Rad9 
foci in S phase (Figure  4C). As the amount of Rad9 foci in G2 was very low, we could not 
draw conclusions about the involvement of NER in Rad9 focus formation in this phase.
Scoring IR-induced GFP-Rad9 foci throughout the cell cycle after downregulation of CtIP 
showed that the loss of CtIP resulted in a dramatic decrease in Rad9 foci during all cell cycle 
phases (Figure  4D). Together these results indicate that recruitment of Rad9 to sites of DNA 
damage is partially controlled by processing of UV light-induced lesions by NER or during 
DNA replication. In contrast, focus formation of Rad9 in response to IR during S and G2 
phase depends on CtIP-mediated resection of DSBs.
92
Cell cycle-dependent localization of Rad9
DISCUSSION
Accumulating evidence suggests that the ATR pathway is responsible for activating a cell 
cycle checkpoint upon a variety of DNA lesions, but how exactly the sensor proteins in 
this pathway can recognize these lesions is not clear. Here we show that putative sensor 
protein Rad9 is able to respond to different types of genotoxic stress, including IR (Figure  1). 
Recently, IR-induced phosphorylation of effector kinase Chk1 was shown to be dependent 
on both ATM and ATR and in addition, ATM was shown to be required for IR-induced focus 
formation of ATR [12, 13]. Our data demonstrating Rad9 focus formation in response to 
IR is in accordance with the fact that the ATR pathway responds to these type of lesions. 
Interestingly, the cell cycle phase in which Rad9 relocalizes to sites of damage depends on 
the type of DNA lesion. Using Cyclin A, Cyclin B1 and CENP-F as markers of different phases in 
the cell cycle, both endogenous Rad9 and GFP-Rad9 were shown to accumulate into nuclear 
foci in S and G2 phase in response to IR treatment. Strikingly, Rad9 foci predominantly 
appear in G1 and S phase cells after exposure to UV light, whereas we only observe a small 
amount of such foci in G2 cells (Figure  3). A possible explanation for this observation is 
that the recognition of UV light-induced lesions is not very efficient in G2, and instead, such 
lesions are predominantly repaired during the G1 or S phase of the next cell cycle.
Our data studying the dynamic behaviour of GFP-Rad9 by live-cell imaging show that a 
significant proportion of Rad9 is immobilized in response to DNA damage, and the fraction 
of immobile Rad9 is highest upon UV light damage in S phase cells (Figure  2C). In addition, 
the recruitment of GFP-Rad9 to sites of UV lesions in living cells is much faster when cells are 
in S phase at the time of damage induction (Figure  2D). Together these data indicate that 
the 9-1-1 complex is more vigilant when cells are undergoing DNA replication.
UV light produces pyrimidine dimers and other photoproducts, which are basically bulky 
adducts that can lead to replication fork stalling. Rad9 foci in S phase cells display several 
patterns, either equally distributed throughout the nucleus or situated at the nuclear 
periphery (Figure  3A). A similar foci pattern is seen for TopBP1 (Figure  1B), which activates 
ATR near sites of damage by interaction with Rad9 [7]. Given the resemblance and partial 
colocalization of these foci with replication foci marked by PCNA [31, 32] this indicates that 
the 9-1-1 complex localizes to sites of stalled replication forks in response UV light and 
suggests that 9-1-1 acts as sensor of DNA damage during replication.
Although UV-induced ATR activation was reported to require replication stress [22]. others 
have shown that Rad9 binds chromatin after damage in a G1-enriched cell population [34]. 
In agreement with this, we observe Rad9 foci after exposure to UV light in a proportion of 
G1 cells (Figure  3), which demonstrates that processing of UV light lesions per se and not 
just UV light lesions that result in a block in replication fork progression, trigger a response 
by the 9-1-1 complex. However, UV light-induced Rad9 relocalization does seem to be cell 
cycle regulated, as we observe little cells with foci in G2 (Figure  3). 
As the ATR pathway is triggered by a broad spectrum of DNA lesions, the ATR kinase is thought 
to sense a common DNA intermediate. The principle DNA architecture recognized by ATR is 
ssDNA coated by the ssDNA protein binding complex RPA. RPA-coated ssDNA facilitates the 
recruitment of ATR to sites of damage through an interaction with ATR-associated protein 
ATRIP [16, 17]. Even though RPA-coated ssDNA induced phosphorylation of Rad17 by the 
ATR-ATRIP complex in vitro, [17] it seems likely that RPA and ssDNA additionally facilitate 
activation of ATR in other ways, for example by the recruitment of other checkpoint 
proteins. The observed co-localization of Rad9 with RPA in response to UV light and IR 
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(Figure  1B and C) is in accordance with this idea, which is supported by biochemical data 
showing that the 9-1-1 complex is loaded onto DNA in an RPA-dependent manner in vitro, 
[35] and interaction studies of Rad9 and RPA in mammalian cells [36, 37]. In addition, RPA 
bound to ssDNA replication intermediates during unperturbed replication might enhance 
the efficiency of recognition of genotoxic stress by sensor proteins, which could explain the 
Figure 2: Genotoxic stress-induced chromatin binding of Rad9 leads to immobilization of the protein. 
(A) GFP-Rad9 expressing cells were left untreated or exposed to UV or aphidicolin, after which cells 
were fractionated as described in materials and methods. Soluble and chromatin fractions were ana-
lyzed using the indicated antibodies. (B) GFP-Rad9 expressing cells were left untreated or exposed to 
UV light or aphidicolin. A small strip of the nucleus was bleached for 20 milliseconds at 100% laser 
intensity, after which redistribution of fluorescence was monitored every 20 milliseconds. (C) Cells 
expressing GFP-Rad9 and mCherry-PCNA were left untreated or treated with UV light. Then FRAP 
analysis was performed for GFP-Rad9 as in (B). Cells were divided into the group of S or G1/G2 phase 
cells based on the mCherry-PCNA pattern. (D) A small area of the nucleus of cells expressing GFP-
Rad9 and mCherry-PCNA was exposed to UV light using a 266 nm laser for ~1 second, after which 
the fluorescence was monitored by recording images every 60 seconds. Note that fluorescence at 
time of irradiation was normalized to 0 and steady-state level to 1 (right panel) for individual mea-
surements. Nuclear distribution patterns of PCNA were used to determine the cell cycle phase.
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Figure 3: DNA damage-induced focus formation of Rad9 during different phases of the cell cycle. (A) 
U2OS cells expressing GFP-Rad9 and mCherry-PCNA were left untreated or treated with UV light. 
One hour later, cells were fixed and analyzed by direct fluorescence. Note that PCNA localizes into 
subnuclear foci during S phase. (B) GFP-Rad9 expressing cells were left untreated or exposed to UV 
light. One hour later, cells were fixed. GFP-Rad9 was detected by direct fluorescence and Cyclin A by 
immunofluorescence. Cells without Cyclin A are in G1 phase, cells with intermediate levels of Cy-
clin A in S (asterisk) and G2 phase cells display high Cyclin A levels (arrow). (C) GFP-Rad9 express-
ing cells were treated with UV light or aphidicolin.  After fixing the cells, GFP-Rad9 was detected by 
direct fluorescence and Cyclin A by immunofluorescence. Only S phase cells were scored, depend-
ing on Cyclin A levels, and the total number of S phase cells was set to 100%. Shown is the per-
centage of cells with >10 GFP-Rad9 accumulations, either distributed throughout the nucleus (‘dis-
persed foci’) or localized at the nuclear periphery (‘peripheral foci’). Error bars represent the SEM 
of three independent experiments. (D) GFP-Rad9 expressing cells were exposed to UV light or IR. 
After fixing the cells, GFP-Rad9 was detected by direct fluorescence and Cyclin A by immunofluo-
rescence. Cell cycle phase was judged on levels of Cyclin A and the total number of cells in each 
phase was set to 100%. (E). As in (D), but with staining for CENP-F instead of Cyclin A. (F). U2OS 
cells were left untreated or treated with UV light or IR. After fixing the cells, endogenous Rad9 and 
Cyclin B1 were analyzed after immunostaining. Arrows point to G2 cells that express Cyclin B1.
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Figure 4: Rad9 focus formation is dependent on processing of DNA lesions. (A) U2OS cells express-
ing GFP-Rad9 were transfected with luciferase (Luc), XPA, XPC or CtIP siRNA oligonucleotides. Sev-
enty two hours after transfection, cells were lysed and western blot analysis was performed with 
the indicated antibodies. (B) Cells were transfected as in (A). After 72 hours, cells were left untreat-
ed or exposed to UV light or IR. GFP-Rad9 foci were detected by direct fluorescence. Shown is the 
percentage of cells with >10 GFP-Rad9 foci with error bars representing the SEM of at least three 
independent experiments. Total number of cells in each cell cycle phase was set to 100%. (C) GFP-
Rad9 expressing cells were transfected with luciferase, XPA or XPC siRNA oligos. Cells were treated 
with UV light, fixed and stained for Cyclin A. Cell cycle phase was determined on Cyclin A levels and 
foci were quantified as in (B). (D) GFP-Rad9 expressing cells were transfected with luciferase or CtIP 
siRNA oligos. After 72 hours, cells were exposed to IR and further treated as described as in (C).
observed faster accumulation of Rad9 to sites of damage during S phase (Figure  2D). 
RPA-coated ssDNA is generated by uncoupling of the replicative helicase from stalled 
replication forks [38] but is also formed during the repair of DNA lesions. During NER for 
example, lesion processing involves base excision of the damaged DNA resulting in an ssDNA 
gap intermediate [33]. However, conflicting results have been reported for the involvement 
of NER in checkpoint activation. Whereas some suggested that UV light-induced ATR 
activation only requires replication stress, [22] others implied the involvement of NER in 
triggering ATR checkpoint signalling, either during replication [21] or outside S phase [19, 
39]. Our data demonstrate that upon downregulation of XPA and XPC, proteins involved 
in early stages of NER, UV light-induced Rad9 focus formation is decreased (Figure  4B), 
indicating that processing of UV light lesions during NER indeed generates a signal that 
is recognized by Rad9. NER has an important role during G1, although its activity is not 
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thought to be restricted to this phase of the cell cycle [40]. Indeed, focus formation in G1 
was more affected than in S phase cells, mainly after knockdown of XPC (Figure  4C), which 
could explain why UV-induced focus formation of Rad9 is not completely abrogated in an 
asynchronous population, even though downregulation of XPA and XPC was quite efficient 
(Figure  4A). Our results suggest a model that could explain the apparently contradictory 
results, in which a fail-safe mechanism ensures triggering the ATR pathway in several ways: 
RPA-coated ssDNA can be generated during the repair of UV light-induced damage by NER 
but also when replication forks encounter UV light lesions. Consequently, NER plays a more 
important role in this process outside S phase. In contrast, resection of DSBs into ssDNA, 
which, after the subsequent coating by RPA enhances ATR recruitment, is promoted by CtIP 
[18]. Our data demonstrate that CtIP also facilitates the recruitment of the 9-1-1 complex 
to sites of damage upon the induction of DSBs, as downregulation of CtIP protein levels 
abrogate IR-, but not UV-induced Rad9 foci (Figure  4B). As for ATR, CtIP is required for Rad9 
recruitment in both S and G2 phases of the cell cycle (Figure  4D). Together these results 
indicate that each type of DNA lesion is processed into an intermediate DNA structure, by a 
different cellular process.
Here we show that the response of checkpoint protein Rad9 is cell cycle-regulated. Even 
though Rad9 can localize to sites of DNA lesions throughout the cell cycle, the immobilization 
is larger and the accumulation faster when cells are undergoing replication. Our data 
demonstrate that proteins involved in NER and processing of DNA DSB lesions are required 
for localization of Rad9 to sites of damage, most likely by the generation of RPA-coated 
ssDNA, which makes this the first report investigating factors outside the ATR checkpoint 
pathway that are involved in the localization of Rad9 to sites of damage and shows that DNA 
repair mechanisms and checkpoint signalling are interconnected. Concomitant localization 
of ATR and the 9-1-1 complex at sites of DNA damage leads to the recruitment of ATR-
activating protein TopBP1 by Rad9, [7, 10] thereby ensuring full activation of the ATR 
pathway and downstream checkpoint response.
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Genotoxic stress activates DNA damage checkpoints that cause a delay at multiple points 
during the cell cycle. The highly conserved G2 checkpoint is the last critical barrier before 
the physical separation of the cell into two daughter cells and prevents cells with DNA 
damage from entering mitosis. The ATR tranducer kinase is activated after the generation 
of single-stranded DNA intermediates that are formed in response to ultra violet light and 
replication types of DNA damage, and was thought to play an important role in the UV-
induced G2 checkpoint. However, upon UV irradiation, Rad9, a component of the ATR-Chk1 
pathway, localizes to sites of damage in G1 and S phase cells but not in G2 cells, unlike 
G2 cells treated with ionizing radiation. We set out to investigate why UV-induced DNA 
damage does not result in Rad9 focus formation in G2 cells and what are the implications 
of this observation. Like Rad9, RPA also does not localize to sites of DNA lesions in UV 
irradiated G2 cells, suggesting that single-stranded DNA intermediates are not generated or 
recognized properly. Further analysis of UV-treated G2 cells indicate that PIKK-dependent 
DNA damage signalling does not occur. On the contrary, the p38 MAP kinase, a protein 
involved in the checkpoint response, is phosphorylated in G2 phase cells after UV damage. 
PIKK-dependent signalling is dispensable for the UV-induced cell cycle arrest in G2 cells, 
unlike p38, which is partially responsible for the UV-induced G2 cell cycle arrest. However, 
the combined inhibition of the PIKK- and p38-dependent checkpoint pathways results in a 
complete abrogation of the G2/M cell cycle arrest after UV-irradiation, suggesting that these 





In response to genotoxic stress eukaryotic cells activate DNA damage checkpoint and repair 
pathways that ensure an intact transmission of the DNA into the next cell cycle phase [1-
3].  Inefficient repair of DNA lesions leads to genomic instability, a source of cancer [4]. 
Exogenous DNA damaging agents cause different types of DNA alterations that will lead 
to activation of specific DNA repair and checkpoint mechanisms [5, 6]. The ATM and 
ATR kinases, members of the phosphatidyl inositol 3’ kinase-related (PIKK) kinases, are 
the master regulators of the DNA damage-induced checkpoint response [7]. In response 
to double-stranded breaks (DSBs) ATM is activated leading to the phosphorylation and 
subsequent activation of effector kinase Chk2 [8]. In response to genotoxic stress induced 
by replication fork stalling, ultra violet (UV) damage and after the resection of DSBs, the ATR 
kinase is activated [9-12].
The single-stranded DNA (ssDNA) intermediates that are formed after these types of DNA 
damage are coated rapidly by RPA [13]. Thereafter, the Rad17-RFC and ATRIP-ATR complexes 
are independently recruited to sites of RPA-coated ssDNA and Rad17-RFC(2-4) then loads 
the Rad9-Rad1-Hus1 (9-1-1) PCNA-like sliding clamp onto chromatin [14-16]. Subsequently, 
TopBP1 binds to the C-terminus of Rad9 and activates ATR [17, 18]. An active ATR kinase 
phosphorylates a number of protein including the effector kinase Chk1, which results into a 
temporal halt of the cell cycle to gain time for DNA repair [7]. 
The recruitment of proteins to sites of DNA damage can be observed as the localization of 
these proteins into nuclear foci. Artificial localization of the Mec1 and Ddc1, the S. cerevisiae 
equivalents of ATR and Rad9 is enough to trigger a checkpoint response in the absence of 
DNA damage [19]. This suggests that ATR activation and subsequent checkpoint triggering 
is dependent on the close proximity of these two complexes. We previously reported that 
in response to DNA damage mammalian Rad9 localizes to sites of damage in a cell cycle-
dependent manner, depending on the type of DNA lesion. In response to ionizing radiation 
(IR), Rad9 localizes into foci in S and G2 cells [12, 20, 21], whereas UV light induces Rad9 foci 
in G1 and S phase cells [22]. Interestingly, UV-induced Rad9 focus formation does not occur 
in G2 cells [22]. We were interested in why Rad9 does not localize to sites of UV damage 
in G2 cells and what the implications are for checkpoint activation. Therefore we analyzed 
the nuclear localization of different DNA damage response proteins in G2 cells upon UV-
irradiation. We show that PIKK kinase-mediated signalling is dispensable for UV-induced 
damage signalling and subsequent cell cycle arrest in G2 cells, probably because RPA-coated 
ssDNA intermediates are not formed. Conversely, we show that the p38 MAP kinase is 
activated in G2 cells in response UV irradiation, and (partially) required to prevent cells 
from entering mitosis. Interestingly, combined inhibition of PIKK and p38 kinases leads to a 
complete loss of the UV-induced G2 checkpoint arrest suggesting that ATM/ATR might act 
redundantly in the absence of p38 and thereby functioning in parallel to the p38 pathway. 
Collectively these results suggest that checkpoint activation in G2 after UV-induced DNA 





U2OS, HeLa and T24 cells were grown using standard procedures. U2OS cells stably 
expressing eGFP-HA
2
-Rad9 (GFP-Rad9) were grown in standard medium supplemented with 
700 mg/ml G418. For stable expression of Cyclin B-mCherry, GFP-Rad9 expressing U2OS cells 
were transfected with Cyclin B-mCherry (kindly provided by R. Wolthuis, NKI, Amsterdam, 
The Netherlands) together with a pBabepuro plasmid. Positive clones were picked after a 
selection with 20 mg/ml of puromycin for two weeks. Thereafter, stable clones expressing 
GFP-Rad9 and Cyclin B-mCherry were grown in medium supplemented with G418 and 
puromycin.
Transfection and plasmids
Plasmid DNA was transfected into cells using the calcium phosphate transfection method. 
pCI neo Flag-Chk1 wt and S317A/S345A were a kind gift from Jiri Bartek (Institute of Cancer 
Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, Copenhagen, 
Denmark).
Cell synchronization 
To synchronize T24 cells in G0, cells were kept confluent for 5 days, changing the medium 
every day. Cells were released from the arrest by trypsinization and replating in low dilutions 
and then fixed at the indicated time points. 
Antibodies and inhibitors
Antibodies obtained from commercial sources were as following: RPA (Ab2, Oncogene), 
Flag (Sigma), MPM2, gH2AX and pATM (Upstate Biotechnology), 53BP1, SMC1, pS1083 
SMC3 (Bethyl), pThr180/Tyr182 p38, pS317 and pS345 Chk1 (Cell Signaling), the following 
antibodies were obtained from Santa Cruz Biotechnology: Cyclin A (H-432), Cyclin B1 (GNS1), 
Ku86 (C-20), p38 (C-20), Cdc25A (F-6) and Chk1 (G-4).
Caffeine (Sigma), p38 inhibitor BIRB 796 (Axon Medchem) and Chk1 inhibitor SB 218078 
(Calbiochem) were administrated 30 minutes before UV treatment and directly after the 
treatment the medium including the inhibitors was added back to the cells.
G2 checkpoint assay
U2OS cells were UV- or mock-irradiated with 20 J/m2 and incubated for 1 hr at 37°C. 
Subsequently, they were collected by trypsinization and fixed in 70% ethanol overnight at 
4°C. After fixation, cells were washed with PBS and incubated with MPM2 antibody for 1 hr 
at 4°C. After washing with PBS, cells were incubated with a Cy5-labeled secondary antibody 
(Jackson Immunoresearch) for 30 min at 4°C, followed by staining the DNA with propidium 
iodide (PI). MPM2 and PI staining were analyzed by flow cytometry with FACSCaliber and 
CellQuest Pro software (Becton Dickinson). 
Unscheduled DNA synthesis (UDS) assay
The UDS assay was performed as described previously [23]. Briefly, U2OS cells were untreated 
or UV-irradiated with 16 J/m2 and then incubated in medium containing EdU (5-ethynyl-2’-
deoxyuridine) for 1 hour before fixation with PFA. EdU incorporation was visualized using 




For immunostaining, cells were fixed in 2% paraformaldehyde containing 0.2% Triton X-100 
for 20 minutes at RT and then permeabilized with 0.1% Triton X-100 for 5 minutes. Samples 
were blocked in 1% FCS and immunostained with antibodies as indicated. For detection of 
GFP-Rad9 or Cyclin B-mCherry in U2OS cells, living cells were studied, or cells were fixed and 
permeabilized as above.
In all instances, error bars on graphs represent the standard error of the mean of three 
independent experiments.
Images were made using a Cell Observer fluorescent microscope equipped with Axiovision 
software (Zeiss) or a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 560 nm long pass filter. For strip-FRAP experiments and 
time lapse imaging after UV laser induction, GFP-Rad9 and Cyclin B-mCherry were detected 
in living cells using a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 575-615 nm band pass filter.
Generation of DNA damage and photobleaching techniques
UV-irradiation was performed using a 254 nm UV-C lamp (Philips) at 20 J/m2 and cells were 
processed 1 hour post treatment. IR (10 Gy) was induced using a 137Cs source or a linear 
accelerator (LINAC) and cells were processed 1 or 2 hours after treatment. 
In the FRAP experiments, a strip spanning the nucleus was photobleached for 20 milliseconds 
using an Ar-laser (488 nm) at 100% laser intensity, which irreversibly bleaches all GFP 
molecules in that area. Subsequently, the redistribution of fluorescence in the strip was 
monitored taking confocal images every 20 milliseconds for a total of 25 seconds at low laser 
intensity to avoid further bleaching. The fluorescence before bleaching (I
t<0
) was set to 1 and 
the intensity immediately after bleaching (I
0
) was set to 0. The recovery of fluorescence was 
plotted against time.
RESULTS
Less RPA focus formation and Rad9 immobilization after UV damage in G2
We previously reported that in response to DNA damage Rad9, a component of the Rad9-
Rad1-Hus1 putative DNA damage sensor complex, localizes to sites of damage in a cell cycle-
dependent manner [22]. Rad9 localization after DNA damage is dependent on the formation 
of RPA-coated ssDNA intermediates that are generated after many types of genotoxic stress 
including UV light and IR [16]. Therefore we investigated if RPA localizes to sites of UV-
induced damage in G2 cells and determined RPA focus formation together with a Cyclin 
A immunofluorescence staining (Figure 1A). Cyclin A protein levels increase from S to G2 
phase enabling us to discriminate all phases of the cell cycle [12, 22]. RPA localized into foci 
in S and G2 cells after IR, whereas UV-treatment induced RPA focus formation in G1 and S, 
but much less in G2 phase cells. These results suggest that RPA-coated ssDNA intermediates 
are not formed in UV-irradiated G2 cells. 
The most common UV-induced DNA lesions are 6-4 photoproducts and cyclobutane 
pyrimidine dimers that are mainly repaired by nucleotide-excision repair (NER). ATR-
dependent checkpoint activation after UV in G1 phase is (partially) dependent on NER 
106
UV-induced G2 arrest
Figure 1: Cell cycle-dependent RPA focus formation and Rad9 immobilization (A) U2OS cells were un-
treated or treated with IR (10 Gy) or UV (20 J/m2). Two or one hour later, respectively. cells were 
fixed and stained using immunofluorescence with antibodies against RPA and Cyclin A. Cells without 
Cyclin A are in G1 phase, with intermediate levels in S and G2 phase cells display high Cyclin A levels 
(arrow). Right panel: the percentage of cells with RPA foci in the different phases of the cell cycle. 
(B) U2OS cells were incubated with nucleotide analogue EdU as describe in materials and methods. 
Cells were left untreated or UV-irradiated, fixed after one hour and stained using immunofluorescence 
with the indicated antibodies. G2 cells are indicated with an arrow. (C) U2OS cells stably express-
ing GFP-Rad9 and Cyclin B-mCherry were transiently transfected with CFP-PCNA and 48 hours later 
UV-irradiated, fixed after one hour and analyzed by direct immunofluorescence. The arrow indicates 
centrometric Cyclin B-mCherry. (D) Time-lapse analysis of stable GFP-Rad9 and Cyclin B-mCherry ex-
pressing cells, indicating that during G2, Cyclin B-mCherry localizes into centromeres. Cells express-
ing GFP-Rad9 and Cyclin B-mCherry were left untreated or treated with UV light. Then FRAP anal-
ysis was performed. Briefly, a small strip of the nucleus was bleached for 20 msec. at 100% laser 
intensity, after which redistribution of fluorescence was monitored every 20 msec. Cells were divided 
into the group of G1/S or G2 phase cells based on the presence of centromeric Cyclin B-mCherry. 
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[22, 24, 25]. NER is most probably required for the formation of small ssDNA gaps that can 
trigger ATR-mediated checkpoint activation. We investigated if NER is cell cycle regulated, 
which could explain why we observe less RPA focus formation in G2 cells after UV irradiation. 
UV-treated cells were incubated with nucleotide analogue EdU, which is incorporated in 
newly synthesized DNA in S phase and during NER [23]. The cell cycle phase was determined 
by staining with antibodies for Cyclin A or Cyclin B. The latter localizes in the cytoplasm 
during G2 phase and can therefore be used as a marker for G2 cells. In untreated cells 
EdU incorporation was only present in replicating cells, whereas after UV irradiation EdU 
Figure 2: UV-induced ATR-mediated checkpoint activation is absent in G2 cells (A) U2OS cells were 
untreated or exposed to IR (10 Gy) or UV (20 J/m2), fixed two or one hour later respectively and 
analyzed by immunofluorescence with the indicated antibodies. G2 cells are indicated with an ar-
row. (B) As performed in (A) but with HeLa cells. (C) U2OS cells were treated with different doses 
of UV light (5, 20, 40 J/m2) and fixed one hour later. Shown is the percentage of Cyclin B-positive 
cells that were either negative or positive for phosphorylated Ser317 Chk1. Total number of cells 
in each cell cycle phase was set to 100%. (D) Similar as in (C) but now after one and three hours 
of UV (20 J/m2). (E) U2OS cells were transfected with wild type or S317A/S345A Flag-labelled 
Chk1. 48 hours after transfection cells were UV-treated, fixed one hour later and analyzed by im-
munofluorescence using the indicated antibodies. (F) As performed in (E), shown is the percent-
age of Flag-positive cells that were either negative or positive for phosphorylated Ser317 Chk1.
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incorporation was also present in G1 and G2 cells indicating that NER is active during all cell 
cycle phases (Figure 1B). This indicates that in G2 cells NER is proficient but is not sufficient 
for the formation of extended RPA-coated ssDNA intermediates that trigger ATR signalling. 
In response to UV damage GFP-Rad9 is recruited to sites of damage seen as the formation of 
nuclear foci and thereby GFP-Rad9 becomes immobilized on the chromatin [26]. GFP-Rad9 
immobilization is transient since there is a constant turnover of GFP-Rad9 molecules into 
DNA damage-induced GFP-Rad9 foci, which makes these foci highly dynamic structures [22]. 
To specifically address GFP-Rad9 focus formation and its subsequent immobilization in G2 
cells, we generated a cell line stably expressing GFP-Rad9 together with Cyclin B-mCherry 
(Figure 1C). During S and G2, Cyclin B-mCherry protein levels rise and Cyclin B localizes in 
the cytoplasm. Shortly before mitosis Cyclin B1 appears on centrosomes seen as one or 
two nuclear spots [27, 28] (Figure 1C and 1D left panel). We transiently co-expressed a CFP-
labelled version of PCNA to determine GFP-Rad9 focus formation and centromeric Cyclin 
B1-mCherry after UV-irradiation in all three cell cycle phases. As shown in Figure 1C, cells 
with centromeric Cyclin B-mCherry do not show CFP-PCNA foci indicating these cells are in 
G2. 
GFP-Rad9 immobilization was determined by Fluorescent Recovery After Photobleaching 
(FRAP) in cells co-expressing Cyclin B-mCherry [29]. GFP-Rad9 showed a 20-30% 
immobilization of GFP-Rad9 after UV damage in G1 and S-phase cells. In contrast, UV-treated 
G2 cells did not show any immobilized GFP-Rad9 as the recovery of fluorescence was similar 
to untreated cells (Figure 1D). Additionally, time-lapse video microscopy of UV-treated 
cells did not show formation of GFP-Rad9 foci in G2 cells over a 24 hour period (data not 
shown). Collectively these experiments suggest that during G2, GFP-Rad9 does not become 
immobilized by UV-induced DNA damage, possibly due to the absence of RPA-coated ssDNA 
intermediates that are long enough to elicit a checkpoint response [30].
UV-induced ATR-mediated Chk1 phosphorylation is absent in G2 cells
The observed decreased RPA focus formation and the high mobility of Rad9 after UV damage 
in G2 cells prompted us to study the consequences for ATR-mediated checkpoint signalling. 
We therefore investigated the phosphorylation of effector kinase Chk1 after UV and IR-
treatment by immunofluorescence. G2 cells were identified by staining for endogenous 
Cyclin B1. In response to UV damage in U2OS cells, Chk1 was not phosphorylated on 
Ser317 in cells positive for cytoplasmic Cyclin B, whereas treatment with IR did result in 
Chk1 phosphorylation (Figure 2A left panel). Similar results were obtained in HeLa cells and 
using antibodies against phosphorylated Ser345, the other ATR-mediated phosphorylation 
site of Chk1 (Figure 2A right panel, 2B). Moreover, Chk1 phoshorylation did not change 
after treatments with higher (40 J/m2) and lower (5 and 10 J/m2) doses of UV (Figure 2C). 
Experiments performed 3 hour after UV irradiation showed similar result as 1 hour after UV-
treatment, indicating that UV dose and time after irradiation did not influence the amount 
of phosphorylated Chk1 in G2 cells (Figure 2D). To address the specificity of the antibody 
against phosphorylated Ser317 of Chk1 we transfected U2OS cells with a mutant form of 
Chk1 that cannot be phosphorylated on Ser317 and Ser345. Transient expression of this 
Flag-tagged version of Chk1 worked as a dominant-negative since cells staining positive for 
Flag did not show phosphorylation of Chk1 [31] (Figure 2E). Hereby we show that effector 
kinase Chk1 is not phosphorylated in G2 cells after UV-irradiation. 
Chapter 5
109
PIKK-dependent UV response is absent in G2 cells
Our data show that UV-induced DNA lesions did not induce the phosphorylation of 
Chk1 in G2 cells. We investigated the localization and activation of other DNA damage 
signalling components in G2 phase after UV damage. Cells were treated with UV or IR and 
immunofluorescence was performed for several proteins involved in the PIKK-dependent 
DNA damage response, namely 53BP1, SMC1 and the phosphorylated forms of ATM and 
H2AX. Additionally we stained cells for the phosphorylated form of the p38 MAP kinase, 
which is implicated in the UV-induced G2 arrest [32]. Cells were co-stained for Cyclin A or 
B to access the cell cycle phases. Figure 3A shows that in response to IR, 53BP1 and SMC1 
formed foci and ATM and H2AX were phosphorylated and also localized to sites of damage 
in G2 cells, unlike p38, which was not phosphorylated (Figure 3A). In contrast, in response to 
UV light, p38 was phosphorylated during all phases of the cell cycle, whereas 53BP1, SMC1, 
gH2AX and pS1981 ATM did not localize into foci during the G2 phase in response to this 
type of DNA damage. 
Next, the experiments were performed in synchronized T24 cells to validate the absence of 
PIKK-dependent signalling after UV damage and confirm the presence of phosphorylated 
p38. At different stages of the cell cycle, cells were UV-irradiated and PIKK-dependent 
signalling was analyzed by western blotting. FACS analysis demonstrated that 30 to 31 
hours after the release from G
0
 approximately 50% of the total cell population was in G2/M 
(Figure 3B left panel). Cells treated with UV damage at this time point showed decreased 
levels of phopshorylated Chk1, H2AX, ATM and SMC3 when compared to asynchronous 
or S-phase cell populations (t=26h) (Figure 3B right panel). Also the DNA damage-induced 
degradation of Cdc25A was decreased at the 30 and 31 hour time points. Together these 
results demonstrate the absence of a PIKK-mediated DNA damage signalling in G2 after 
UV damage. Alternatively, p38 is phoshorylated at every time point in this experiment in 
response to UV damage. The presence of phosphorylated p38 confirms a possible role for 
this kinase in the UV-induced cell cycle arrest in G2 cells.
p38-dependent cell cycle arrest in G2 upon UV irradiation
After DNA damage the G2 checkpoint is the last critical barrier before the physical 
separation of the cell into two daughter cells [33, 34]. After IR, PIKK-dependent targeting 
of the Cdc25A phosphatase inhibits the dephosphorylation of Cdk1 resulting in a temporal 
cell cycle arrest [35, 36]. After UV damage the p38 MAP kinase is thought to control a cell 
cycle arrest via Cdc25B [32, 37-40]. However it remained unclear if ATM/ATR also play a role 
in this checkpoint, possibly by regulating p38 [41]. Alternatively, PIKKs and p38 signalling 
might be parallel pathways controlling the UV-induced G2 arrest. To investigate how the 
UV-induced cell cycle arrest in G2 cells is regulated we analyzed the percentage of cells that 
enters mitosis after UV-irradiation. After treatment with UV light, cells were incubated with 
a low dose of aphidicolin to inhibit S phase cells to progress into mitosis during the time 
course of the experiment. FACS analysis demonstrated that one hour after UV-irradiation 
cells stopped entering mitosis (Figure 4A, left panels). In addition, time-lapse analysis of 
GFP-Rad9 and Cyclin B-mCherry expressing cells showed that G2 cells do not enter mitosis 
after this dose of UV-irradiation (data not shown). To investigate if the UV-induced cell 
cycle arrest was dependent on ATM and ATR, cells were incubated with caffeine, thereby 
inhibiting PIKK kinase activation. Caffeine-treatment did not rescue the G2 arrest in response 
to UV light (Figure 4A). However, treatment of cells with BIRB 796, a specific p38 inhibitor, 
partially abrogated (50%) the UV-induced G2 arrest. Interestingly, combined treatment with 
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Figure 3: UV-induced DNA damage response of the ATR pathway is absent in G2 cells (A) U2OS cells were 
either untreated, treated with IR (10 Gy) and fixed after two hours or UV (20 J/m2) irradiated and fixed 
one hour later. Cells were analyzed by immunofluorescence using the indicated antibodies. (B) T24 cells 
were synchronized, released and at the indicated time points, left untreated or UV-treated and fixed 
or lysed one hour after the treatment. (Left panel) Shown are the (PI) cell cycle profiles of the cells be-
fore UV-irradiation .(Right panel) Western blot analysis was performed using the indicated antibodies.
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caffeine and p38 inhibitor led to a complete loss of the UV-induced arrest in G2 cells (Figure 
4A). To test the specificity of the p38 inhibitor, the phosphorylation of p38 was analyzed 
by immunofluorescence. Incubation of the cells with BIRB 796 completely abrogates the 
UV-induced phosphorylation of p38 (Figure 4B). Western blotting gave the same result: 
UV-induced p38 phosphorylation is inhibited by pre-incubation with BIRB 796. In contrast, 
caffeine treatment only mildly reduced Chk1 phosphorylation after UV (Figure 4C). Although 
these results show that caffeine did not completely inhibit PIKK kinase activity after UV under 
these conditions, it was enough to abrogate the G2-mediated cell cycle arrest after IR (data 
not shown). In addition, caffeine treatment did not inhibit UV-induced p38 phosphorylation, 
indicating that ATM/ATR are not involved in p38 regulation in response to UV light (Figure 
4C). 
Taken together, these results suggest that the p38 kinase is primarily required for the G2 
phase arrest after UV light. ATM/ATR might act redundantly in the absence of p38 and 
thereby functioning in parallel to the p38 pathway. 
Figure 4: UV-induced cell cycle arrest in G2 (A) U2OS cells were incubated with DMSO, caffeine (5mM) 
or BIRB 796 (40 mM) for 30 minutes before UV-irradiation (20 J/m2). One hour later cells were fixed, 
stained for MPM2 and analyzed by FACS (Left panel). Shown is the percentage of mitotic cells after 
the different treatments, error bars represent the SEM of at least three independent experiments. The 
percentage of mitotic cells in the untreated situation was set to 100% (Right panel). (B) U2OS cells were 
incubated with DMSO or BIRB 796 (40 mM) for 30 minutes before UV-irradiation (20 J/m2), fixed and 
analyzed by immunofluorescence with the indicated antibodies. (C) Cells were treated as in (A) but now 




Several studies have previously reported that the ATR-Chk1 pathway is required for the G2 
checkpoint response after DNA damage. Chk1 deficient vertebrate DT40 cells show a G2 
checkpoint defect after IR [42] and Takai et al. demonstrated that Chk1 deficient embryos 
do not arrest at the G2/M border after exposure to UV light [43], indicating that the ATR-
Chk1 pathway is involved in the G2 checkpoint after different types of genotoxic stress. 
We observed however that Rad9, a component of the Rad9-Rad1-Hus1 complex in the 
ATR-mediated checkpoint pathway, did not localize to sites of damage in G2 cells after 
UV-irradiation. Additionally ATRIP, Hus1 and Rad1 also did not localize into UV-induced 
foci specifically in G2 cells, unlike after IR (data not shown). Moreover we observed less 
localization of RPA into foci in G2. The binding of RPA to ssDNA, generated after genotoxic 
stress, is required for the recruitment of the 9-1-1 complex and ATRIP to damaged 
chromatin therefore we suggest that the absence of Rad9 immobilization and RPA focus 
formation after UV-irradiation is because ssDNA intermediates cannot be formed efficiently 
or are inaccessible to RPA molecules. The formation of UV-induced ssDNA intermediates 
in G1 cells is partially dependent on NER [22, 25]. But as our data show that NER is active 
during all phases of the cell cycle (Figure 1B), defective NER cannot be responsible for 
the absence of ssDNA intermediates. IR-induced DSBs in G2 are efficiently repaired by 
homologous recombination, and specifically require ATM and the nuclease Artemis, due to 
the inaccessibility of heterochromatin during this phase of the cell cycle [44]. We therefore 
speculate that nucleases that are normally involved in the resection of UV types of DNA 
lesions might be unable to access UV damage in G2. 
Athough our data suggest that RPA-coated ssDNA intermediates cannot be formed efficiently, 
UV-induced DNA damage leads to a cell cycle arrest in G2 cells. The underlying mechanism 
for the UV-induced G2 checkpoint arrest was unclear though, since a number of studies 
published seemingly conflicting results. PIKK-dependent checkpoint signalling is required for 
the G2 checkpoint after IR and also in response to UV damage ATR signalling was suggested 
to play a role [45, 46]. In addition, the p38 MAP kinase pathway is implicated in the UV-
induced checkpoint response at the G2-M transition by regulating Cdc25B protein levels 
[32, 37-39]. The question remained if the PIKK- and p38-dependent checkpoint pathways 
operate independently or together and separate or in parallel? Stiff et al. reported that 
the UV-induced G2 arrest requires NER-dependent ATR activation [45]. This was supported 
by a study that determined the phosphorylation of Chk1 in different NER deficient cell 
lines, thereby showing the phosphorylation of Chk1 was NER-dependent [25]. Although we 
observed that NER is active in G2 cells treated with UV, we did not detect the localization 
of RPA, SMC1 and 53BP1 into UV-induced foci. Moreover we were unable to detect the 
phosphorylation ATM, SMC3, H2AX and downstream effector kinase Chk1 in G2 cells treated 
with UV. Furthermore we show that PIKK-dependent signalling is dispensable for the G2 
checkpoint-mediated cell cycle arrest directly after UV, but show that this response is partially 
dependent on the p38 MAPK. In support of our findings, Reinhardt et al. and Bulavin et al. 
have shown that the UV-induced damage response, unlike other types of genotoxic stress, 
is independent of the PIKK kinases but requires the p38 MAP kinase signalling pathway [32, 
39, 47]. The discrepancy between these results and those from Stiff et al. could be coming 
from the different cell types that are used. It would therefore be interesting to study the UV-
induced p38 activation in untransformed cells.  
A model was proposed suggesting that the p38 MAP kinase might play a role in the initial 
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response to UV damage in G2, whereas the PIKK kinases maintain checkpoint activation 
at a longer time period [41]. Therefore the p38 and PIKK-mediated checkpoint responses 
may act in parallel. This would explain our observation that inhibition of p38 alone partially 
inhibits the G2 arrest whereas combined inhibition using caffeine and p38 inhibitor 
completely abrogates UV-induced cell cycle arrest. Thereby the PIKK-dependent response 
may take over G2 checkpoint regulation after p38 inhibition indicating that the ATM/ATR-
dependent pathway acts redundantly. Future studies specifically investigating the initiation 
and maintenance of the UV-induced G2 arrest are required to verify this hypothesis.
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ABSTRACT
The cell cycle checkpoint kinase Chk1 is phosphorylated and activated by ATR in response 
to DNA damage and is critical for initiating the DNA damage response. A number of factors 
act in concert with ATR to facilitate Chk1 phosphorylation including Rad17-RFC, the Rad9-
Rad1-Hus1 complex, TopBP1 and Claspin. Rad17 is required for loading of Rad9-Rad1-Hus1 
(9-1-1) onto sites of DNA damage. Although phosphorylation of Rad17 by ATR is required 
for checkpoint function, how this impacts on 9-1-1 regulation remains unclear. We report 
that exposure of cells to DNA damage or replication stress results in Rad17-dependent 
immobilization of Rad9 into nuclear foci. Furthermore, expression of mutant Rad17 
that cannot be phosphorylated by ATR (Rad17AA), or downregulation of ATR, results in a 
decreased number of cells that display Rad9 foci. Photobleaching experiments reveal an 
increase in the dynamic behaviour of Rad9 within remaining foci in the absence of ATR or 
following expression of Rad17AA. Together these data suggest a model in which Rad17 and 




Proteins involved in signalling DNA damage are critical for maintaining genome stability 
and guard against a variety of disease states including a predisposition to malignancy [1]. 
Consequently, the cell has evolved a comprehensive and intricate network of pathways that 
act in concert to detect and signal DNA damage for subsequent processing and repair. The 
phosphatidylinosotol (PI)-3 kinase related kinases (PIKKs) ATM and ATR function in distinct 
but partially overlapping pathways activated in response to genotoxic stress. ATM and ATR 
are recruited to sites of DNA damage, become activated, and subsequently phosphorylate a 
number of proteins that regulate various aspects of the DNA damage response (DDR). Whilst 
ATM is the principle kinase responsible for detecting and signalling DNA double strand breaks 
(DSBs), ATR responds to a wider variety of DNA damage architectures including UV-induced 
base damage, replication stress and DNA DSBs [2-4]. ATR phosphorylates and activates 
the Chk1 kinase in response to genotoxic stress. Chk1 then proceeds to phosphorylate a 
variety of proteins that regulate aspects of the DDR including cell cycle arrest, stabilization 
of stalled replication forks, and DNA repair [5]. As such, the ATR-Chk1 axis is central to the 
DDR and critical for maintaining genome integrity. For example, hypomorphic mutations 
in the ATR gene result in Seckel syndrome, a rare disease characterised by developmental 
abnormalities and genome instability [6].
The principle DNA architecture recognised by ATR is single stranded DNA (ssDNA) generated 
by either nucleases processing sites of DNA damage [3, 4, 7], or uncoupling of the replicative 
helicase from stalled replication forks [8]. Regions of ssDNA are subsequently coated by 
the ssDNA protein binding complex RPA that facilitates the recruitment of ATR to sites of 
DNA damage through an interaction with the ATR associated protein ATRIP [7, 9]. Although 
recognition of ssDNA by ATR is critical in allowing this kinase to phosphorylate and activate 
Chk1, a number of other factors are required for this event. For example, disruption of 
either Rad17 or components of the Rad9-Rad1-Hus1 (9-1-1) complex results in defective 
phosphorylation of Chk1 in response to DNA damage [10]. Rad17 along with the 4 small 
subunits of replication factor C (RFC2-5) acts as a clamp loader of 9-1-1 at or near sites of 
DNA damage [11-13]. Similar to ATR, Rad17/9-1-1 is also recruited to ssDNA coated with 
RPA [14]. However, Rad17/9-1-1 and ATR are recruited to DNA damage independently 
of each other arguing against these two DNA damage sensors acting in a linear pathway 
with regard to activation of Chk1 [13, 15, 16]. Instead, 9-1-1 activates ATR by recruiting the 
ATR-activating protein TopBP1 to DNA damage [17-19]. The final step in Chk1 activation is 
phosphorylation of Claspin by ATR that provides docking sites for Chk1 recruitment and 
subsequent phosphorylation by ATR [20].
Although a unified view of how Rad17, 9-1-1 and ATR access sites of DNA damage and 
facilitate Chk1 activation is beginning to emerge, how these proteins act in concert to 
propagate and maintain the checkpoint response remains unclear. Phosphorylation of Rad17 
by ATR on serines 635 and 645 is required for cells to initiate cell cycle arrest following DNA 
damage [21]. However, the molecular basis of how ATR-mediated Rad17 phosphorylation 
influences the 9-1-1 complex once it has accessed sites of DNA damage remains largely 
unexplored. Here we assess the impact of ATR on 9-1-1 complex regulation once it has 
accumulated at sites of DNA damage and provide data that support a role for ATR-mediated 
Rad17 phosphorylation in maintaining Rad9 at sites of genotoxic stress.
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MATERIALS AND METHODS
Cell culture and maintenance 
HeLa and Swiss 3T3 cells, obtained from the European Collection of Cell Cultures (Health 
Protection Agency, Porton Down, Wiltshire, UK), and U2OS cells were grown using standard 
procedures. U2OS cells stably expressing eGFP-HA
2
-Rad9 were grown in standard medium 
supplemented with 700 mg/ml of geneticin (G418).
The ATM inhibitor KU-55933 [22] and DNA-PK inhibitor KU00557788 [23] were pre-incubated 
with cells for 1 hour before UV treatment, and used at concentrations of 10	mM and 1 mM 
respectively. UV-light was administered using a StrataLinker 2400 source (Stratagene) or a 
254 nm UV-C lamp (Philips) at 20 J/m2 and cells processed 1 hour post treatment. To stall 
replication forks, asynchronously growing cells were incubated in 5 mg/ml of aphidicolin 
(Sigma) for 20 hours prior to processing of samples.
Antibodies
Antibodies obtained from commercial sources were as follows: Chk1 (Cell Signalling 
Technology), Chk1 pS317 (Bethyl), FLAG (M2; Sigma), Orc2 (BD Pharmingen), Rad9 
(Novus Biologicals), Rad17 pS645 (Cell Signalling Technology), RPA (Neomarkers) and RPA 
(Oncogene). The following antibodies were obtained from Santa Cruz Biotechnology: ATR 
(N-19), Chk1 (G-4), Ku86 (C-20), Rad1 (N-18), Rad9 (C-20), Rad9 (M-389) and Rad17 (H-300). 
Rabbit polyclonal anti-Hus1, anti-Rad9 and anti-GFP antibodies were a gift from R. Freire 
(Unidad de Investigación HUC, Tenerife, Spain).
Plasmids and site-directed mutagenesis
pmCherry-C1 was kindly provided by R.Y. Tsien (Department of Pharmacology and Howard 
Hughes Medical Institute, University of California, San Diego, USA). pPCMV eGFP-spectrin 
has been previously described [24].
hRad9 cDNA was digested from pGEX-4T3-GST-Rad9, kindly provided by R. Freire (Unidad 
de Investigación HUC, Tenerife, Spain), and cloned into the MCS of pcDNA3.1+ (Invitrogen). 
eGFP-HA was amplified by PCR from pEGFP-C2 (Clontech) and inserted in frame into 
pcDNA3.1+Rad9 to generate pcDNA3.1+eGFP-HA-Rad9.
A full-length Rad17 clone was purchased from Open Biosystems (Clone ID: 5170876, code: 
MHS1010-7508047). Rad17 was subcloned into the EcoR1 and Kpn1 sites of the pCMV-FLAG-2 
plasmid (Sigma). The full-length cDNA and linker regions were confirmed to be correct by 
sequencing. The pCMV-FLAG-Rad17 construct was subjected to PCR amplification with the 




. PCR products were digested with the 
methylation sensitive restriction enzyme Dpn1 to eliminate any original plasmid. To create 





Generation of FLAG-Rad17 and FLAG-Rad17AA constructs that are resistant to siRNA was 
performed using the same methodology to introduce conservative mutations in the third 
nucleotide of each codon contained within the Rad17 siRNA target sequence. Primers used 







Resulting Rad17 open reading frames, including the linker regions, were fully sequenced to 
confirm mutations of the relevant sites.
Transfection
siRNA oligonucleotides (Dharmacon Research) were transfected into cells using 
Oligofectamine (Invitrogen) according to the manufacturers instructions, and as previously 
described [4, 25, 26]. Cells were incubated for 72 hours after transfection prior to further 






Plasmid DNA was transfected into cells using lipofectamine (Figure  2B) or the calcium 
phosphate transfection method (all other experiments). For stable expression of eGFP-HA-
Rad9 in U2OS cells, positive clones were selected after a selection with G418 (1400 mg/ml) 
for two weeks.
For downregulating endogenous Rad17 while expressing siRNA resistant FLAG-Rad17 
constructs, we transfected plasmid DNA into cells using FuGENE HD transfection reagent 
(Roche) according to the manufacturers instructions. The next day siRNA oligos were 
transfected as described above and cells were harvested 72 hours after transfection.
Immunofluorescence
Cells were grown as monolayers on glass coverslips. For detection of endogenous Rad9, cells 
were pre-extracted in Buffer 1 (1% Triton X-100, 10 mM HEPES (pH 7.4), 10 mM NaCl, 3 mM 
MgCl
2
) for 5 minutes at 40C. Cells were then fixed in 4% paraformaldehyde for 10 minutes 
at 4°C and finally permeabilised further in Buffer 2 (0.5% Triton X-100, 20 mM HEPES pH 
(pH 7.4), 50 mM NaCl, 3 mM MgCl
2
, 300 mM sucrose) for 5 minutes at 4°C. Cells containing 
>10 foci were scored as Rad9 positive. This number reflects the DNA damage inducible 
population within experiments. In all instances, error bars on graphs represent the standard 
error of the mean (SEM) from three independent experiments. For detection of RPA, cells 
were fixed in 4% paraformaldehyde for 10 minutes at 4°C followed by permeabilization in 
0.5% Triton X-100 for 5 minutes at 4°C.
Immunofluorescence was performed using a Axioscope 2 fluorescent microscope equipped 
with Axiovision imaging software (Zeiss).
For detection of GFP-Rad9 in U2OS cells, living cells were studied, or cells were fixed in 2% 
paraformaldehyde containing 0.2% Triton X-100 for 20 minutes at RT and then permeabilised 
with 0.1% Triton X-100 for 5 minutes at RT. 
Imaging and FLIP/FRAP of GFP-Rad9 were performed on a Confocal Laser Scanning 
Microscope LSM 510 (Zeiss), equipped with a 488 nm Ar-laser and a 505-550 nm band 
pass filter. In Figure  5, cells were co-transfected with mCherry-C1, kindly provided by R.Y. 
Tsien (Department of Pharmacology/Department of Chemistry & Biochemistry, University 
of California, San Diego, USA). Red fluorescence was selected using a 514 nm Ar laser and 
575-615 nm band pass filter, after which the FLIP/FRAP measurements of GFP-Rad9 were 
performed, as described, in mCherry-positive cells.
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Cell fractionation and Western blotting
Whole-cell extracts were prepared by washing cultures in PBS before boiling cells in Laemmli 
buffer for 10 minutes. Protein concentrations were determined using the Lowry protein 
assay.
Biochemical fractionation of cells was performed as previously described [25, 27]. 
Figure 1: Rad9 accumulates to nuclear foci in response to genotoxic stress. (A) HeLa and Swiss 3T3 cells 
were left untreated, exposed to UV-light, or treated with aphidicolin. Rad9 was visualised by immuno-
fluorescence. (B) Western blot analysis of untransfected U2OS cells or different U2OS clones stably ex-
pressing GFP-Rad9 (II-5 and II-19), using the indicated antibodies. (C) U2OS cells or clones expressing 
GFP-Rad9 (II-5 and II-19) were lysed and GFP-Rad9 immunoprecipitated using anti-GFP antibodies. The 
presence of associated proteins was analysed by immunoblotting with the indicated antibodies. (D) 
U2OS cells or cells expressing GFP-Rad9 were either left untreated or exposed to UV-light. After 1 hour, 
cells were lysed, and western blot analysis was performed using the indicated antibodies. (E) U2OS cells 
expressing GFP-Rad9 were left untreated, exposed to UV-light, or treated with aphidicolin. GFP-Rad9 was 
visualised by direct fluorescence. (F) GFP-Rad9 expressing U2OS cells were left untreated or exposed to 




For cell cycle analysis, cells were collected by trypsinization and fixed in 70% ethanol at 4˚C 
for minimal 2 hours. After fixation, cells were washed with PBS and the DNA was stained 
with propidium iodide. Cell cycle profiles were analyzed by flow cytometry using an Epics 
XL-MCL from Beckman Coulter.
Photobleaching experiments
In the simultaneous FLIP/FRAP experiments, half of the nucleus was bleached for 2.7 seconds 
at 100% laser intensity, which irreversibly bleaches all GFP-Rad9 molecules. Subsequently, 
the redistribution of fluorescence in the nucleoplasm and the exchange of bleached and 
unbleached molecules between foci and nucleoplasm were monitored taking confocal 
images at fixed time intervals (60 seconds for Figure  4A and 30 seconds for Figs 4B and 
C, and Figure  5A and B). The relative intensities I
R
 of the bleached and unbleached halves 












 is the intensity measured at 
consecutive time points, I
0
 is the intensity of the bleached part of the nucleus immediately 
after bleaching and I
t<0
 is the intensity before bleaching (Figs 4B and 5A). The fluorescence 
before bleaching (I
t<0
) was set to 1 and the intensity immediately after bleaching (I
0
) was set 
to 0. The difference in relative fluorescence in bleached and unbleached parts of the nucleus 
was plotted against time (Figs 4C and 5B).
RESULTS
A fraction of Rad9 is converted into an immobile pool within nuclei in response to DNA 
damage and replication stress
To gain a greater understanding of the events required for regulation of 9-1-1, we examined 
the enrichment of Rad9 into nuclear foci in response to DNA damage or replication stress. 
When examining endogenous Rad9 by immunofluorescence, we observed a diffuse nuclear 
distribution of this protein in untreated human and mouse cells that relocated to discrete 
nuclear retained foci in response to UV-light and aphidicolin treatment (Figure  1A). To 
assess formation of Rad9 foci in live cells, we generated a cell line that stably expressed 
Rad9 tagged with eGFP-HA (GFP-Rad9; Figure  1B). GFP-Rad9 runs as multiple bands on 
SDS-PAGE, as observed by others [13], which partially represents the phosphorylation 
status of the protein (data not shown). GFP-Rad9 co-immunoprecipitated with endogenous 
Hus1 and Rad1 (Figure  1C). Furthermore, cells expressing GFP-Rad9 retained the ability 
to phosphorylate Chk1 in response to UV-light-induced DNA damage (Figure  1D) and did 
not display an increased sensitivity to DNA damaging agents (data not shown). Together 
these data indicate that GFP-Rad9 interacts with its functionally important partners and 
does not interfere with the DDR. Like endogenous Rad9, GFP-Rad9 was equally distributed 
throughout the nucleus in unperturbed cells and relocated into nuclear foci in response 
to UV-light or aphidicolin treatment. The majority of these foci appeared throughout the 
nucleus, but in a subset of the cells the foci were localized at the nuclear periphery (Figure 
1E). UV-light-induced GFP-Rad9 foci became apparent between 10-30 minutes following 
irradiation (data not shown) and colocalized with RPA (Figure  1F), indicating that GFP-Rad9 
is recruited to sites of ssDNA generated in response to DNA damage.
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Figure 2: Rad17 is required for Rad9 to form foci in response to DNA damage. (A) HeLa cells were 
transfected with siRNA oligonucleotides as indicated and were left untreated or exposed to aphidi-
colin. Whole cell extracts were prepared for western blotting (left panel) and the percentage of cells 
exhibiting >10 Rad9 foci were determined (right panel). (B) U2OS cells expressing GFP-Rad9 were 
transfected with empty vector, or vector containing FLAG-Rad17 or FLAG-Rad17AA. Cells were left 
untreated or exposed to aphidicolin. Chromatin fractions were prepared and extracts subjected to 
western blotting using antibodies as indicated.(C) U2OS cells stably expressing GFP-Rad9 were trans-
fected with FLAG-Rad17 or FLAG-Rad17AA constructs prior to treating cells with aphidicolin. FLAG-
positive (transfected) or FLAG-negative (untransfected) cells were identified by immunofluorescence 
and cells scored for GFP-Rad9 foci.(D) U2OS cells stably expressing GFP-Rad9 were transfected as 
in (C), after which cells were treated with UV-light. FLAG-positive (transfected) or FLAG-negative 
(untransfected) cells were identified by immunofluorescence and cells scored for GFP-Rad9 foci.
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Figure 3: ATR is required for formation of a subset of UV-light and aphidicolin-induced Rad9 foci. 
(A) HeLa cells were transfected with siRNA oligonucleotides as indicated, exposed to UV-light and 
chromatin fractions prepared as described in materials and methods. Western blot analysis was per-
formed using the indicated antibodies. (B) HeLa cells were transfected with siRNA oligonucleotides 
as indicated. Cells were treated with UV-light and harvested for western blotting (upper panel). The 
percentage of cells exhibiting >10 Rad9 foci was determined by immunoflourescence (lower panel). 
* represents a P value of 0.017 between these two data points indicating statistical significance at 
the 95% confidence level. (C) Cells were subjected to siRNA and treated as in (B). The percentage of 
cells exhibiting >10 RPA (p34 subunit) foci was determined by immunoflourescence. (D) HeLa cells 
were transfected with siRNA oligonucleotides as indicated and at 72 hours after transfection treated 
with a combination of ATM (10 mM) and DNA-PK (1 mM) inhibitors, or left untreated for 1 hour prior 
to exposure to aphidicolin. Cells were fractionated to obtain chromatin-enriched proteins and west-
ern blotting performed using the indicated antibodies. (E) HeLa cells were transfected with siRNA 
oligonucleotides as indicated and whole cell extracts prepared for western blotting (upper panel). 
In parallel cells were treated with ATM (10 mM) and/or DNA-PK (1 mM) inhibitors, or left untreated 
prior to exposure to aphidicolin. The percentage of cells exhibiting >10 Rad9 foci was determined.
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Rad17 phosphorylation is required for Rad9 to form foci in response to DNA damage and 
replication stress
Although ATR-mediated phosphorylation of Rad17 on serines 635 and 645 is required for 
checkpoint activation [21], how this impacts on the ability of the 9-1-1 complex to access 
and be retained at sites of DNA damage remains unclear. For example, loading of 9-1-1 
onto sites of DNA damage occurs independently of ATR, arguing that ATR-mediated Rad17 
phosphorylation is not required for 9-1-1 to access sites of DNA damage [13, 15, 16, 28, 29]. 
Conversely, DNA damage-induced phosphorylation of Rad17 has been reported to promote 
the interaction of this protein with the 9-1-1 complex [21], suggesting that ATR may affect 
the ability of 9-1-1 to interact with sites of DNA damage.
To further assess how Rad17 contributes towards the ability of 9-1-1 to interact with 
sites of DNA damage, we examined the requirement for ATR-mediated phosphorylation 
of Rad17 in allowing Rad9 to accumulate in nuclear foci following genotoxic stress. 
Repression of Rad17 expression by siRNA resulted in a decrease from 35% to 10% of HeLa 
cells that displayed aphidicolin-induced Rad9 foci when compared to cells transfected 
with a control oligonucleotide (Figure  2A). A similar dependence on Rad17 was observed 
for UV-light or aphidicolin-induced GFP-Rad9 foci formation (data not shown). To assess 
how phosphorylation of Rad17 by ATR impacts on Rad9 foci formation, we generated 
FLAG-Rad17 and FLAG-Rad17 in which the S635 and S645 ATR phosphorylation sites were 
substituted with alanine (FLAG-Rad17AA). When introduced into U2OS cells expressing GFP-
Rad9, FLAG-Rad17 and FLAG-Rad17AA were present in chromatin-enriched cellular fractions 
independently of replication stress, confirming that the FLAG-tag does not interfere with the 
DNA binding properties of these proteins (Figure  2B). Neither siRNA-mediated knockdown 
of Rad17, or overexpression of FLAG-Rad17AA dramatically impacted on cell cycle progression 
in U2OS cells (Supplemental Figure 1). In cells transfected with empty expression vector, 
phosphorylation of endogenous Rad17 at S645 increased in response to aphidicolin (Figure 
2B). Whilst aphidicolin-induced phosphorylation of Rad17 at S645 remained apparent 
in cells expressing FLAG-Rad17, this was reduced in cells transfected with FLAG-Rad17AA 
(Figure  2B), confirming the dominant negative nature of this mutant [21].
To assess Rad9 foci in cells that express FLAG-Rad17 or FLAG-Rad17AA, we introduced these 
proteins into U2OS cells stably expressing GFP-Rad9 using a low efficiency transfection 
procedure. Scoring FLAG-negative or FLAG-positive cells for GFP-Rad9 foci allowed a 
comparison of transfected and untransfected cells within the same population. Untransfected 
cells exhibited an induction of GFP-Rad9 foci formation in response to aphidicolin or UV-
light and this remained largely unaffected by expression of FLAG-Rad17 (Figure  2C and 
D). However, FLAG-Rad17AA expressing cells displayed a reduced ability to form aphidicolin 
and UV-light-induced GFP-Rad9 foci when compared to control cells expressing FLAG-Rad17 
(Figure  2C and D). Expression of FLAG-Rad17AA resulted in an increased number of cells 
that exhibit Rad9 foci in the absence of damaging agents. Given that Rad17AA expression 
induces genomic instability in the absence of exogenous stress (Wang et al., 2006), the 
increased number of FLAG- Rad17AA cells that display Rad9 foci in the absence of UV-light or 
aphidicolin likely reflects recruitment of Rad9 to sites of endogenous DNA damage induced 
by expression of FLAG-Rad17AA.
In order to discount the possibility that the reduced ability to form GFP-Rad9 foci in FLAG-
Rad17AA cells is a consequence of expressing mutant Rad17 in the presence of endogenous 
Rad17, we expressed siRNA resistant wild-type or mutant versions of FLAG-Rad17 in cells 
that had been subjected to Rad17 siRNA. Staining with FLAG antibodies identified cells 
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that expressed siRNA resistant FLAG-Rad17 in the presence of Rad17 knockdown. Whereas 
expression of siRNA resistant FLAG-Rad17 restored DNA damage-induced GFP-Rad9 foci 
formation in Rad17 downregulated cells, expression of siRNA resistant FLAG-Rad17AA failed 
to restore the defect caused by downregulation of endogenous Rad17 (Supplemental Figure 
2). Together, these data argue that the observed phenotype of FLAG-Rad17AA expression is 
not due to the presence of endogenous Rad17 and illustrate that phosphorylation of Rad17 
on S635 and/or S645 impacts on the ability of Rad9 to form foci in response to endogenous 
or exogenous genotoxic stress.
Disruption of ATR function results in a decreased number of cells that exhibit Rad9 foci in 
response to UV-light and replication stress
ATR and the 9-1-1 complex are recruited independently of each other to sites of DNA damage 
[13, 15, 16, 28, 29]. However, in vertebrates much of the literature describing the relationship 
between these two DNA damage sensors has focussed on examining enrichment of proteins 
in chromatin fractions isolated from cells following exposure to genotoxic stress [13, 28]. 
Consistent with these reports, we also observed that repression of ATR levels using siRNA 
did not affect enrichment of Rad9 in chromatin-containing fractions following exposure of 
cells to UV-light (Figure  3A).
Our observations that FLAG-Rad17AA expression results in a reduced number of cells that 
exhibit DNA damage or replication stress-induced Rad9 foci led us to assess the requirement 
for ATR in Rad9 foci formation following genotoxic stress. As predicted, repression of 
Rad9 expression by siRNA abrogated formation of UV-light-induced Rad9 foci formation 
(Figure  3B). Consistent with our biochemical data (Figure  3A), UV-light-induced Rad9 foci 
formation was still apparent in cells that had been subjected to ATR siRNA. However, in 
these experiments we observe a modest but nonetheless significant decrease from 32% to 
24% of cells that exhibited UV-light-induced Rad9 foci in the absence of ATR (Figure  3B). 
Importantly, UV-light-induced RPA foci remained intact following transfection with ATR or 
Rad9 siRNA (Figure  3C), arguing that the reduction of Rad9 foci is not a consequence of 
inefficient ssDNA formation and/or recruitment of RPA to sites of DNA damage. Although 
we observe a reproducible decrease in efficiency of Rad9 foci formation in ATR siRNA cells, 
this is not as dramatic as that achieved by overexpression of FLAG-Rad17AA. Therefore, we 
cannot formally rule out additional effects of Rad17 phosphorylation on Rad9 foci formation 
in response to UV-light. Alternatively, these observations could be explained by increased 
genomic instability cells lacking ATR [30].
Similar to UV-light-induced DNA damage, repression of ATR using siRNA did not affect 
enrichment of Rad9 in chromatin-containing fractions following administration of aphidicolin 
(Figure  3D). However, similar to UV-light-induced damage, we also detected a decrease in 
the number of cells that exhibited aphidicolin-induced Rad9 or GFP-Rad9 foci formation in 
the absence of ATR (Figure  4E and data not shown). 
To establish whether the absence of an absolute requirement for ATR in loading Rad9 
onto chromatin or formation of Rad9 foci following administration of aphidicolin could be 
explained by a functional redundancy between ATR, ATM and/or DNA-PK, we combined 
siRNA of ATR with ATM [22] and DNA-PK [23] specific inhibitors prior to assessing either 
enrichment of Rad9 in chromatin-containing cellular fractions, or formation of Rad9 
foci following administration of aphidicolin. Loading of Rad9 onto chromatin following 
administration of aphidicolin remained intact in cells subjected to ATR siRNA either in 
the absence or presence of ATM and DNA-PK specific inhibitors (Figure  3D). Similarly, 
addition of ATM and/or DNA-PK inhibitors to cells that had been treated with ATR siRNA 
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oligonucleotides did not result in a further dramatic decrease in the number of cells that 
exhibited Rad9 foci (Figure  3E). Together, these data argue against a functional redundancy 
being the explanation for a lack of total dependency of Rad9 foci formation on ATR.
ATR and Rad17 phosphorylation influence Rad9 retention at DNA damage sites
Our findings that the number of cells that display Rad9 foci is reduced by the absence of ATR 
prompted us to consider whether ATR might have an alternative effect on 9-1-1 function 
other than facilitating its ability to be recruited to sites of DNA damage. For example, should 
ATR be required to amplify or retain Rad9 at sites of DNA damage, it is conceivable that Rad9 
may still transiently interact with DNA lesions in the absence of this kinase. Therefore, we 
assessed whether Rad9 proteins within established foci are immobile or whether these foci 
are more dynamic structures in which Rad9 proteins turnover, a process that could possibly be 
affected by ATR. To assess this, we used simultaneous fluorescence-loss-in-photobleaching 
(FLIP)/fluorescence-recovery-after-photobleaching (FRAP) technology, an assay employed 
in living cells that has been successfully used to monitor protein redistribution in real-
time [31-35]. In these experiments, GFP-Rad9 expressing U2OS cells were transfected with 
control or ATR siRNA oligonucleotides. Subsequently, cells were treated with either UV-light 
or aphidicolin, half the nucleus containing the resulting GFP-Rad9 foci was photobleached, 
and cells were followed in real-time by video-microscopy (Figure  4A). The redistribution 
of fluorescence was monitored by measuring FRAP in the bleached part and FLIP in the 
unbleached part of the nucleus and the change in fluorescence versus time, indicative of 
GFP-Rad9 turnover, was quantified (Figure  4B).
Whereas GFP-Rad9 was highly mobile in undamaged cells and cells without foci, turnover 
of GFP-Rad9 within DNA damage-induced foci was comparatively slow. In addition, the 
FLIP and FRAP curves of control-transfected cells did not converge during the time span of 
our experiments (800-1000 seconds), suggesting the presence of a stably associated Rad9 
fraction in damaged areas (Figure  4B and data not shown). Similar to luciferase-transfected 
control cells, UV-light and aphidicolin-induced foci formation also resulted in a decrease in 
the mobility of GFP-Rad9 in cells transfected with ATR siRNA oligonucleotides. However, in 
this case, the FLIP/FRAP curves almost fully converged, suggesting the absence of a long-
lived immobile fraction of GFP-Rad9 in foci when ATR protein levels are repressed (Figure 
4B). The time-lapse images in Figure  4A additionally demonstrate faster redistribution of 
fluorescence within damage-induced foci upon repression of ATR protein levels, as compared 
to control cells, which is confirmed by the slopes of the FLIP/FRAP curves (Figure  4B). 
In addition, the difference in relative fluorescence intensities between the FRAP and FLIP 
areas was plotted against time and the time it took to reach full redistribution (>90%) was 
determined as a measure for mobility. Full redistribution of GFP-Rad9 within DNA damage-
induced foci was not reached during the time course of our experiments (800-1000 seconds; 
Figure  4C and data not shown). However, following repression of ATR levels using siRNA, 
full redistribution was reached within 450-500 seconds after bleaching, indicating an 
increase in protein mobility upon downregulation of ATR (Figure  4C). Together these results 
demonstrate that in cells in which DNA damage-induced foci formation of GFP-Rad9 is not 
affected by the absence of ATR, Rad9 proteins in such foci display a higher turnover.
Our results suggest that the effect of ATR on the stability of GFP-Rad9 in damage-induced 
foci is mediated by phosphorylation of Rad17. To test if this is indeed the case, we performed 
simultaneous FLIP/FRAP measurements on UV-induced GFP-Rad9 foci in cells expressing 
FLAG-Rad17 or FLAG-Rad17AA. Although wild-type FLAG-Rad17 did not interfere with the 
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slow dynamic behaviour of GFP-Rad9 within foci, expression of FLAG-Rad17AA resulted in a 
similar phenotype as observed upon downregulation of ATR, an increased mobility of GFP-
Rad9 within foci (Figure  5A). Furthermore, full redistribution of GFP-Rad9 in UV-induced foci 
was reached within 450-500 seconds after the bleach pulse upon FLAG-Rad17AA expression, 
whereas this equilibrium was not reached in control cells (Figure  5B). Taken together, these 
data demonstrate that Rad17 impacts on the turnover of Rad9 molecules in foci, a process 
that critically depends on ATR-mediated phosphorylation.
DISCUSSION
In this report we present data that suggest a model in which Rad17 and ATR collaborate 
in regulating the localization of the 9-1-1 complex at sites of damage. The ability of Rad9 
to form DNA damage-induced nuclear foci in the absence of ATR has not previously been 
reported in mammalian cells. However, analysis of Saccharomyces cerevisiae 9-1-1 (Ddc1-
Rad17-Mec3) has revealed that formation of DNA DSB-induced Ddc1-Rad17-Mec3 nuclear 
foci can still occur in the absence of functional ATR (Mec1p) [15, 29]. In accordance with 
these findings, we also observe Rad9 foci formation in cells that have been treated with ATR 
siRNA following UV-light-induced DNA damage or replication stress (Figs 3 and 4). Taken 
together with our biochemical data that illustrates ATR is not required for Rad9 enrichment 
on chromatin in response to DNA damage or replication stress (Figs. 3A and D), our data 
support the currently accepted dogma that ATR is not required for 9-1-1 to access sites 
of DNA damage. Importantly, however, our experiments studying the dynamic behaviour 
of GFP-Rad9 foci by live-cell imaging suggest that whilst ATR does not influence the initial 
recruitment of Rad9 to DNA lesions, it does impact on the ability of this protein complex to 
be maintained within nuclear foci.
As the number of reports examining DNA damage checkpoint regulation in living cells is 
limited [35-37], our experiments provide valuable insights into understanding this complex 
process, which appears to be more dynamic than originally anticipated [38]. Whilst the Chk2 
and Chk1 effector kinase are phosphorylated at sites of damage, induction of genotoxic 
stress does not lead to their immobilization, demonstrating the dynamic nature of these 
proteins [26, 35]; VAJS and DOW, unpublished). In contrast, several checkpoint proteins 
involved in the early stages of the checkpoint response, such as NBS1, MDC1 and 53BP1, 
are transiently immobilized in DNA damaged areas [35-37]. The observed immobilization of 
GFP-Rad9 in DNA damage-induced foci is in accordance with the suggested function of Rad9 
as a DNA damage sensor protein, that upon recruitment to sites of damage contributes 
to activation of the checkpoint. However, the observed function of ATR in Rad9 turnover 
in established foci was unexpected in light of previous reports [13, 15, 16, 28, 29], and 
demonstrates a more subtle control of checkpoint regulation than initially envisaged.
These findings are of particular interest given the emerging theme that signalling DNA 
damage is not a purely linear pathway and that a variety of parallel mechanisms exists 
that contribute towards maintenance or amplification of the signal. For example, although 
histone H2AX phosphorylation is not essential for the initial recruitment of certain DNA 
damage signalling proteins to DNA DSBs, it is required for these proteins to persist at 
break sites and form DNA damage-induced nuclear foci [39]. Similarly, ATM-mediated 
phosphorylation of H2AX in response to DNA DSBs has been proposed to amplify the initial 
signal generated at a break site by recruiting additional ATM via an interaction with the 
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Mre11/Rad50/Nbs1/Mdc1 protein complex [40]. Therefore, one possible interpretation of 
our data is that activation of ATR serves as a signal to 9-1-1 that subsequently stabilises the 
interaction of this protein complex with sites of DNA damage resulting in amplification or 
maintenance of the checkpoint signal.
A link between ATR and the ability of 9-1-1 to be maintained at sites of genotoxic stress 
is further supported by our observations that expression Rad17 that is unable to be 
phosphorylated by ATR results in a similar increased dynamic behaviour of Rad9 within foci. 
Figure 4: ATR influences the retention time of GFP-Rad9 in damage-induced foci. (A) GFP-Rad9 U2OS ex-
pressing cells were transfected with ATR or Luciferase siRNA oligonucleotides, and treated with aphidi-
colin. Half the nucleus containing GFP-Rad9 foci (see rectangle) was bleached for 2.7 seconds at 100% 
laser intensity, after which redistribution of fluorescence was monitored by recording images every 60 
seconds. Western blot analysis of cell extracts from a representative experiment is illustrated (right pan-
el). (B) Quantification of simultaneous FLIP/FRAP experiment as in A, with the exception that the cells 
were imaged every 30 seconds. Cells were treated with aphidicolin (left panel) or UV (right panel), after 
which FLIP was measured in the unbleached part of the cell and FRAP was measured in the bleached 
part of the cell. Control cells (UNT) are either left untreated or treated with damaging agents but not dis-
playing GFP-Rad9 foci. The mean of the data points of individual cells analyzed is illustrated (n=number 
of cells) with error bars representing the SEM. (C) Difference in relative fluorescence in bleached and 
unbleached parts of the nucleus from (B), plotted against time. Error bars represent twice the SEM.
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Figure 5: Rad17 phosphorylation at serines 635 and 645 decreases the mobility of GFP-Rad9 in 
damage-induced foci. GFP-Rad9 expressing U2OS cells were transfected with FLAG-Rad17 or FLAG-
Rad17AA constructs, together with mCherry-C1, to detect transfected cells. Cells were left untreated 
(UNT) or treated with UV-light and FLIP/FRAP analysis was performed on red cells. (A) Quantification 
of FLIP and FRAP as described in Figure  5B. (B) Difference in relative fluorescence, plotted against 
time, as described in Figure  5C. (C) ATR and Rad17 collaborate in modulating Rad9 localization at 
sites of DNA damage. ssDNA generated as a result of DNA damage or replication stress is recognized 
by RPA (1). Recognition of ssDNA by RPA leads to the independent recruitment of ATR and Rad17 to 
DNA lesions. Rad17 loads the 911 complex at sites of ssDNA and facilitates activation of ATR through 
an interaction with TopBP1 (2). ATR subsequently phosphorylates Claspin that acts to recruit Chk1 
and promote its phosphorylation by ATR. ATR also phosphorylates Rad17 (3). ATR-mediated phos-
phorylation of Rad17 stabilizes the 911 complex at sites of DNA lesions. This in turn could result in the 
maintenance of activated ATR and continued checkpoint signalling until DNA damage is repaired (4).
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How DNA damage-induced phosphorylation of Rad17 contributes towards the regulation of 
9-1-1 has been a matter of debate. The observation that ATR is not required for enrichment 
of 9-1-1 on chromatin in response to genotoxic stress argues against phosphorylation of 
Rad17 contributing towards regulating the access of 9-1-1 to sites of DNA damage [13, 28]. 
Conversely, phosphorylation of Rad17 on serines 635 and 645 promotes an interaction with 
the 9-1-1 complex, raising the possibility that ATR-mediated phosphorylation of Rad17 can 
influence the ability of 9-1-1 to interact with sites of DNA damage [21]. Together our results 
unify these findings and demonstrate that whilst phosphorylation of Rad17 by ATR is not 
required for 9-1-1 to access DNA damage sites per se, it does contribute to retention of 9-1-1 
within the vicinity of the DNA lesion.
The 9-1-1 complex facilitates activation of ATR not through promoting its interaction with 
DNA damage sites, but by recruiting the ATR activating protein TopBP1 to sites of DNA 
damage [17-19]. It is interesting to speculate, therefore, that the initial activation of ATR by 
TopBP1 results in phosphorylation of Rad17 and subsequent stabilization of the Rad17/9-1-
1/TopBP1 complex at DNA lesions. This in turn could result in the maintenance of activated 
ATR and continued checkpoint signalling until DNA damage is repaired (Figure  5C). This 
hypothesis is particularly interesting in light of the recent observations illustrating that 
ATR-mediated phosphorylation of Rad17 is not absolutely required for activation of Chk1 
in response to replication fork stalling, but is instead required for the maintenance of the 
checkpoint following removal of stress [41]. Taken together, our findings may be indicative 
a biphasic response to genotoxic stress that constitutes an initial recruitment of signalling 
proteins to DNA damage followed by subsequent regulation of checkpoint proteins at 
damage sites in order to maintain the checkpoint.
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Supplementary Figure 1: Downregulation of Rad17 and ATR, or overexpression of FLAG-Rad17AA 
does not affect cell cycle progression. (A) U2OS cells were transfected with control Luciferase 
(Luc), Rad17 or ATR siRNA oligonucleotides as indicated. 72 hours after transfection, cells were ei-
ther subjected to western blotting using the indicated antibodies (left panel), or the cell cycle pro-
files analyzed by flow cytometry (right panel). (B) U2OS cells were transfected with empty vector, 
FLAG-Rad17 or FLAGRad17AA in conjunction with a GFP-spectrin expression vector. 36 hours af-
ter transfection, cells were either subjected to western blotting using the indicated antibodies 
(left panel), or the cell cycle profiles of GFP-positive cells analyzed by flow cytometry (right panel).
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Supplementary Figure 2: Expression of siRNA resistant FLAG-Rad17AA fails to restore UV-light-
induced GFP-Rad9 foci formation. U2OS cells expressing GFPRad9 were transfected with siRNA re-
sistant FLAG-Rad17 or FLAG-Rad17AA constructs and subsequently with either control (A) or Rad17 
(B) siRNA oligonucleotides. Cells were left untreated or exposed to UV. Cells were fixed and stained 
with FLAG antibodies to identify those expressing recombinant siRNA resistant FLAG-Rad17. FLAG-
positive (transfected) or FLAG-negative (untransfected) cells were scored for GFP-Rad9 foci. As would 
be predicted, Rad17 siRNA abrogates GFP-Rad9 foci formation following exposure to UV-light, illus-
trating the efficiency of Rad17 knockdown in these cells. FLAG-Rad17AA expressing cells exhibit a 
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Critical in the response to genotoxic stress is the capability of mammalian cells to activate 
DNA repair and checkpoint pathways. Failures associated with these responses may lead 
to genomic instability and cancer predisposition. The ATR-mediated checkpoint response is 
essential for cell viability and the cellular response to UV light and replication-associated DNA 
damage. A common intermediate in the repair of these lesions is RPA-coated single-stranded 
DNA.  Proteins recruited to this intermediate include the Rad9-Rad1-Hus1 (9-1-1) sliding 
clamp. This protein complex shares high structural similarity with PCNA and is necessary for 
proficient genotoxic stress-induced checkpoint activation. In response to DNA damage, the 
9-1-1 complex is regulated by post translation modifications. Here we show that the human 
9-1-1 complex is modified by ubiquitination. Mass spectrometry analysis indicates that Hus1 
is ubiquitinated on lysine 136 and identifies novel proteins involved in the regulation of the 
9-1-1 complex. Our data indicates that the Hus1 ubiquitination is regulated by the E3 ligase 
EDD, whose loss results in a decrease in UV-induced Chk1 phosphorylation. We additionally 
demonstrate that the Rad18 E3 ligase is involved in ATR-mediated checkpoint signalling by 
stabilizing the 9-1-1 complex after DNA damage induction, possibly through ubiquitination. 
Furthermore, depletion of Rad18 negatively influences UV-induced foci formation of Hus1. 






Genotoxic stress in eukaryotic cells originates from endogenous metabolic cellular processes 
and exogenous DNA damaging agents, both of which lead to the activation of DNA damage 
checkpoint and repair pathways [1-3]. The activation of DNA damage response pathways 
ensures an intact transmission of the DNA to the daughter cells and failures associated with 
these processes can lead to genomic instability, which is a common cause of cancer [4, 5]. 
The DNA damage-induced checkpoint response temporally halts cell cycle progression to 
create the necessary time for DNA repair to remove genotoxic DNA lesions that might be 
present [6]. The major regulators of the DNA damage-induced checkpoint response are the 
transducer kinases ATM and ATR [7]. Whereas ATM is activated in response to DNA damaging 
agents that induce DNA double-stranded breaks (DSBs), the ATR-mediated response is mainly 
triggered by ultraviolet (UV) light and replication stress [7]. The latter types of genotoxic 
stress lead to the formation of single-stranded DNA (ssDNA) intermediates that become 
coated by RPA, subsequently leading to the recruitment of the ATR-ATRIP heterodimer and 
Rad17-RFC complexes to these sites of damage [8, 9]. Rad17-RFC is required for the loading 
of the Rad9-Rad1-Hus1 (9-1-1) PCNA-like sliding clamp onto damaged chromatin [10, 11]. 
After loading of the 9-1-1 clamp, TopBP1 binds to the N-terminal region of Rad9 and triggers 
the activation of the ATR kinase which subsequently leads to the phosphorylation and 
activation of effector kinase Chk1 responsible for cell cycle arrest [12-15]. The 9-1-1 complex 
was proposed to be critical in the response to genotoxic stress since Hus1-deficient mouse 
embryonic fibroblasts (MEFs) are hypersensitive to hydroxyurea (HU) and UV-irradiation 
[11, 16-18]. Knocking out Rad9 in mouse embryonic stem cells or chicken DT40 cells also 
results in increased sensitivity to DNA damaging agents [19, 20]. This can be explained 
partially by the requirement of Hus1 and Rad9 in the DNA damage-induced phosphorylation 
of Chk1and the subsequent cell cycle arrest [11, 17, 20, 21]. 
Post-translational modifications are of crucial importance for the regulation of the cellular 
response to DNA damage. Phosphorylation activates kinases in the pathway, leading to the 
recruitment of proteins to DNA lesion and to the regulation of the retention of factors in 
DNA damage-induced nuclear foci [22-24]. Besides the phosphorylation of Chk1, Rad17 
and Rad9, ATR is also responsible for the phosphorylation of a number of other proteins, 
including RFC, RPA, TopBP1, ATRIP, and Claspin [7, 22-25]. In addition, ubiquitination has 
recently been implicated in checkpoint regulation, specifically for Claspin, RFC2 and TopBP1 
[26-29].
The 9-1-1 complex is also suggested to be regulated by ubiquitination. Hus1 is degraded in 
a proteasome-dependent manner [30, 31]. More recently it was reported that S. cerevisiae 
rad17 (homologue of human Rad1) is ubiquitinated in response to DNA damage [32]. Cells 
harbouring a mutation in lysine 197 of rad17 show reduced ddc1 (homologue of human Rad9) 
focus formation in response to DSBs and show decreased rad53 (functional homologue of 
human Chk1) phosphorylation levels after DNA damage induction. Collectively these results 
indicate the importance of rad17 ubiquitination in checkpoint activation. Interestingly, the 
E3 ubiquitin ligase rad18, necessary for DNA damage-induced ubiquitination of PCNA, is 
required for rad17 ubiquitination [33-35]. 
We set out to investigate if the members 9-1-1 complex are ubiquitinated in human cells 
and if so what the functional relevance of this modification might be. We performed mass-
spectrometry analysis of purified ubiquitinated Hus1 and demonstrated the ubiquitination 
of Hus1 on lysine 136. A number of E3 ubiquitin ligases were identified as Hus1-interaction 
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partners that might be involved in the ubiquitination of the 9-1-1 complex. Although the 
obtained findings are reproducible we emphasize that this work is unfinished and therefore 
further research has to be undertaken to gain a better understanding of the underlying 
mechanisms of 9-1-1 ubiquitination. Nevertheless our preliminary results suggest that Hus1 
is regulated in a manner that is dependent on E3 ligase EDD, possibly through ubiquitination. 
Importantly, depletion of EDD leads to increased sensitivity of cells to UV damage, a 
decrease in DNA damage-induced Chk1 phosphorylation and inefficient recruitment of 
the 9-1-1 complex to chromatin after genotoxic stress. In contrast to EDD, Rad18 seems to 
stabilize the 9-1-1 complex protein levels. Depletion of Rad18 decreases cell viability after 
UV damage and moreover it affects GFP-Rad9 focus formation and recruitment of the 9-1-1 
complex to chromatin in response to DNA damage. The interesting results presented here 
create preliminary insight into the mechanism(s) of 9-1-1 ubiquitination and suggest that 
the E3 ubiquitin ligases EDD and Rad18 are implicated in the response of cells to UV damage.
MATERIALS AND METHODS
Plasmids and site-directed mutagenesis
The pcDNA3-myc-Rad1 and pcDNA3-myc-Hus1 were a kind gift from H.G. Wang (H. Lee 
Moffitt Cancer Center and Research Institute, Tampa, USA) and described previously [30, 36]. 
YFP-Rad18 by A. Inagaki [37] (Erasmus MC, Rotterdam, The Netherlands). eGFP-HA2-Rad9 
(GFP-Rad9) was described before [24]. Flag-EDD was a gift from R.L. Sutherland (Garvan 
Institute of Medical Research, Sydney, Australia). Wild type and mutated (K48R and K63R) 
His-tagged ubiquitin expression plasmids were kindly provided by M. Benkirane (Institut de 
Génétique Humaine, Montpellier, France). Hus1 lysines 136, 141 and 144 were changed to 
arginine and EDD serine at position 2071 was changed to alanine using the QuickChange 
site-directed mutagenesis kit from Stratagene. To produce truncated Flag-EDD proteins we 
introduced a stop codon in the Flag-EDD cDNA at the positions 2446, 1369 or 577 using the 
indicated primers:
EDD D2446-2798 forward  agagcaagagtggatgaggcctaggaactcattattgcacatgg 
EDD D2446-2798 reverse  ccatgtgcaataatgagttcctaggcctcatccactcttgctct
EDD D1369-2798 forward  catcttttgccagaagagcaataatacctcaatcagcaaagtgg 
EDD D1369-2798 reverse  ccactttgctgattgaggtattattgctcttctggcaaaagatg
EDD D577-2798 forward  gacagctgtagatttcaactttgatctcctgaaagcttgaaaa 
EDD D577-2798 reverse  ttttcaagctttcaggagatcaaagttgaaatctacagctgtc
GFP-Rad1 and Hus1-GFP cDNA was produced by PCR on pcDNA3-myc-Rad1 and pcDNA3-
myc-Hus1 introducing a BamH1 and EcoR1 restriction-site at opposite sites of the amplified 
cDNA. The templates were ligated into pEGFP-C1 and N1 (Invitrogen) digested previously 
with BamH1 and EcoR1 restriction enzymes to generate C and N-terminally labeled eGFP 
versions of Rad1 and Hus1. Tagging of Hus1 at either side maintained interactions with 
endogenous Rad9 and Rad1, whereas C-terminal tagging of Rad1 disrupts the interaction 
with endogenous Rad9 and Hus1 (data not shown).
Cell culture and maintenance
U2OS and HEK 293T cells were grown using standard procedures. U2OS cells expressing 
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GFP-Rad9 and Hus1-GFP were grown in standard medium supplemented with 700 mg/ml 
of G418. 
UV-light was administered using a 254 nm UV-C lamp (Philips) at 20 J/m2 and cells harvested 1 
hour post treatment. To stall replication forks, asynchronously growing cells were incubated 
with 5 mg/ml of aphidicolin (Sigma) for 20 hours, or 10 mM HU for 2 hours. IR (10 Gy) was 
induced using a 137Cs source or a linear accelerator (LINAC) and cells were harvested 2 hours 
after treatment. MMS-treatment (0.02%) was performed for 1 hour.
Antibodies
Antibodies obtained from commercial sources were as follows: Orc2 (BD Pharmingen), Grb2 
(BD Transduction), Rad9 (Novus), pS317 and pS345 Chk1 (Cell Signaling), Flag (Sigma), HA 
(Covance), Chk1, Rad18 and EDD (Abcam), and the following antibodies were obtained from 
Santa Cruz Biotechnology: Ku86 (C-20), Rad1 (N-18), Rad17 (H-300) and Chk1 (G-4). 
Rabbit polyclonal anti-GFP, anti-TopBP1 and anti-Rad9 were described before [38-40]. 
Rabbit polyclonal Hus1 antibody was raised against recombinant Hus1 full length protein. 
Recombinant protein was obtained by cloning the cDNA corresponding in pET-28 (Novagen) 
expressed in E. coli and soluble protein was purified and used to immunize. A similar method 
was used to obtain antibodies against EDD, Rad18 and Rad1. 
Transfection
Plasmid DNA was transfected into cells using the calcium phosphate transfection method. 
siRNA oligonucleotides (Dharmacon Research) were transfected into cells using 
Oligofectamine (Invitrogen) according to the manufacturers instructions, and as previously 
described [16, 41, 42]. Cells were incubated for 48-72 hours after transfection prior to 
further analysis. Sequences of oligonucleotides were as follows: 
Luc   CGUACGCGGAAUACUUCGAdTdT
Chk1  UCGUGAGCGUUUGUUGAACdTdT
EDD   GCAGUGUUCCUGCCUUCUUdTdT  
HUWE1   GAGUUUGGAGUUUGUGAAGdTdT
Rad18   GGAAAGCCUCAGAAGUUCUUU
Ubc13   CAGAUUUGUGUUAAGAUAGUAUU
USP1   UCGGCAAUACUUGCUAUCUUAUU
Colony survival assays
Cells that were downregulated for either luciferase, Chk1, EDD, HUWE1 and Rad18 were 
counted and 1000 cells were seeded onto 60 mm diameter dishes and left for 12 hours to 
attach. Cells were treated with different doses of UV (5, 10, 15, 20 J/m2) and incubated with 
fresh medium for 7-14 days, after which the colonies were fixed, stained and counted. All 
experiments were performed in triplicate.
Whole cell extracts and cell fractionation
For whole cell extracts, cells were washed in cold PBS, after which the cells were resuspended 
in Laemmli sample buffer (4% SDS, 20% glycerol, 120 mM Tris pH 6.8) and boiled for 5 
min. Protein concentrations were determined using the Lowry protein assay. Chromatin 




HEK 293T-transfected cells were collected by trypsinization, washed with ice-cold PBS, 
and lysed in buffer (A) containing 50 mM HEPES [pH 7.5], 150 mM NaCl, 2 mM MgCl
2
, 5 
mM EGTA, 0.5% NP40, 10% glycerol and 1 mM DTT, supplemented with protease inhibitor 
cocktail (Roche), 1 mM NaF (Sigma), 1 mM Na3VO4 (Sigma) and 2 mM N-Etylmaleimide 
(Sigma) for 20 minutes on ice, in the presence of MG132 (Calbiochem) when indicated. 
Immunoprecipitation experiments were carried out using Flag M2-Agarose beads (Sigma), 
HA (F-7) beads (Santa Cruz), Protein A Sepharose beads (GE Healthcare) or Magnetic Ni-
particles (Promega) and analyzed by Western blotting with the indicated antibodies. 
For mass spectrometry, the purification of Flag tagged Hus1 and Rad9 was carried in HEK 
293T cells transfected with His-ubiquitin and Flag-Hus1 or Flag-Rad9. Briefly, after lysis in 
buffer A for 1 hour the cellular extracts were spun down and the supernatant was incubated 
with Flag beads for 3 hours at 4ºC on a spinning wheel. Beads were washed 4 times with 
buffer A and Flag tagged proteins were eluted from the beads in four steps using 0.2 mg/
ml Flag peptides (Sigma) under cold conditions. The elution fractions were pooled and 
incubated in buffer A with Magnetic Ni-particles (Promega) for 1 hour at 4ºC on a spinning 
wheel. After incubation the beads were washed 4 times in buffer A and the beads were 
collected using a magnet. Sample buffer (120 mM Tris [pH 6.8], 4% SDS, 20% Glycerol, 10% 
b-mercaptoethanol and 0.005% bromophenolblue) was than added to remove all proteins 
attached to the beads. Eluted protein extract were run on two SDS-PAGE gels, one would be 
analyzed by western blotting with the indicated antibodies and the other stained with the 
quick-CBB kit (Wako) for subsequent mass spectrometry analysis.
For mass spectrometric analysis ubiquitinated peptides were analyzed on an LTQ-Orbitrap 
(Thermo).
Immunofluorescence
For immunostaining, cells were fixed in 2% paraformaldehyde containing 0.2% Triton X-100 
for 20 minutes at RT and then permeabilized with 0.1% Triton X-100 for 5 minutes. Samples 
were blocked in 1% FCS and immunostained with antibodies as indicated.
For detection of Hus1-GFP and GFP-Rad9 in U2OS, cells were fixed and permeabilized as 
above.
Cells containing >10 Hus1-GFP foci were scored as positive. Error bars on graphs represent 
the standard error of the mean of at least two independent experiments.
Images were made using a Cell Observer fluorescent microscope equipped with Axiovision 
software (Zeiss) or a Confocal Laser Scanning Microscope LSM 510 (Zeiss), equipped with a 
488 nm Ar-laser and a 505-530 nm band pass filter for green fluorescence. Red fluorescence 
was detected using a 543 nm laser and 560 nm long pass filter. 
RESULTS
Hus1 is ubiquitinated at lysine 136
To investigate if the 9-1-1 complex is modified through ubiquitination we set up an assay 
using transiently expressed Flag- or GFP-tagged Hus1, Rad1 or Rad9 together with epitope-
labeled ubiquitin in human HEK 293T cells. Since a previous report suggested that human 
Hus1 is ubiquitinated we concentrated most of our investigation on the Hus1 subunit of 
the complex [30]. Cell extracts containing Flag-Hus1 were lysed and incubated with beads 
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containing covalently linked Flag antibodies. Immunoprecipitated Flag-Hus1 was eluted 
from the beads in denaturing conditions. Upon overexpression of ubiquitin, Hus1 was 
mono- and poly-ubiquitinated, seen as Hus1 running with slower mobility (Figure 1A). 
Similar results were obtained when a pulldown for His tagged ubiquitin in the presence 
of Hus1 was performed (Figure 1B). Treatment with the replication inhibitor HU did not 
influence Hus1 ubiquitination in this assay (data not shown). Besides Hus1, GFP-Rad9 also 
became mono- and poly-ubiquitinated and interestingly GFP-Rad1 was mono-ubiquitinated 
in our experimental setup (Figure 7A and B). 
To identify the lysine(s) in Hus1 that is ubiquitinated and additionally reveal potential proteins 
involved in Hus1 ubiquitination, we performed a tandem tag purification for ubiquitinated 
Hus1 followed by mass spectrometry analysis of (co-)immunoprecipitated proteins [44, 45]. 
Flag-Hus1 was immunoprecipitated in the presence of His-tagged ubiquitin (Figure 1C). 
Using Flag peptides Flag-Hus1 was specifically eluted from the beads. The elution fractions 
were pooled and incubated with magnetic His-beads to enrich for ubiquitinated Hus1. 
Protein samples were run on SDS-PAGE, stained with Coomassie and the complete lanes 
were analyzed by mass spectrometry (Figure 2A).
Mass spectrometry results identified lysine 136 of Hus1 as being ubiquitinated. To validate 
and address the function of this modification we mutated lysine 136 to arginine disrupting 
its potential ubiquitination. We also mutated the two closely located lysines 141 and 
Figure 1: Hus1 ubiquitination and purification. (A) HEK 293T cells were transfected with HA-
ubiquitin and Flag-Hus1, cell extracts with Flag beads to perform immunoprecipitation as de-
scribed in materials and methods. Protein extracts were analyzed by western blotting with 
the indicated antibodies. (B) As in (A) but now incubated with His-beads. (C) Tandem tag pu-
rification of ubiquitinated Hus1 in HEK 293T cells as described in materials and methods.
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144 to exclude the possibility that these neighbouring lysines would be ubiquitinated 
instead. Expression of the K136R and triple K136R/K141R/K144R mutant only slightly 
influenced Hus1 ubiquitination in our ubiquitination assay (Figure 2B). Although lysine 136 
is situated in a well conserved part of the Hus1 protein the lysine itself is not conserved 
throughout different species (Figure 2C). These results suggest that additional lysine(s) in 
Hus1 are ubiquitinated, but those were not identified by the mass spectrometry analysis. 
Alternatively the ubiquitination of Hus1 might be influenced by overexpressing of ubiquitin 
in our assay, since we did not observe ubiquitination of Hus1 in cell extracts without 
transient overexpression of ubiquitin (Figure 1). We were also unable to immunoprecipitate 
endogenous Hus1 with or without overexpression of ubiquitin (data not shown). To minimize 
potential adverse effects of transiently expressed ubiquitin we titrated down the amount of 
ubiquitin necessary to detect Hus1 ubiquitination on western blotting and used this low 
amount to test ubiquitination of the Hus1-K136R mutant and even under those conditions 
the Hus1 mutant became ubiquitinated (data not shown). Nonetheless we cannot be 
absolutely certain that we are able to address the loss of ubiquitination in the K136R mutant 
under these experimental conditions. Further investigations will be necessary to address 
the relevance of Hus1 ubiquitination on lysine 136.
EDD, the candidate E3 ligase for Hus1 ubiquitination 
Mass spectrometry analysis of purified (ubiquitinated) Hus1 also identified potential 
interaction partners of Hus1, which are depicted in Table 1. Selections of the results 
are shown in three categories, namely proteins from the ATR-Chk1 pathway (including 
known Hus1 interaction partners), DNA repair proteins and potential regulators involved 
Figure 2: Identification of ubiquitinated lysine(s) in Hus1. (A) Coomassie stained SDS-PAGE gel for mass 
spectrometry containing the purified Hus1 and Rad9 protein extracts. (B) HEK 293T cells were transfect-
ed with HA-ubiquitin together with Flag-Hus1 wild type, K136R or K136R, K141R, K144R triple mutant. 
After lysis extracts were used for anti-Flag immunoprecipitation and protein extracts were analyzed 
by western blotting. (C) Hus1 amino acid sequence comparison between different species, shown are 
the 77 amino acids in between position 92 and 196, in total Hus1 contains 280 amino acids. Depicted 
is the ubiquitinated Hus1 peptide (IVTHDIPIKVIPR) that was identified through mass spectrometry.
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Figure 3: Functional relationship between Hus1 and the EDD ubiquitin ligase. (A) Co-immunoprecipi-
tation experiment in HEK 293T cells transfected with Hus1-GFP and Flag-EDD using Flag beads. Protein 
extracts were analyzed by western blotting with the indicated antibodies. (B) Diagram describing the 
different EDD domain mutants. HEK 293T cells were transfected with the indicated Flag-EDD mutants 
together with Hus1-GFP. Flag immunoprecipitation was performed and analyzed as previously dis-
cussed (C) Different EDD mutant constructs were expressed in U2OS cells, after lysis the extracts were 
analyzed by western blotting using the indicated antibodies. (D) U2OS cells were transfected with 
siRNA oligos as described in materials and methods targeting luciferase, EDD, Rad18 and HUWE1. 
After 48 hours the cells were lysed and run on SDS-PAGE and analyzed by western blotting with the 
indicated antibodies. (E) Hus1-GFP cells were untreated or treated with MG132 (10 mM) or UV-ir-
radiation (20 J/m2) or a combination of both. MG132 was added 30 minutes before administrating 
UV light, cells were fixed 1,5 hours later. (F) HEK 293T cells were transfected with Flag-Hus1 and in-
creasing amounts of HA-ubiquitin in the presence of either wild type or a HECT domain mutant of 
EDD. Immunoprecipitation was performed using HA-beads in the presence of MG132 (10 mM). The 
extracts were loaded on SDS-PAGE and analyzed by western blotting with the indicated antibody.
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in ubiquitination. The listed proteins were not present in the control samples without 
expression of Flag-Hus1. The mascot scores indicate the probability of the described protein 
as a potential Hus1 interacting protein (we take scores of 45 or higher as indicative of a 
bone fide interaction). Importantly, the results in Table 1 show that, in the presence of 
ubiquitin, Hus1 interacts with a number of E3 ubiquitin ligases, namely EDD (UBR5), HUWE1 
and Rad18. In parallel we performed mass spectrometry analysis on the lanes containing 
purified ubiquitinated Rad9, as shown in Figure 2A. The results from this analysis are 
summarized in Table 2 and also identified EDD (UBR5), HUWE1 and Rad18 as potential Rad9 
interacting proteins. Mass spectrometry did not identify any ubiquitinated lysines in Rad9, 
which was surprising since the immunoprecipitation of GFP-Rad9 in the presence of His-
tagged ubiquitin resulted in slower migrating forms of Rad9 as seen in Figure 7A. Possibly 
the abundance of ubiquitinated Rad9 was not high enough to be identified by the mass 
spectrometry analysis. 
EDD and HUWE1, HECT domain-containing E3 ligases, were identified as interactors of the 
9-1-1 complex. Both proteins were previously implicated in the DNA damage response such 
as the ubiquitination of TopBP1 [27, 28, 46-50] and activation of Chk2 and the checkpoint 
arrest upon DSB induction [51, 52]. This makes them interesting candidates for regulating 
the 9-1-1 complex.
To investigate the functional relationship between EDD and Hus1 we started by confirming the 
interaction between EDD and Hus1 through co-immunoprecipitation. After overexpression 
of Flag-labelled EDD together with GFP-tagged Hus1 and immunoprecipitation of Flag-
EDD, Hus1-GFP was identified, thereby confirming that EDD and Hus1 interact (Figure 3A). 
Damage induction by UV light did not change this binding (data not shown). To identify the 
region of EDD important for the interaction with Hus1, we performed a Hus1 binding analysis 
using different Flag-tagged EDD deletion mutants. Additionally we mutated EDD serine 
2071, a site that is phosphorylated in response to DNA damage in an ATM/ATR-dependent 
manner, to determine if phosphorylation of this serine is required for the binding of EDD to 
Hus1 [49]. Flag immunoprecipitations indicated that Hus1 binds to the N-terminal region 
of EDD, as it is still able to bind to small EDD fragment A, containing the E3 ubiquitin ligase 
domain (Figure 3B). Mutation of serine 2071 did not abrogate the Hus1-EDD interaction, 
demonstrating that the ATM/ATR-dependent phosphorylation of EDD is not necessary for 
the interaction with Hus1. 
To investigate if EDD regulates Hus1 protein levels we overexpressed EDD in U2OS cells. 
Expression of full length EDD or the EDD-S2071A mutant resulted in a small but significant 
decrease of Rad9 protein levels as judged by western blotting (Figure 3C). Deletion of the 
HECT domain resulted in an increase of Rad9 protein back to wild type levels suggesting 
that the HECT domain might be necessary for Rad9 degradation (Figure 3C). Next we 
downregulated EDD protein levels in U2OS by siRNA. In the same experiment we performed 
siRNA-mediated downregulation of HUWE1 and Rad18. Depletion of EDD and HUWE1 
resulted in slightly higher Rad9 and Rad1 proteins levels. In contrast, depletion of Rad18 
resulted in a decrease of Rad9 and Rad1 protein levels (Figure 3D). These results suggest 
that EDD and HUWE1 might regulate the 9-1-1 complex by targeting the proteins for 
ubiquitin-dependent, proteosomal-mediated degradation. To investigate this hypothesis 
we treated Hus1-GFP expressing cells with proteosome-inhibitor (MG132) and UV light 
and thereafter analyzed them under the microscope. In the presence of MG132, Hus1-GFP 
protein levels rise substantially both in the nucleus and the cytoplasm, suggesting inhibition 
of proteasome-dependent degradation (Figure 3E). In the presence of UV damage, Hus1-
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GFP localization into foci is abrogated in the presence of MG132. Our results collectively 
suggest that Hus1 localization and protein levels are regulated through ubiquitination.
To address if EDD is involved in the ubiquitination of Hus1, a HECT domain mutant or the 
full length version of EDD were expressed and the amount of Hus1 ubiquitination after 
immunoprecipitation using HA-tagged ubiquitin was determined. Western blotting shows 
that expression of full length EDD resulted in more ubiquitinated Hus1, whereas the 
expression of the EDD-HECT domain mutant resulted in less Hus1 ubiquitination (Figure 
3F). These data suggest that EDD is an attractive candidate E3 ligase involved in Hus1 
ubiquitination mediated by its HECT domain.
EDD is involved in the ATR-mediated DNA damage response
Since EDD was described to be involved in the DNA damage-induced checkpoint activation 
after ionizing radiation (IR) and the results described above suggest that EDD regulates 
Hus1 ubiquitination [51, 52], we wondered if EDD also plays a role in the ATR-mediated 
checkpoint response in general. We set out by determining the UV-sensitivity of U2OS cells 
after siRNA-mediated downregulation of EDD. A similar experiment was performed after 
depletion of HUWE1. Downregulation of either EDD or HUWE1 increased the sensitivity of 
cells for UV damage, although to a lesser extent as knock down of Chk1 (Figure 4A). 
Next we determined if EDD is required for Chk1 phosphorylation by depleting EDD and 
investigating the phosphorylation status of Chk1 in response to UV or HU. Downregulation 
of EDD caused a defect in UV-induced phosphorylation of Chk1 on serine 317 and serine 
345 but the effect was less obvious after HU treatment (Figure 4B). Phosphorylation of 
Chk1 was also studied by immunofluorescence, combined with Cyclin B staining. During S 
phase Cyclin B levels start to increase and Cyclin B localizes in the cytoplasm until the G2/M 
transition [53]. Figure 4C shows a decrease in UV-induced Chk1 phosphorylation in cells 
depleted for EDD. Downregulation of EDD also results in less Cyclin B staining suggesting 
that EDD depletion affects cell cycle progression. Depletion of EDD for 72 hours prevented 
cells from entering S-phase resulting in an increased population of cells at the G1/S border 
(data not shown). The low amount of S phase cells might therefore be an explanation for 
the decreased levels of UV-induced Chk1 phosphorylation that were observed in Figures 4B 
and 4C. 
In response to DNA damage the 9-1-1 complex is loaded onto the DNA by Rad17-RFC, 
seen by the accumulation of these proteins onto damaged chromatin [11]. To address 
the efficiency of 9-1-1 recruitment to chromatin after DNA damage in EDD-depleted cells, 
chromatin fractionation was performed. Whereas the 9-1-1 complex proteins were recruited 
to chromatin upon UV and HU treatment in control downregulated cells, EDD depletion 
resulted in less 9-1-1 proteins in the chromatin fraction (Figure 4D). These results suggest 
a role for EDD in the regulation of 9-1-1 complex localization in response to DNA damage, 
possibly through the ubiquitination of Hus1. 
Rad18-dependent regulation of the 9-1-1 complex 
Although the mass spectrometry results indicate a relatively low mascot score for the Hus1-
Rad18 interaction (Table 1), Rad18 is an interesting candidate for regulating 9-1-1 because 
of its involvement in the ubiquitination of the Rad1 homologue in S. cerevisiae and its 
requirement for the ubiquitination of the PCNA trimer in human cells [32, 54]. Therefore 
we were interested in addressing its possible function in regulation of human 9-1-1. First, 
we confirmed the interaction between Hus1 and Rad18 by co-immunoprecipitation, which 
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shows that YFP-Rad18 binds immunoprecipitated Flag-Hus1 (Figure 5A). 
Upon replication stress induced by aphidicolin, GFP-Rad9 localizes into discrete nuclear foci 
as shown in Figure 5B [40]. Staining of these cells with antibodies recognizing Rad18 resulted 
in aphidicolin-induced Rad18 foci, which partially colocalized with GFP-Rad9 (Figure 5B), 
suggesting that Rad9 and Rad18 are involved in the cellular response to similar types of 
replication stress-induced DNA lesions. 
To investigate the relationship between the 9-1-1 complex proteins and Rad18 after DNA 
Figure 4: EDD involved in the DNA damage response through regulation of Hus1. (A) Cellular sur-
vival assay after different doses of UV using U2OS cells depleted for the indicated proteins. (B) U2OS 
cells were transfected with siRNA oligos targeting luciferase or EDD for 72 hours and thereafter un-
treated or treated with HU (10 mM) for 3 hours or UV (20 J/m2) and fixed after 1 hour. Cell extracts 
were analyzed by western blotting with the indicated antibodies. (C) U2OS cells were depleted for 
72 hours with oligos directed against luciferase or EDD, than untreated or UV-irradiated (20 J/m2) 
and fixed 1 hour later. Immunofluorescence was performed with antibodies directed against the indi-
cated proteins. (D) U2OS cells were transfected with siRNA oligos against luciferase and EDD. 48 hrs 
later cells were left untreated, incubated with 10 mM HU for 3 hours or UV-irradiated (20 J/m2) and 
lysed 1 hour later. Chromatin fractionation was performed as described in materials and methods.
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damage, cells were transfected with Flag-Rad9 and YFP-Rad18 and treated with the DNA 
damaging agent methyl methanesulfonate (MMS) and proteosome inhibitor MG132. 
Combined expression of Rad9 and Rad18 resulted in significantly higher Rad9 protein levels 
compared to the expression of Rad9 without Rad18 (Figure 5C). This was reduced after 
treatment with MMS and moreover the expression of Rad9 in the presence of MMS without 
Rad18 resulted in a reduction of Rad9 protein levels. Inhibition of proteosomal-mediated 
degradation by MG132 only mildly affected Rad9 proteins levels (Figure 5C). 
To rule out any possible bias due to the transient expression of one single 9-1-1 subunit 
we overexpressed each of the components of the 9-1-1 complex and treated the cells with 
MMS. As was observed after the expression of only Rad9, MMS-treatment resulted in lower 
protein levels of Rad9. Expression of Rad18 greatly enhanced Rad9 protein levels as seen 
before therefore we conclude that the expression of one single 9-1-1 complex subunit did 
not influence the outcome of the experiments (Figure 5D). All together, these results suggest 
that Rad18 might stabilize 9-1-1 complex protein levels.
As mentioned before, Rad18 is responsible for the ubiquitination of the PCNA complex 
[54]. Ubc13 acts as the E2 ubiquitin conjugating enzyme in that reaction and USP1 is the 
responsible deubiquitinating enzyme [55, 56]. To investigate the relationship between the 
9-1-1 complex and Rad18, Ubc13 and USP1, these proteins were depleted in U2OS cells. 
Downregulation of Rad18 resulted in a small decrease in Hus1 protein levels (Figure 5E). In 
contrast, depletion of Ubc13 resulted in higher Hus1 protein levels, whereas knock down of 
Figure 5: Rad18 involved in the regulation of the 9-1-1 complex. (A) HEK 293T cells were trans-
fected with Flag-Hus1 and YFP-Rad18 plasmid DNA. 48 hours later cell extracts were prepared and 
used for immunoprecipitation using Flag beads. Protein extracts were analyzed by western blot-
ting with the indicated antibody. (B) GFP-Rad9 cells were treated with 5 mg/ml aphidicolin for 16 
hours, cells were fixed and stained with antibodies against Rad18 by immunofluorescence. (C) 
HEK 293T cells expressing Flag-Rad9 and YFP-Rad18 were treated with 0.02% MMS for 1 hour. 
MG132 (10 mM) was added 30 minutes before treatment with MMS. Cell extracts were analyzed 
by western blotting with the indicated antibodies. (D) Similar as in (C) however cells were trans-
fected with different plasmids as indicated. (E) U2OS and Hus1-GFP cells were depleted for lu-
ciferase, Rad18, Ubc13 and USP1. 48 hrs after transfection cells were lysed and analyzed by west-
ern blotting with the indicated antibodies. (F) 48 hours after transfection with siRNA oligos against 
luciferase or Rad18 U2OS cells exposed to CHX (Sigma) and fixed at the indicated timepoints.
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USP1 did not have an effect (Figure 5E). Although preliminary, these results may point out 
that Ubc13 may also be involved in the regulation of Hus1. 
Although the depletion of Rad18 led to a decrease in Hus1 levels, we investigated if the loss 
of Rad18 would influence Hus1 protein stability over time. Rad18 was downregulated in 
U2OS cells and cycloheximide was added to inhibit protein synthesis. Depletion of Rad18 did 
not influence Hus1 turnover, but it did reduce the initial Hus1 protein levels suggesting that 
Rad18 is not involved in the regulation of Hus1 protein levels through degradation (Figure 
5F).
To obtain more evidence for the involvement of Rad18 in regulating the ATR-mediated 
checkpoint response we tested the UV sensitivity of cells depleted of Rad18. Cells lacking 
Rad18 become more sensitive for UV damage than control cells, indicating that Rad18 plays 
a role in the UV-induced DNA damage response (Figure 6A). 
The results above indicate that Rad18 regulates 9-1-1 protein levels. To address the function 
of Rad18 in Hus1-GFP localization we performed immunofluorescence of Hus1-GFP cells 
after depletion of Rad18. In response to UV-irradiation Hus1-GFP, like GFP-Rad9, localizes 
into nuclear foci [24]. siRNA-mediated downregulation of Rad18 resulted in lower Hus1-
GFP protein levels, which are comparable to the results in Figure 5E (Figure 6B left panel). 
Depletion of Rad18 resulted in 20-30% reduction of cells with UV-induced Hus1-GFP foci 
(Figure 6B). In response to UV or HU, Hus1-GFP, endogenous Rad9 and Rad1 present in 
the chromatin fractions increased. Downregulation of Rad18 resulted in a less efficient 
recruitment of the 9-1-1 complex proteins to damaged chromatin (Figure 6C). Taken 
together, these results suggest that Rad18 might stabilize the 9-1-1 complex protein levels 
and thereby may facilitate the localization of the 9-1-1 complex to sites of DNA lesions. 
DISCUSSION
The preliminary results that are presented in this chapter imply that the 9-1-1 complex 
is modified by ubiquitination. To detect this post-translational modification we setup an 
experimental assay to detect and purify ubiquitinated 9-1-1. We were able to demonstrate 
ubiquitination of the 9-1-1 complex members upon overexpression only and in the presence 
of exogenous ubiquitin. It will therefore be challenging but necessary to demonstrate the 
ubiquitination of the endogenous 9-1-1 complex components without the expression of 
ubiquitin in future research. 
The recently published crystal structure of the 9-1-1 complex indicates that Hus1 lysine 136 
is an accessible amino acid, supporting our mass spectrometry results showing that this 
lysine is ubiquitinated [57]. However, we failed to detect a major decrease in ubiquitination 
of Hus1 in the K136R mutant, which might have different explanations. First, additional 
lysines in Hus1 are ubiquitinated under normal conditions. Second, the overexpression 
of ubiquitin could trigger the ubiquitination of other lysines. Lysines that normally do not 
get ubiquitinated are more prone for ubiquitination in the presence of large quantities 
of ubiquitin. Third, the results might be influenced by the presence of endogenous 
Hus1. Immunoprecipitation of epitope tagged-Hus1 resulted in binding of endogenous 
ubiquitinated Hus1, thereby possibly influencing the results obtained with the Hus1 K136R 
mutant (Figure 1A, 1C, 2B). Fourth, the mutation of an ubiquitinated lysine residue results 
in the ubiquitination of adjacent (accessible) lysine(s). Lysines residues that are in close 
proximity to the E3 ubiquitin binding site may adversely become ubiquitinated due to the 
K to R mutation. However, additional mutation of the 2 lysines close to lysine 136 (141 and 
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144) also did not abrogate ubiquitination of Hus1 (Figure 2B). Expression of Hus1 K136R 
in cells lacking Hus1 may avoid some of these discussed problems, additionally the DNA 
damage-induced focus formation of Hus1 K136R could also be addressed in this manner. 
Mouse cells lacking Hus1 exist and furthermore lysine 136 is conserved in mice, making this 
a suitable system [18]. 
The 9-1-1 complex shows structural similarities to the PCNA trimer, the processivity factor 
for replicative DNA polymerases [57]. PCNA is mono- and poly-ubiquitinated on lysine 
164 in an Rad18/Rad6-dependent manner and is also  sumoylated at this residue [54]. 
Whereas lysine 48 polyubiquitination results in degradation of the target protein via the 
proteasome, lysine 63 polyubiquitination leads to modification of protein function. PCNA 
can be polyubiquitinated in both ways [58] and  these different types of ubiquitination are 
likely to also play a role in the regulation of the 9-1-1 checkpoint clamp. Our preliminary 
results show that the 9-1-1 complex can be regulated in different ways, possibly through 
both monoubiquitination and lysine 48- and lysine 63-linked polyubiquitination.
Mass spectrometry experiments identified a number of enzymes involved in ubiquitination, 
as Hus1-interactors. Among these enzymes were the E3 ligases EDD, HUWE1 and Rad18, 
the E2 Ubc13 and deubiquitin enzyme (DUB) USP1. Experiments overexpressing or 
depleting EDD suggest that it regulates 9-1-1 complex levels through ubiquitin-mediated 
degradation. Protein levels were nonetheless only slightly affected and in particular those 
of Rad9, which might suggest that other E3 ubiquitin ligases like HUWE1 may also be 
involved or act redundantly upon EDD depletion. It will therefore be interesting to see how 
simultaneous overexpression or depletion of EDD and HUWE1 (or UBR2 and UBR4) affects 
9-1-1 protein levels. Depletion of EDD also affected 9-1-1 localization and subsequent 
Chk1 phosphorylation suggesting that 9-1-1 polyubiquitination is necessary for checkpoint 
function and therefore does not target the complex for degradation but modifies its activity. 
Although we cannot rule our either hypothesis at this point, we favour this explanation since 
the 9-1-1 complex levels only seemed to be mildly affected in the absence of EDD, whereas 
the checkpoint defects were much more obvious. 
Due to the structural similarity between 9-1-1 and PCNA, E3 ligase Rad18 is an interesting 
candidate to be involved in Hus1 ubiquitination. However, Rad18 does not seem to be 
involved in the ubiquitin-mediated degradation of the 9-1-1 complex since Rad18 depletion 
does not change Hus1 protein stability, as shown in Figure 5F. In addition, overexpression of 
Rad18 resulted in an increase in Rad9 levels, therefore Rad18 might stabilize 9-1-1 protein 
through an ubiquitin-modification (mono- or lysine 63-linked ubiquitination) resulting in a 
more stable version of the 9-1-1 complex, which is required for the localization to sites of 
DNA damage. Alternatively, Rad18 might regulate 9-1-1 in an indirect manner, possibly by 
regulating an E3 ligase involved in 9-1-1 ubiquitination like EDD. 
Our analysis also identified Ubc13, an E2 conjugating enzyme as Hus1-interacting protein. 
Depletion of an E2 conjugating enzyme involved in the proteosome-mediated ubiquitination 
of the 9-1-1 complex would indeed result in higher complex protein levels. Depletion of 
Ubc13 resulted in higher Hus1 protein levels, suggesting that Ubc13 might also regulate 
the 9-1-1 complex (Figure 5E). The DUB USP1 is involved in deubiquitinating PCNA and 
depletion of this enzyme could result in higher protein levels, however only if it would 
remove ubiquitin moieties that are responsible for ubiquitin-mediated degradation [56, 59]. 
Further research is required to clarify these preliminary observations regarding regulatory 
enzymes of ubiquitination of the 9-1-1 complex.
The S. cerevisiae homologue of Rad1 is mono-ubiquitinated on lysine 197 and this 
modification is required for efficient phosphorylation of scRad53 (ref). It will therefore be 
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interesting to address the phenotype of this modification in mammalian cells [32]. As the 
S. cerevisiae and mammalian 9-1-1 amino acid sequences vary greatly, direct comparison 
between the two proteins cannot be made. But as mentioned before, the 9-1-1 complex 
shares structural resemblance to the PCNA sliding clamp and the crystal structure of the 
human 9-1-1 complex reveals that Rad1 lysine 185 is the structural equivalent of the well 
known ubiquitinated lysine 164 in PCNA. It will be interesting to determine if Rad1 lysine 
185 becomes ubiquitinated and what the function of this modification in human cells is [33, 
57, 60, 61]. A similar experimental setup as described in this chapter can be used to purify 
and identify any ubiquitinated lysines in Rad1. 
Besides a function for 9-1-1 ubiquitination in the regulation of the DNA damage checkpoint, 
we speculate that it could also be important in other cellular processes. In response to DNA 
damage and the subsequent formation of RPA-coated ssDNA, the 9-1-1 complex is placed at 
the 3’ssDNA/dsDNA junction, opposite from PCNA at the 5’ssDNA/dsDNA junction [10]. In 
yeast, the 9-1-1 clamp can physically interact with translesion synthesis (TLS) polymerases 
[62, 63]. Possibly mediated through ubiquitination, the 9-1-1 complex may facilitate TLS by 
loading low fidelity DNA polymerases onto DNA. This might be in cooperation with PCNA, 
which was demonstrated to be involved in TLS [57, 64]. 
In conclusion, we have shown that the human Hus1 subunit of the 9-1-1 complex is 
ubiquitinated in our experimental conditions. In addition, different E3 ubiquitin ligases were 
implicated in the regulation of 9-1-1, possibly through ubiquitination. These results suggest 
that similar to PCNA, different proteins are responsible for modifying the 9-1-1 through 
ubiquitination. 
Figure 6: Rad18 involved in the UV-induced DNA damage response. (A) Cellular survival of U2OS cells 
depleted for the indicated proteins using different doses of UV light. (B) Hus1-GFP cells were transfect-
ed with siRNA oligos against luciferase or Rad18 and untreated or treated with UV (20 J/m2) and fixed 
after 1 hour. The number of cells containing (more than 10) Hus1-GFP foci was counted. Error bars 
represent the SEM of two independent experiments. (C) U2OS cells were depleted with siRNA oligos 
against luciferase or Rad18 for 48 hours and then untreated or treated with HU (10 mM) or UV (20 J/m2) 
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Table 1: Hus1 interaction partners identified by mass spectrometry analysis of Flag-Hus1 immono-
precipitations in presence or absence of His-ubiquitin.
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9-1-1 ubiquitination 
Table 2: Rad9 interaction partners identified by mass spectrometry analysis of Flag-Rad9 immono-





AA  amino acid
AT  ataxia telangiectasia
ATM   ataxia telangiectasia mutated
ATR  ATM- and Rad3-related
ATRIP  ATR-interacting protein
BrdU  bromodeoxyuridine
cDNA  complementary DNA
CPD  cyclobutane pyrimidine dimer
DNA  deoxyribonucleic acid
DSB  double-stranded break
FACS  fluorescence-activated cell sorting
FRAP  fluorescence recovery after photobleaching
FLIP  fluorescence loss in photobleaching
gH2AX  phosphorylated H2AX
GFP  green fluorescent protein
Gy  Gray
HR  homologous recombination
HU  hydroxyurea
IR  ionizing radiation 
MAPK  mitogen-activated protein kinase 
MEF  mouse embryonic fibroblast
MMS  methyl methanesulfonate
Nbs1  Nijmegen breakage syndrome protein 1
NER  nucleotide excision repair
NHEJ  non-homologous end-joining
PCNA  proliferating cell nuclear antigen
PI  propidium iodide
PIKK  phosphoinositide 3-kinase-like protein kinase
RFC  replication factor C
RPA  replication protein A
S.cerevisiae Saccharomyces cerevisiae
S.pombe  Schizosaccharomyces pombe
ssDNA  single-stranded DNA
TLS  DNA translesion synthesis
TopBP1  topoisomerase IIb binding protein 
UV  ultraviolet
6-4 PP  pyrimidine (6-4) pyrimidone photoproduct
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Nederlandse samenvatting
DNA is de drager van erfelijke eigenschappen van cellen, de bouwstenen van het lichaam. 
Beschadigingen in het DNA, veroorzaakt door bijvoorbeeld ioniserende en ultraviolette (UV) 
straling in zonlicht, moeten zo goed mogelijk hersteld worden omdat fouten in het DNA 
kunnen leiden tot het ontstaan van kanker. 
Tijdens de deling doorloopt de cel de celcyclus, waarin het erfelijke materiaal verdubbeld 
wordt en dit vervolgens verdeeld wordt over de twee dochtercellen. Om te voorkomen 
dat beschadigingen in het DNA doorgegeven worden aan de dochtercellen bestaan er 
controlemechanismen die continue het DNA afspeuren op beschadigingen. Bij de detectie 
van DNA schade worden deze controlemechanismen geactiveerd, zodat de celdeling wordt 
geblokkeerd om de cel tijd te geven het beschadigde DNA te herstellen. Wanneer cellen 
niet efficiënt reageren op DNA schade kan dit ten eerste lijden tot een versnelde celdeling. 
Ten tweede, door het niet correct repareren van DNA, kunnen er mutaties en breuken 
ontstaan. Beide zorgen voor een abnormaal functioneren van de cel met op een lange 
termijn tumorvorming tot gevolg. Een juiste reactie op DNA schade is daarom essentieel 
voor het voortbestaan van cellen en het organisme. Mijn proefschrift beschrijft de initiële 
respons van cellen op DNA schade. Door het analyseren van eiwitten die betrokken zijn bij 
de reactie op DNA schade in levende cellen met behulp van de microscoop zijn wij meer te 
weten gekomen over de regulatie van dit belangrijke proces.
Onderzoek in de laatste decennia heeft aangetoond dat het ATR-Chk1 controlemechanisme 
(checkpoint) een belangrijke sleutel is in de reactie van cellen op DNA schade. Een veelvoud 
aan verschillende eiwitten zijn betrokken in deze eiwitcascade ofwel ‘pathway’. In Hoofdstuk 
1 worden de verschillende componenten van de ATR-Chk1 pathway geïntroduceerd en hun 
functie besproken. Hoe het ATR-Chk1 en andere signaaltransductieroutes samenwerken 
met DNA reparatie mechanismen wordt beschouwd in Hoofdstuk 2. 
Tot op heden waren de eiwitten die betrokken zijn bij de ATR-Chk1 pathway vooral door 
middel van biochemische technieken onderzocht en er was nog maar weinig bekend 
over hoe deze eiwitten zich gedragen in levende cellen. Om dit te onderzoeken hebben 
wij verschillende eiwitten in de ATR-Chk1 pathway gelabeld met een fluorescerend eiwit 
genaamd GFP (groen fluorescerend eiwit). In Hoofdstuk 3 beschrijven wij de methode die 
is opgezet om dit te doen en om cellen te maken die deze eiwitten stabiel tot expressie 
brengen om ze zodoende geschikt te maken voor levende cel analyse onder de confocale 
fluorescentie microscoop. Door middel van deze stabiele cellijnen, het bleken van de 
fluorescentie en videomicroscopie (mobiliteitstudies) laten wij zien dat het ATRIP-ATR eiwit 
complex zich anders gedraagt na UV straling dan het Rad9-Rad1-Hus1 (9-1-1) complex. 
ATRIP lijkt zich sneller naar het beschadigde DNA te bewegen dan de eiwitten van het 
9-1-1 complex. Beide complexen zijn betrokken bij het detecteren van DNA schade en het 
activeren van het controlemechanisme dat de celdeling tijdelijk blokkeert.
De eiwitten die betrokken zijn bij DNA schade detectie hopen zich na het geven van schade 
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op in zogenaamde foci in de kern van de cel. Door middel van deze observatie bestuderen 
wij in Hoofdstuk 4 de relatie tussen celdeling en DNA reparatie mechanismen. De lokalisatie 
van Rad9 in de cel blijkt afhankelijk te zijn van het type DNA schade en de celcyclus fase 
waarin deze schade wordt veroorzaakt. In Hoofdstuk 4 gaan wij hier verder op in en laten 
zien dat na UV straling, in tegenstelling tot ioniserende straling, de ATR-Chk1 pathway niet 
wordt geactiveerd in de G2 fase van de celcyclus. De p38 signaaltransductieroute speelt 
hierbij een veel belangrijkere rol, wat laat zien dat verschillende controlemechanismen 
tijdens de celcyclus differentieel gereguleerd worden. 
In reactie op DNA schade is de ATR kinase verantwoordelijk voor de modificatie van Chk1. Dit 
proces is afhankelijk van het 9-1-1 eiwit complex. De modificatie van Chk1 zorgt ervoor dat 
de celcyclus wordt stopgezet om het DNA te repareren. In Hoofdstuk 5 onderzoeken wij deze 
gebeurtenis in detail door middel van mobiliteitstudies en laten zien dat de fosforylering van 
Rad17 door ATR nodig is voor een stabiele associatie van het 9-1-1 complex op beschadigd 
DNA, wat implicaties heeft voor de werking van het ATR-Chk1 controlemechanisme. Wij 
laten hiermee ook zien dat mobiliteitstudies een goede aanvulling zijn op bestaande 
biochemische technieken doordat zij het effect van kortdurende eiwit-eiwit interacties en 
eiwit modificaties op het gedrag van eiwitten laten zien. In Hoofdstuk 6 laten wij zien dat 
het 9-1-1 complex wordt gemodificeerd door ubiquitinering, en dan met name de Hus1 
component van het 9-1-1 complex. Met behulp van massa-spectrometrie hebben wij het 
gemodificeerde aminozuur in Hus1 geïdentificeerd en ten slotte speculeren wij over welke 
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The last couple of pages in this thesis,... finally! Curious if you might be in there? Or 
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dat je de supervisie hebt doorgezet, ook na je vertrek uit Rotterdam. Ik wil je bedanken voor 
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een bevoorrecht mens!
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gracias to another very important person. Raimundo, thanks for the excellent collaboration, 
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Thank you, to all the past and present people in the Molecular Radiation Biology lab. In the 
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one of you. Zo nu en dan was ik misschien wel eens wat chagrijnig, vooral als ik het druk had. 
Soms was ik misschien wel heel overtuigd van mezelf. Soms was ik het er niet helemaal mee 
eens. Soms was ik aan het klagen. Maar het was wel gezellig J. 
I would like to specially mention a few people in particular. Dear Magda, you will probably 
not believe me, but I learned a lot from you scientifically. Besides, I have always immensely 
enjoyed our talks over coffee or beers. I feel honoured that you will come all the way from 
the not so sunny east coast to be there at my thesis defence! Cecile je bent te gek, bedankt 
voor alle hulp, gesprekjes, commentaren, recepten en niet te vergeten: check! Many thanks 
Tommy for being a perfect conference roommate and such a good friend. Joyce, ik mis onze 
omhelzingen en wederzijds weerzin tegen carnaval nu al! Thanks Mauro for showing me the 
fancy way to make buffers. Alex en Esther, jammer dat we maar kort het lab hebben gedeeld, 
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het wel en niet moet. Berina, veel succes met je postdoc onderzoek. Paula, maak je niet 
te druk en succes met al je plannen! Eri, arigatō for our interesting conversations and koi! 
Eva, success met het afronden van je studie en je verdere wetenschappelijke loopbaan. 
Claire, Jeroen, Dik en Koos bedankt voor alle hulp, feedback en input. Nicole, Anja en Hanny 
bedankt voor de altijd even gezellige gesprekjes bij de koffie. 
Ik wil ook graag iedereen in het Vermeulen lab bedanken en in het speciaal Wim, Jurgen 
en Hannes voor de leuke samenwerking en feedback. Thanks Filipo, unfortunately our 
experiments ended without any success.
Martijn, bedankt voor de samenwerkingen en succes met het afronden van je postdoc 
in Stockholm. Stavros thanks for the pleasant collaboration and I hope things work out 
with the remaining experiments. I would also like to acknowledge Nick Lakin and Annette 
Medhurst for our successful collaboration and thank Nick for being a member in my 
defence committee. Muchas gracias to all the members of the Freire lab for their help, nice 
atmosphere and tenderete! Jeroen, bedankt voor de mass-spec analyzes en samenwerking.
Veel van mijn experimenten zijn uitgevoerd met de confocale microscoop en daarbij heb ik 
ondersteuning gehad van Gert, Alex, Adriaan, Chris en Martin. Heel erg bedankt daarvoor! 
Jasperina en Marieke bedankt voor alle hulp en het oplossen van al die verschillende regel-
dingetjes. 
De leden van de organisatie van de MGC graduate workshop 2007 in Maastricht wil ik graag 
bedanken voor de leuke tijd en samenwerking. 
I would also like to thank the members of the Cimprich lab at Stanford for a pleasant 
welcome!
Naast het Erasmus MC en de wetenschap zijn er een aantal mensen die van onschatbare 
waarde zijn voor mij persoonlijk en die ik hierbij ook graag wil noemen en bedanken. Mijn 
lieve moeder voor haar altijd onvoorwaardelijke steun. De familie Warmerdam en in het 
bijzonder Corry en Evert voor hun betrokkenheid. Hans, ik weet ook dat jij trots op me bent. 
Naomi, je grote broer is er altijd voor jou!
Allerliefste vrienden; @, plien, chris, juud, har, lin en al die anderen, jullie zijn allemaal 
schatten! Ed, ik ben blij dat je naast me staat op 24 september!
Lieve Eva, ik heb zo ontzettend veel zin in al onze nieuwe avonturen. Bedankt voor je 
onvoorwaardelijke steun en liefde. Ik hou van jou voor altijd!
While I’m typing these last words, the sun is slowly disappearing behind one of the buildings, 
the radio is playing:
Hold your own, know your name and go your own way ................ and everything will be 
fine! 
(Jason Mraz feat. James Morrison - Details in the Fabric)

